JP5229236B2 - Liquid crystal aligning agent and liquid crystal display element using the same - Google Patents
Liquid crystal aligning agent and liquid crystal display element using the same Download PDFInfo
- Publication number
- JP5229236B2 JP5229236B2 JP2009548952A JP2009548952A JP5229236B2 JP 5229236 B2 JP5229236 B2 JP 5229236B2 JP 2009548952 A JP2009548952 A JP 2009548952A JP 2009548952 A JP2009548952 A JP 2009548952A JP 5229236 B2 JP5229236 B2 JP 5229236B2
- Authority
- JP
- Japan
- Prior art keywords
- ring
- liquid crystal
- group
- formula
- crystal aligning
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000004973 liquid crystal related substance Substances 0.000 title claims description 325
- 239000003795 chemical substances by application Substances 0.000 title claims description 137
- 239000004642 Polyimide Substances 0.000 claims description 142
- 229920001721 polyimide Polymers 0.000 claims description 142
- 125000004432 carbon atom Chemical group C* 0.000 claims description 74
- -1 Amine compound Chemical class 0.000 claims description 58
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 55
- 125000000962 organic group Chemical group 0.000 claims description 42
- 229920005575 poly(amic acid) Polymers 0.000 claims description 39
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 35
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 claims description 24
- 229920000642 polymer Polymers 0.000 claims description 23
- 229910052757 nitrogen Inorganic materials 0.000 claims description 22
- 125000001931 aliphatic group Chemical group 0.000 claims description 21
- 238000000034 method Methods 0.000 claims description 20
- 125000002947 alkylene group Chemical group 0.000 claims description 19
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims description 17
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims description 17
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims description 16
- 239000003960 organic solvent Substances 0.000 claims description 16
- ORILYTVJVMAKLC-UHFFFAOYSA-N adamantane Chemical group C1C(C2)CC3CC1CC2C3 ORILYTVJVMAKLC-UHFFFAOYSA-N 0.000 claims description 15
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims description 15
- 125000003518 norbornenyl group Chemical group C12(C=CC(CC1)C2)* 0.000 claims description 15
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims description 14
- 125000002883 imidazolyl group Chemical group 0.000 claims description 14
- 125000003226 pyrazolyl group Chemical group 0.000 claims description 14
- 125000000714 pyrimidinyl group Chemical group 0.000 claims description 14
- 125000000168 pyrrolyl group Chemical group 0.000 claims description 14
- JYEUMXHLPRZUAT-UHFFFAOYSA-N 1,2,3-triazine Chemical group C1=CN=NN=C1 JYEUMXHLPRZUAT-UHFFFAOYSA-N 0.000 claims description 13
- 125000003373 pyrazinyl group Chemical group 0.000 claims description 13
- PBMFSQRYOILNGV-UHFFFAOYSA-N pyridazine Chemical group C1=CC=NN=C1 PBMFSQRYOILNGV-UHFFFAOYSA-N 0.000 claims description 13
- 125000001425 triazolyl group Chemical group 0.000 claims description 13
- LMGZGXSXHCMSAA-UHFFFAOYSA-N cyclodecane Chemical group C1CCCCCCCCC1 LMGZGXSXHCMSAA-UHFFFAOYSA-N 0.000 claims description 12
- DDTBPAQBQHZRDW-UHFFFAOYSA-N cyclododecane Chemical group C1CCCCCCCCCCC1 DDTBPAQBQHZRDW-UHFFFAOYSA-N 0.000 claims description 12
- 125000004113 cyclononanyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 claims description 12
- 125000000640 cyclooctyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 claims description 12
- KYTNZWVKKKJXFS-UHFFFAOYSA-N cycloundecane Chemical group C1CCCCCCCCCC1 KYTNZWVKKKJXFS-UHFFFAOYSA-N 0.000 claims description 12
- 125000001567 quinoxalinyl group Chemical group N1=C(C=NC2=CC=CC=C12)* 0.000 claims description 12
- 229910003849 O-Si Inorganic materials 0.000 claims description 11
- 229910003872 O—Si Inorganic materials 0.000 claims description 11
- KATXJJSCAPBIOB-UHFFFAOYSA-N cyclotetradecane Chemical group C1CCCCCCCCCCCCC1 KATXJJSCAPBIOB-UHFFFAOYSA-N 0.000 claims description 11
- UEVXKGPJXXDGCX-UHFFFAOYSA-N cyclotridecane Chemical group C1CCCCCCCCCCCC1 UEVXKGPJXXDGCX-UHFFFAOYSA-N 0.000 claims description 11
- 125000002755 pyrazolinyl group Chemical group 0.000 claims description 11
- 125000000217 alkyl group Chemical group 0.000 claims description 10
- 238000002156 mixing Methods 0.000 claims description 10
- 125000002971 oxazolyl group Chemical group 0.000 claims description 10
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 10
- 125000004956 cyclohexylene group Chemical group 0.000 claims description 9
- ZBLGFUHEYYJSSE-UHFFFAOYSA-N cycloicosane Chemical group C1CCCCCCCCCCCCCCCCCCC1 ZBLGFUHEYYJSSE-UHFFFAOYSA-N 0.000 claims description 9
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 claims description 9
- 125000005577 anthracene group Chemical group 0.000 claims description 8
- SUAZRRTWDATHDK-UHFFFAOYSA-N cycloheptadecane Chemical group C1CCCCCCCCCCCCCCCC1 SUAZRRTWDATHDK-UHFFFAOYSA-N 0.000 claims description 8
- ARUKYTASOALXFG-UHFFFAOYSA-N cycloheptylcycloheptane Chemical group C1CCCCCC1C1CCCCCC1 ARUKYTASOALXFG-UHFFFAOYSA-N 0.000 claims description 8
- JJWIOXUMXIOXQN-UHFFFAOYSA-N cyclohexadecane Chemical group C1CCCCCCCCCCCCCCC1 JJWIOXUMXIOXQN-UHFFFAOYSA-N 0.000 claims description 8
- SMTWDFISDOTPCZ-UHFFFAOYSA-N cyclononadecane Chemical group C1CCCCCCCCCCCCCCCCCC1 SMTWDFISDOTPCZ-UHFFFAOYSA-N 0.000 claims description 8
- JNFIMRWCDIOUMT-UHFFFAOYSA-N cyclooctadecane Chemical group C1CCCCCCCCCCCCCCCCC1 JNFIMRWCDIOUMT-UHFFFAOYSA-N 0.000 claims description 8
- SRONXYPFSAKOGH-UHFFFAOYSA-N cyclopentadecane Chemical group C1CCCCCCCCCCCCCC1 SRONXYPFSAKOGH-UHFFFAOYSA-N 0.000 claims description 8
- 125000004855 decalinyl group Chemical group C1(CCCC2CCCCC12)* 0.000 claims description 8
- 125000003983 fluorenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3CC12)* 0.000 claims description 8
- 125000001624 naphthyl group Chemical group 0.000 claims description 8
- 125000004955 1,4-cyclohexylene group Chemical group [H]C1([H])C([H])([H])C([H])([*:1])C([H])([H])C([H])([H])C1([H])[*:2] 0.000 claims description 7
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical group N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 claims description 7
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical group C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 claims description 7
- DGEZNRSVGBDHLK-UHFFFAOYSA-N [1,10]phenanthroline Chemical group C1=CN=C2C3=NC=CC=C3C=CC2=C1 DGEZNRSVGBDHLK-UHFFFAOYSA-N 0.000 claims description 7
- 125000000641 acridinyl group Chemical group C1(=CC=CC2=NC3=CC=CC=C3C=C12)* 0.000 claims description 7
- IOJUPLGTWVMSFF-UHFFFAOYSA-N benzothiazole Chemical group C1=CC=C2SC=NC2=C1 IOJUPLGTWVMSFF-UHFFFAOYSA-N 0.000 claims description 7
- 125000000609 carbazolyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3NC12)* 0.000 claims description 7
- 125000001041 indolyl group Chemical group 0.000 claims description 7
- 125000002183 isoquinolinyl group Chemical group C1(=NC=CC2=CC=CC=C12)* 0.000 claims description 7
- WCPAKWJPBJAGKN-UHFFFAOYSA-N oxadiazole Chemical group C1=CON=N1 WCPAKWJPBJAGKN-UHFFFAOYSA-N 0.000 claims description 7
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 7
- 125000003072 pyrazolidinyl group Chemical group 0.000 claims description 7
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 claims description 7
- DYLIWHYUXAJDOJ-OWOJBTEDSA-N (e)-4-(6-aminopurin-9-yl)but-2-en-1-ol Chemical compound NC1=NC=NC2=C1N=CN2C\C=C\CO DYLIWHYUXAJDOJ-OWOJBTEDSA-N 0.000 claims description 6
- UGUHFDPGDQDVGX-UHFFFAOYSA-N 1,2,3-thiadiazole Chemical group C1=CSN=N1 UGUHFDPGDQDVGX-UHFFFAOYSA-N 0.000 claims description 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 6
- 125000003545 alkoxy group Chemical group 0.000 claims description 6
- 125000003828 azulenyl group Chemical group 0.000 claims description 6
- 238000010438 heat treatment Methods 0.000 claims description 6
- 125000003454 indenyl group Chemical group C1(C=CC2=CC=CC=C12)* 0.000 claims description 6
- 125000001828 phenalenyl group Chemical group C1(C=CC2=CC=CC3=CC=CC1=C23)* 0.000 claims description 6
- YNPNZTXNASCQKK-UHFFFAOYSA-N phenanthrene Chemical group C1=CC=C2C3=CC=CC=C3C=CC2=C1 YNPNZTXNASCQKK-UHFFFAOYSA-N 0.000 claims description 6
- CXWXQJXEFPUFDZ-UHFFFAOYSA-N tetralin Chemical group C1=CC=C2CCCCC2=C1 CXWXQJXEFPUFDZ-UHFFFAOYSA-N 0.000 claims description 6
- 125000001484 phenothiazinyl group Chemical group C1(=CC=CC=2SC3=CC=CC=C3NC12)* 0.000 claims description 5
- OBSWMVCSYZHGIQ-UHFFFAOYSA-N 7-aminophenothiazin-3-one Chemical group C1=CC(=O)C=C2SC3=CC(N)=CC=C3N=C21 OBSWMVCSYZHGIQ-UHFFFAOYSA-N 0.000 claims description 4
- 125000004428 fluoroalkoxy group Chemical group 0.000 claims description 4
- 125000003709 fluoroalkyl group Chemical group 0.000 claims description 4
- 150000002430 hydrocarbons Chemical group 0.000 claims description 4
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical group C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 claims description 3
- 125000000532 dioxanyl group Chemical group 0.000 claims description 3
- 125000004193 piperazinyl group Chemical group 0.000 claims description 3
- 125000003386 piperidinyl group Chemical group 0.000 claims description 3
- 230000008569 process Effects 0.000 claims description 3
- CBFCDTFDPHXCNY-UHFFFAOYSA-N icosane Chemical group CCCCCCCCCCCCCCCCCCCC CBFCDTFDPHXCNY-UHFFFAOYSA-N 0.000 claims description 2
- ONDPHDOFVYQSGI-UHFFFAOYSA-N zinc nitrate Chemical compound [Zn+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O ONDPHDOFVYQSGI-UHFFFAOYSA-N 0.000 claims description 2
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 171
- 238000011156 evaluation Methods 0.000 description 90
- 210000002858 crystal cell Anatomy 0.000 description 75
- 239000000243 solution Substances 0.000 description 75
- 239000010408 film Substances 0.000 description 57
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 45
- 230000015572 biosynthetic process Effects 0.000 description 38
- 238000003756 stirring Methods 0.000 description 37
- 238000003786 synthesis reaction Methods 0.000 description 34
- 239000000843 powder Substances 0.000 description 32
- 150000004985 diamines Chemical class 0.000 description 30
- 238000001556 precipitation Methods 0.000 description 29
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 27
- 239000002904 solvent Substances 0.000 description 24
- 239000000758 substrate Substances 0.000 description 24
- 230000005856 abnormality Effects 0.000 description 22
- 238000006243 chemical reaction Methods 0.000 description 22
- 230000010287 polarization Effects 0.000 description 22
- 239000011347 resin Substances 0.000 description 22
- 229920005989 resin Polymers 0.000 description 22
- 238000006358 imidation reaction Methods 0.000 description 19
- 150000001875 compounds Chemical class 0.000 description 17
- 239000003054 catalyst Substances 0.000 description 15
- 125000003277 amino group Chemical group 0.000 description 12
- 238000000576 coating method Methods 0.000 description 12
- 230000000052 comparative effect Effects 0.000 description 12
- 125000001424 substituent group Chemical group 0.000 description 12
- 229910052799 carbon Inorganic materials 0.000 description 11
- 239000011248 coating agent Substances 0.000 description 11
- 239000000203 mixture Substances 0.000 description 10
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 10
- 239000002253 acid Substances 0.000 description 9
- YEJRWHAVMIAJKC-UHFFFAOYSA-N 4-Butyrolactone Chemical compound O=C1CCCO1 YEJRWHAVMIAJKC-UHFFFAOYSA-N 0.000 description 8
- GTDPSWPPOUPBNX-UHFFFAOYSA-N ac1mqpva Chemical compound CC12C(=O)OC(=O)C1(C)C1(C)C2(C)C(=O)OC1=O GTDPSWPPOUPBNX-UHFFFAOYSA-N 0.000 description 8
- 125000005842 heteroatom Chemical group 0.000 description 8
- 125000004430 oxygen atom Chemical group O* 0.000 description 8
- 239000002244 precipitate Substances 0.000 description 8
- 239000002994 raw material Substances 0.000 description 8
- 229910052717 sulfur Inorganic materials 0.000 description 8
- 125000004434 sulfur atom Chemical group 0.000 description 8
- 150000000000 tetracarboxylic acids Chemical class 0.000 description 8
- 0 *C1(*C(CO*)=CC2[N+]([O-])=O)C2=C1 Chemical compound *C1(*C(CO*)=CC2[N+]([O-])=O)C2=C1 0.000 description 7
- POAOYUHQDCAZBD-UHFFFAOYSA-N 2-butoxyethanol Chemical compound CCCCOCCO POAOYUHQDCAZBD-UHFFFAOYSA-N 0.000 description 7
- WVOLTBSCXRRQFR-SJORKVTESA-N Cannabidiolic acid Natural products OC1=C(C(O)=O)C(CCCCC)=CC(O)=C1[C@@H]1[C@@H](C(C)=C)CCC(C)=C1 WVOLTBSCXRRQFR-SJORKVTESA-N 0.000 description 7
- WVOLTBSCXRRQFR-DLBZAZTESA-M cannabidiolate Chemical compound OC1=C(C([O-])=O)C(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)=C)CCC(C)=C1 WVOLTBSCXRRQFR-DLBZAZTESA-M 0.000 description 7
- 238000007865 diluting Methods 0.000 description 7
- 125000005843 halogen group Chemical group 0.000 description 7
- 238000005259 measurement Methods 0.000 description 7
- 125000004433 nitrogen atom Chemical group N* 0.000 description 7
- 125000006158 tetracarboxylic acid group Chemical group 0.000 description 7
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- 125000000753 cycloalkyl group Chemical group 0.000 description 6
- 125000000623 heterocyclic group Chemical group 0.000 description 6
- 150000003839 salts Chemical class 0.000 description 6
- FLBAYUMRQUHISI-UHFFFAOYSA-N 1,8-naphthyridine Chemical group N1=CC=CC2=CC=CN=C21 FLBAYUMRQUHISI-UHFFFAOYSA-N 0.000 description 5
- 125000002785 azepinyl group Chemical group 0.000 description 5
- 125000002576 diazepinyl group Chemical group N1N=C(C=CC=C1)* 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 229910052731 fluorine Inorganic materials 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 5
- 125000001791 phenazinyl group Chemical group C1(=CC=CC2=NC3=CC=CC=C3N=C12)* 0.000 description 5
- LFSXCDWNBUNEEM-UHFFFAOYSA-N phthalazine Chemical group C1=NN=CC2=CC=CC=C21 LFSXCDWNBUNEEM-UHFFFAOYSA-N 0.000 description 5
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- 206010047571 Visual impairment Diseases 0.000 description 4
- 150000008065 acid anhydrides Chemical class 0.000 description 4
- 238000005227 gel permeation chromatography Methods 0.000 description 4
- 125000006850 spacer group Chemical group 0.000 description 4
- HHVIBTZHLRERCL-UHFFFAOYSA-N sulfonyldimethane Chemical compound CS(C)(=O)=O HHVIBTZHLRERCL-UHFFFAOYSA-N 0.000 description 4
- 125000001140 1,4-phenylene group Chemical group [H]C1=C([H])C([*:2])=C([H])C([H])=C1[*:1] 0.000 description 3
- ARXJGSRGQADJSQ-UHFFFAOYSA-N 1-methoxypropan-2-ol Chemical compound COCC(C)O ARXJGSRGQADJSQ-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 239000008186 active pharmaceutical agent Substances 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- 230000009881 electrostatic interaction Effects 0.000 description 3
- LZCLXQDLBQLTDK-UHFFFAOYSA-N ethyl 2-hydroxypropanoate Chemical compound CCOC(=O)C(C)O LZCLXQDLBQLTDK-UHFFFAOYSA-N 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 239000011737 fluorine Substances 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
- 125000005462 imide group Chemical group 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- LTEKQAPRXFBRNN-UHFFFAOYSA-N piperidin-4-ylmethanamine Chemical compound NCC1CCNCC1 LTEKQAPRXFBRNN-UHFFFAOYSA-N 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- AVQQQNCBBIEMEU-UHFFFAOYSA-N 1,1,3,3-tetramethylurea Chemical compound CN(C)C(=O)N(C)C AVQQQNCBBIEMEU-UHFFFAOYSA-N 0.000 description 2
- JOLQKTGDSGKSKJ-UHFFFAOYSA-N 1-ethoxypropan-2-ol Chemical compound CCOCC(C)O JOLQKTGDSGKSKJ-UHFFFAOYSA-N 0.000 description 2
- CTMHWPIWNRWQEG-UHFFFAOYSA-N 1-methylcyclohexene Chemical compound CC1=CCCCC1 CTMHWPIWNRWQEG-UHFFFAOYSA-N 0.000 description 2
- HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical compound C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 description 2
- AOBIOSPNXBMOAT-UHFFFAOYSA-N 2-[2-(oxiran-2-ylmethoxy)ethoxymethyl]oxirane Chemical compound C1OC1COCCOCC1CO1 AOBIOSPNXBMOAT-UHFFFAOYSA-N 0.000 description 2
- HXDLWJWIAHWIKI-UHFFFAOYSA-N 2-hydroxyethyl acetate Chemical compound CC(=O)OCCO HXDLWJWIAHWIKI-UHFFFAOYSA-N 0.000 description 2
- PPPFYBPQAPISCT-UHFFFAOYSA-N 2-hydroxypropyl acetate Chemical compound CC(O)COC(C)=O PPPFYBPQAPISCT-UHFFFAOYSA-N 0.000 description 2
- XLLIQLLCWZCATF-UHFFFAOYSA-N 2-methoxyethyl acetate Chemical compound COCCOC(C)=O XLLIQLLCWZCATF-UHFFFAOYSA-N 0.000 description 2
- QCAHUFWKIQLBNB-UHFFFAOYSA-N 3-(3-methoxypropoxy)propan-1-ol Chemical compound COCCCOCCCO QCAHUFWKIQLBNB-UHFFFAOYSA-N 0.000 description 2
- SYBYTAAJFKOIEJ-UHFFFAOYSA-N 3-Methylbutan-2-one Chemical compound CC(C)C(C)=O SYBYTAAJFKOIEJ-UHFFFAOYSA-N 0.000 description 2
- CUYKNJBYIJFRCU-UHFFFAOYSA-N 3-aminopyridine Chemical compound NC1=CC=CN=C1 CUYKNJBYIJFRCU-UHFFFAOYSA-N 0.000 description 2
- FFWSICBKRCICMR-UHFFFAOYSA-N 5-methyl-2-hexanone Chemical compound CC(C)CCC(C)=O FFWSICBKRCICMR-UHFFFAOYSA-N 0.000 description 2
- RGSFGYAAUTVSQA-UHFFFAOYSA-N Cyclopentane Chemical compound C1CCCC1 RGSFGYAAUTVSQA-UHFFFAOYSA-N 0.000 description 2
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 2
- ZWXPDGCFMMFNRW-UHFFFAOYSA-N N-methylcaprolactam Chemical compound CN1CCCCCC1=O ZWXPDGCFMMFNRW-UHFFFAOYSA-N 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- 239000004952 Polyamide Substances 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical group [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 2
- DKPFZGUDAPQIHT-UHFFFAOYSA-N butyl acetate Chemical compound CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 2
- XUPYJHCZDLZNFP-UHFFFAOYSA-N butyl butanoate Chemical compound CCCCOC(=O)CCC XUPYJHCZDLZNFP-UHFFFAOYSA-N 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 2
- SWXVUIWOUIDPGS-UHFFFAOYSA-N diacetone alcohol Chemical compound CC(=O)CC(C)(C)O SWXVUIWOUIDPGS-UHFFFAOYSA-N 0.000 description 2
- XXJWXESWEXIICW-UHFFFAOYSA-N diethylene glycol monoethyl ether Chemical compound CCOCCOCCO XXJWXESWEXIICW-UHFFFAOYSA-N 0.000 description 2
- SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 description 2
- 125000001153 fluoro group Chemical group F* 0.000 description 2
- 229920001519 homopolymer Polymers 0.000 description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- AMXOYNBUYSYVKV-UHFFFAOYSA-M lithium bromide Chemical compound [Li+].[Br-] AMXOYNBUYSYVKV-UHFFFAOYSA-M 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 2
- 229920002647 polyamide Polymers 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 238000007639 printing Methods 0.000 description 2
- 230000009257 reactivity Effects 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 229910052710 silicon Inorganic materials 0.000 description 2
- 150000003462 sulfoxides Chemical class 0.000 description 2
- 230000002194 synthesizing effect Effects 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- WYTZZXDRDKSJID-UHFFFAOYSA-N (3-aminopropyl)triethoxysilane Chemical compound CCO[Si](OCC)(OCC)CCCN WYTZZXDRDKSJID-UHFFFAOYSA-N 0.000 description 1
- RYNQKSJRFHJZTK-UHFFFAOYSA-N (3-methoxy-3-methylbutyl) acetate Chemical compound COC(C)(C)CCOC(C)=O RYNQKSJRFHJZTK-UHFFFAOYSA-N 0.000 description 1
- MPBCUCGKHDEUDD-UHFFFAOYSA-N (5-methylpyrazin-2-yl)methanamine Chemical compound CC1=CN=C(CN)C=N1 MPBCUCGKHDEUDD-UHFFFAOYSA-N 0.000 description 1
- JDGFELYPUWNNGR-UHFFFAOYSA-N 1,2,3,3a,4,5,6,6a-octahydropentalene-1,3,4,6-tetracarboxylic acid Chemical compound OC(=O)C1CC(C(O)=O)C2C(C(=O)O)CC(C(O)=O)C21 JDGFELYPUWNNGR-UHFFFAOYSA-N 0.000 description 1
- CYSGHNMQYZDMIA-UHFFFAOYSA-N 1,3-Dimethyl-2-imidazolidinon Chemical compound CN1CCN(C)C1=O CYSGHNMQYZDMIA-UHFFFAOYSA-N 0.000 description 1
- DQVRVXRIKVWXQH-UHFFFAOYSA-N 1,8-bis(oxiran-2-yl)-4,6-bis(oxiran-2-ylmethyl)octane-3,5-diol Chemical compound C1OC1CC(C(O)C(CCC1OC1)CC1OC1)C(O)CCC1CO1 DQVRVXRIKVWXQH-UHFFFAOYSA-N 0.000 description 1
- COLYDFXUNAQRBZ-UHFFFAOYSA-N 1-(1-ethoxypropan-2-yloxy)propan-2-yl acetate Chemical compound CCOCC(C)OCC(C)OC(C)=O COLYDFXUNAQRBZ-UHFFFAOYSA-N 0.000 description 1
- PNBCGVPSRHMZDO-UHFFFAOYSA-N 1-(1-propoxypropan-2-yloxy)propan-2-yl acetate Chemical compound CCCOCC(C)OCC(C)OC(C)=O PNBCGVPSRHMZDO-UHFFFAOYSA-N 0.000 description 1
- UWFRVQVNYNPBEF-UHFFFAOYSA-N 1-(2,4-dimethylphenyl)propan-1-one Chemical compound CCC(=O)C1=CC=C(C)C=C1C UWFRVQVNYNPBEF-UHFFFAOYSA-N 0.000 description 1
- QWOZZTWBWQMEPD-UHFFFAOYSA-N 1-(2-ethoxypropoxy)propan-2-ol Chemical compound CCOC(C)COCC(C)O QWOZZTWBWQMEPD-UHFFFAOYSA-N 0.000 description 1
- ZFPGARUNNKGOBB-UHFFFAOYSA-N 1-Ethyl-2-pyrrolidinone Chemical compound CCN1CCCC1=O ZFPGARUNNKGOBB-UHFFFAOYSA-N 0.000 description 1
- HASUCEDGKYJBDC-UHFFFAOYSA-N 1-[3-[[bis(oxiran-2-ylmethyl)amino]methyl]cyclohexyl]-n,n-bis(oxiran-2-ylmethyl)methanamine Chemical compound C1OC1CN(CC1CC(CN(CC2OC2)CC2OC2)CCC1)CC1CO1 HASUCEDGKYJBDC-UHFFFAOYSA-N 0.000 description 1
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 description 1
- RWNUSVWFHDHRCJ-UHFFFAOYSA-N 1-butoxypropan-2-ol Chemical compound CCCCOCC(C)O RWNUSVWFHDHRCJ-UHFFFAOYSA-N 0.000 description 1
- RQUBQBFVDOLUKC-UHFFFAOYSA-N 1-ethoxy-2-methylpropane Chemical compound CCOCC(C)C RQUBQBFVDOLUKC-UHFFFAOYSA-N 0.000 description 1
- BMVXCPBXGZKUPN-UHFFFAOYSA-N 1-hexanamine Chemical compound CCCCCCN BMVXCPBXGZKUPN-UHFFFAOYSA-N 0.000 description 1
- BPIUIOXAFBGMNB-UHFFFAOYSA-N 1-hexoxyhexane Chemical compound CCCCCCOCCCCCC BPIUIOXAFBGMNB-UHFFFAOYSA-N 0.000 description 1
- ONDSSKDTLGWNOJ-UHFFFAOYSA-N 1-methoxyhexan-2-ol Chemical compound CCCCC(O)COC ONDSSKDTLGWNOJ-UHFFFAOYSA-N 0.000 description 1
- IBLKWZIFZMJLFL-UHFFFAOYSA-N 1-phenoxypropan-2-ol Chemical compound CC(O)COC1=CC=CC=C1 IBLKWZIFZMJLFL-UHFFFAOYSA-N 0.000 description 1
- GQCZPFJGIXHZMB-UHFFFAOYSA-N 1-tert-Butoxy-2-propanol Chemical compound CC(O)COC(C)(C)C GQCZPFJGIXHZMB-UHFFFAOYSA-N 0.000 description 1
- HXJZEGBVQCRLOD-UHFFFAOYSA-N 1-triethoxysilylpropan-2-amine Chemical compound CCO[Si](CC(C)N)(OCC)OCC HXJZEGBVQCRLOD-UHFFFAOYSA-N 0.000 description 1
- KBRVQAUYZUFKAJ-UHFFFAOYSA-N 1-trimethoxysilylpropan-2-amine Chemical compound CO[Si](OC)(OC)CC(C)N KBRVQAUYZUFKAJ-UHFFFAOYSA-N 0.000 description 1
- IVIDDMGBRCPGLJ-UHFFFAOYSA-N 2,3-bis(oxiran-2-ylmethoxy)propan-1-ol Chemical compound C1OC1COC(CO)COCC1CO1 IVIDDMGBRCPGLJ-UHFFFAOYSA-N 0.000 description 1
- FXNDIJDIPNCZQJ-UHFFFAOYSA-N 2,4,4-trimethylpent-1-ene Chemical group CC(=C)CC(C)(C)C FXNDIJDIPNCZQJ-UHFFFAOYSA-N 0.000 description 1
- OAYXUHPQHDHDDZ-UHFFFAOYSA-N 2-(2-butoxyethoxy)ethanol Chemical compound CCCCOCCOCCO OAYXUHPQHDHDDZ-UHFFFAOYSA-N 0.000 description 1
- MTVLEKBQSDTQGO-UHFFFAOYSA-N 2-(2-ethoxypropoxy)propan-1-ol Chemical compound CCOC(C)COC(C)CO MTVLEKBQSDTQGO-UHFFFAOYSA-N 0.000 description 1
- XXXFZKQPYACQLD-UHFFFAOYSA-N 2-(2-hydroxyethoxy)ethyl acetate Chemical compound CC(=O)OCCOCCO XXXFZKQPYACQLD-UHFFFAOYSA-N 0.000 description 1
- XYVAYAJYLWYJJN-UHFFFAOYSA-N 2-(2-propoxypropoxy)propan-1-ol Chemical compound CCCOC(C)COC(C)CO XYVAYAJYLWYJJN-UHFFFAOYSA-N 0.000 description 1
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 1
- PTTPXKJBFFKCEK-UHFFFAOYSA-N 2-Methyl-4-heptanone Chemical compound CC(C)CC(=O)CC(C)C PTTPXKJBFFKCEK-UHFFFAOYSA-N 0.000 description 1
- HDPLHDGYGLENEI-UHFFFAOYSA-N 2-[1-(oxiran-2-ylmethoxy)propan-2-yloxymethyl]oxirane Chemical compound C1OC1COC(C)COCC1CO1 HDPLHDGYGLENEI-UHFFFAOYSA-N 0.000 description 1
- FVCHRIQAIOHAIC-UHFFFAOYSA-N 2-[1-[1-[1-(oxiran-2-ylmethoxy)propan-2-yloxy]propan-2-yloxy]propan-2-yloxymethyl]oxirane Chemical compound C1OC1COC(C)COC(C)COC(C)COCC1CO1 FVCHRIQAIOHAIC-UHFFFAOYSA-N 0.000 description 1
- WAEVWDZKMBQDEJ-UHFFFAOYSA-N 2-[2-(2-methoxypropoxy)propoxy]propan-1-ol Chemical compound COC(C)COC(C)COC(C)CO WAEVWDZKMBQDEJ-UHFFFAOYSA-N 0.000 description 1
- GLUOGZCHYVWCAK-UHFFFAOYSA-N 2-[2-(3-triethoxysilylpropylamino)ethylamino]ethyl acetate Chemical compound CCO[Si](OCC)(OCC)CCCNCCNCCOC(C)=O GLUOGZCHYVWCAK-UHFFFAOYSA-N 0.000 description 1
- CYPTUSHYKRVMKI-UHFFFAOYSA-N 2-[2-(3-trimethoxysilylpropylamino)ethylamino]ethyl acetate Chemical compound CO[Si](OC)(OC)CCCNCCNCCOC(C)=O CYPTUSHYKRVMKI-UHFFFAOYSA-N 0.000 description 1
- WTYYGFLRBWMFRY-UHFFFAOYSA-N 2-[6-(oxiran-2-ylmethoxy)hexoxymethyl]oxirane Chemical compound C1OC1COCCCCCCOCC1CO1 WTYYGFLRBWMFRY-UHFFFAOYSA-N 0.000 description 1
- KUAUJXBLDYVELT-UHFFFAOYSA-N 2-[[2,2-dimethyl-3-(oxiran-2-ylmethoxy)propoxy]methyl]oxirane Chemical compound C1OC1COCC(C)(C)COCC1CO1 KUAUJXBLDYVELT-UHFFFAOYSA-N 0.000 description 1
- ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 description 1
- SVONRAPFKPVNKG-UHFFFAOYSA-N 2-ethoxyethyl acetate Chemical compound CCOCCOC(C)=O SVONRAPFKPVNKG-UHFFFAOYSA-N 0.000 description 1
- IDLHTECVNDEOIY-UHFFFAOYSA-N 2-pyridin-4-ylethanamine Chemical compound NCCC1=CC=NC=C1 IDLHTECVNDEOIY-UHFFFAOYSA-N 0.000 description 1
- UENRXLSRMCSUSN-UHFFFAOYSA-N 3,5-diaminobenzoic acid Chemical compound NC1=CC(N)=CC(C(O)=O)=C1 UENRXLSRMCSUSN-UHFFFAOYSA-N 0.000 description 1
- WONYMNWUJVKVII-UHFFFAOYSA-N 3,5-diiodothyropropionic acid Chemical compound IC1=CC(CCC(=O)O)=CC(I)=C1OC1=CC=C(O)C=C1 WONYMNWUJVKVII-UHFFFAOYSA-N 0.000 description 1
- JRXXEXVXTFEBIY-UHFFFAOYSA-N 3-ethoxypropanoic acid Chemical compound CCOCCC(O)=O JRXXEXVXTFEBIY-UHFFFAOYSA-N 0.000 description 1
- KDHWOCLBMVSZPG-UHFFFAOYSA-N 3-imidazol-1-ylpropan-1-amine Chemical compound NCCCN1C=CN=C1 KDHWOCLBMVSZPG-UHFFFAOYSA-N 0.000 description 1
- MFKRHJVUCZRDTF-UHFFFAOYSA-N 3-methoxy-3-methylbutan-1-ol Chemical compound COC(C)(C)CCO MFKRHJVUCZRDTF-UHFFFAOYSA-N 0.000 description 1
- HTNUUDFQRYBJPH-UHFFFAOYSA-N 3-methoxypropanehydrazide Chemical compound COCCC(=O)NN HTNUUDFQRYBJPH-UHFFFAOYSA-N 0.000 description 1
- RHLVCLIPMVJYKS-UHFFFAOYSA-N 3-octanone Chemical compound CCCCCC(=O)CC RHLVCLIPMVJYKS-UHFFFAOYSA-N 0.000 description 1
- LVNLBBGBASVLLI-UHFFFAOYSA-N 3-triethoxysilylpropylurea Chemical compound CCO[Si](OCC)(OCC)CCCNC(N)=O LVNLBBGBASVLLI-UHFFFAOYSA-N 0.000 description 1
- SJECZPVISLOESU-UHFFFAOYSA-N 3-trimethoxysilylpropan-1-amine Chemical compound CO[Si](OC)(OC)CCCN SJECZPVISLOESU-UHFFFAOYSA-N 0.000 description 1
- LVACOMKKELLCHJ-UHFFFAOYSA-N 3-trimethoxysilylpropylurea Chemical compound CO[Si](OC)(OC)CCCNC(N)=O LVACOMKKELLCHJ-UHFFFAOYSA-N 0.000 description 1
- YGYCECQIOXZODZ-UHFFFAOYSA-N 4415-87-6 Chemical compound O=C1OC(=O)C2C1C1C(=O)OC(=O)C12 YGYCECQIOXZODZ-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- MRABAEUHTLLEML-UHFFFAOYSA-N Butyl lactate Chemical compound CCCCOC(=O)C(C)O MRABAEUHTLLEML-UHFFFAOYSA-N 0.000 description 1
- OZJGFOICLOFTSP-UHFFFAOYSA-N CNC[N](C)(N)#C Chemical compound CNC[N](C)(N)#C OZJGFOICLOFTSP-UHFFFAOYSA-N 0.000 description 1
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 1
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 1
- VYZAHLCBVHPDDF-UHFFFAOYSA-N Dinitrochlorobenzene Chemical compound [O-][N+](=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 VYZAHLCBVHPDDF-UHFFFAOYSA-N 0.000 description 1
- XXRCUYVCPSWGCC-UHFFFAOYSA-N Ethyl pyruvate Chemical compound CCOC(=O)C(C)=O XXRCUYVCPSWGCC-UHFFFAOYSA-N 0.000 description 1
- KMTRUDSVKNLOMY-UHFFFAOYSA-N Ethylene carbonate Chemical compound O=C1OCCO1 KMTRUDSVKNLOMY-UHFFFAOYSA-N 0.000 description 1
- 101150026303 HEX1 gene Proteins 0.000 description 1
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 description 1
- UIHCLUNTQKBZGK-UHFFFAOYSA-N Methyl isobutyl ketone Natural products CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 description 1
- 239000006001 Methyl nonyl ketone Substances 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- ZQMWQUQQDBBEBB-MXVIHJGJSA-N NC1=CC(=C(C=C1)OC1=CC=C(C=C1)[C@@H]1CC[C@H](CC1)CCCCCCC)N Chemical compound NC1=CC(=C(C=C1)OC1=CC=C(C=C1)[C@@H]1CC[C@H](CC1)CCCCCCC)N ZQMWQUQQDBBEBB-MXVIHJGJSA-N 0.000 description 1
- VSNWUEPEAISDGB-HCGLCNNCSA-N NC1=CC(=CC(=C1)COC1=CC=C(C=C1)C1=CC=C(C=C1)[C@@H]1CC[C@H](CC1)CCCCC)N Chemical compound NC1=CC(=CC(=C1)COC1=CC=C(C=C1)C1=CC=C(C=C1)[C@@H]1CC[C@H](CC1)CCCCC)N VSNWUEPEAISDGB-HCGLCNNCSA-N 0.000 description 1
- MSWILMWGBXSUDW-MVBYDDMTSA-N NC1=CC(=CC(=C1)COC1=CC=C(C=C1)[C@@H]1CC[C@H](CC1)[C@@H]1CC[C@H](CC1)CCCCC)N Chemical compound NC1=CC(=CC(=C1)COC1=CC=C(C=C1)[C@@H]1CC[C@H](CC1)[C@@H]1CC[C@H](CC1)CCCCC)N MSWILMWGBXSUDW-MVBYDDMTSA-N 0.000 description 1
- NIIKXMRDKINCQO-YROJFRDXSA-N NC1=CC=C(C(=C1)COC1=CC=C(C=C1)[C@@H]1CC[C@H](CC1)[C@@H]1CC[C@H](CC1)CCCCC)N Chemical compound NC1=CC=C(C(=C1)COC1=CC=C(C=C1)[C@@H]1CC[C@H](CC1)[C@@H]1CC[C@H](CC1)CCCCC)N NIIKXMRDKINCQO-YROJFRDXSA-N 0.000 description 1
- 239000004988 Nematic liquid crystal Substances 0.000 description 1
- ILOCNLYUKFZVBP-UHFFFAOYSA-N O=C(C(CC12)C(C(C3)C(O4)=O)C1C3C4=O)OC2=O Chemical compound O=C(C(CC12)C(C(C3)C(O4)=O)C1C3C4=O)OC2=O ILOCNLYUKFZVBP-UHFFFAOYSA-N 0.000 description 1
- 101100408244 Oryza sativa subsp. japonica PHT1 gene Proteins 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 229920000297 Rayon Polymers 0.000 description 1
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 1
- 238000003848 UV Light-Curing Methods 0.000 description 1
- KMPQYAYAQWNLME-UHFFFAOYSA-N Undecanal Natural products CCCCCCCCCCC=O KMPQYAYAQWNLME-UHFFFAOYSA-N 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 125000002723 alicyclic group Chemical group 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 229940072049 amyl acetate Drugs 0.000 description 1
- PGMYKACGEOXYJE-UHFFFAOYSA-N anhydrous amyl acetate Natural products CCCCCOC(C)=O PGMYKACGEOXYJE-UHFFFAOYSA-N 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- RRIRSNXZGJWTQM-UHFFFAOYSA-N butyl 3-methoxypropanoate Chemical compound CCCCOC(=O)CCOC RRIRSNXZGJWTQM-UHFFFAOYSA-N 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 150000001244 carboxylic acid anhydrides Chemical group 0.000 description 1
- 125000002843 carboxylic acid group Chemical group 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 125000004427 diamine group Chemical group 0.000 description 1
- 239000003989 dielectric material Substances 0.000 description 1
- UYAAVKFHBMJOJZ-UHFFFAOYSA-N diimidazo[1,3-b:1',3'-e]pyrazine-5,10-dione Chemical compound O=C1C2=CN=CN2C(=O)C2=CN=CN12 UYAAVKFHBMJOJZ-UHFFFAOYSA-N 0.000 description 1
- POLCUAVZOMRGSN-UHFFFAOYSA-N dipropyl ether Chemical compound CCCOCCC POLCUAVZOMRGSN-UHFFFAOYSA-N 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 125000003700 epoxy group Chemical group 0.000 description 1
- 125000004185 ester group Chemical group 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- VCTPUASWJKHYRO-UHFFFAOYSA-N ethoxyethane;methyl 2-hydroxypropanoate Chemical compound CCOCC.COC(=O)C(C)O VCTPUASWJKHYRO-UHFFFAOYSA-N 0.000 description 1
- CNEKKZXYBHKSDC-UHFFFAOYSA-N ethyl acetate;propane-1,2-diol Chemical compound CC(O)CO.CCOC(C)=O CNEKKZXYBHKSDC-UHFFFAOYSA-N 0.000 description 1
- 229940116333 ethyl lactate Drugs 0.000 description 1
- MVUXVDIFQSGECB-UHFFFAOYSA-N ethyl n-(3-triethoxysilylpropyl)carbamate Chemical compound CCOC(=O)NCCC[Si](OCC)(OCC)OCC MVUXVDIFQSGECB-UHFFFAOYSA-N 0.000 description 1
- MHBPZEDIFIPGSX-UHFFFAOYSA-N ethyl n-(3-trimethoxysilylpropyl)carbamate Chemical compound CCOC(=O)NCCC[Si](OC)(OC)OC MHBPZEDIFIPGSX-UHFFFAOYSA-N 0.000 description 1
- 229940117360 ethyl pyruvate Drugs 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 238000010304 firing Methods 0.000 description 1
- ANSXAPJVJOKRDJ-UHFFFAOYSA-N furo[3,4-f][2]benzofuran-1,3,5,7-tetrone Chemical compound C1=C2C(=O)OC(=O)C2=CC2=C1C(=O)OC2=O ANSXAPJVJOKRDJ-UHFFFAOYSA-N 0.000 description 1
- 238000001879 gelation Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- DMEGYFMYUHOHGS-UHFFFAOYSA-N heptamethylene Natural products C1CCCCCC1 DMEGYFMYUHOHGS-UHFFFAOYSA-N 0.000 description 1
- MNWFXJYAOYHMED-UHFFFAOYSA-M heptanoate Chemical compound CCCCCCC([O-])=O MNWFXJYAOYHMED-UHFFFAOYSA-M 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000007373 indentation Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- IPLONMMJNGTUAI-UHFFFAOYSA-M lithium;bromide;hydrate Chemical compound [Li+].O.[Br-] IPLONMMJNGTUAI-UHFFFAOYSA-M 0.000 description 1
- LPEKGGXMPWTOCB-UHFFFAOYSA-N methyl 2-hydroxypropionate Chemical compound COC(=O)C(C)O LPEKGGXMPWTOCB-UHFFFAOYSA-N 0.000 description 1
- BDJSOPWXYLFTNW-UHFFFAOYSA-N methyl 3-methoxypropanoate Chemical compound COCCC(=O)OC BDJSOPWXYLFTNW-UHFFFAOYSA-N 0.000 description 1
- CWKLZLBVOJRSOM-UHFFFAOYSA-N methyl pyruvate Chemical compound COC(=O)C(C)=O CWKLZLBVOJRSOM-UHFFFAOYSA-N 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- NHBRUUFBSBSTHM-UHFFFAOYSA-N n'-[2-(3-trimethoxysilylpropylamino)ethyl]ethane-1,2-diamine Chemical compound CO[Si](OC)(OC)CCCNCCNCCN NHBRUUFBSBSTHM-UHFFFAOYSA-N 0.000 description 1
- URMCFMOUMIWRAH-UHFFFAOYSA-N n'-[3-[dimethoxy(methyl)silyl]propyl]ethane-1,2-diamine;n'-(3-trimethoxysilylpropyl)ethane-1,2-diamine Chemical compound CO[Si](C)(OC)CCCNCCN.CO[Si](OC)(OC)CCCNCCN URMCFMOUMIWRAH-UHFFFAOYSA-N 0.000 description 1
- XTAZYLNFDRKIHJ-UHFFFAOYSA-N n,n-dioctyloctan-1-amine Chemical compound CCCCCCCCN(CCCCCCCC)CCCCCCCC XTAZYLNFDRKIHJ-UHFFFAOYSA-N 0.000 description 1
- LIBWSLLLJZULCP-UHFFFAOYSA-N n-(3-triethoxysilylpropyl)aniline Chemical compound CCO[Si](OCC)(OCC)CCCNC1=CC=CC=C1 LIBWSLLLJZULCP-UHFFFAOYSA-N 0.000 description 1
- KBJFYLLAMSZSOG-UHFFFAOYSA-N n-(3-trimethoxysilylpropyl)aniline Chemical compound CO[Si](OC)(OC)CCCNC1=CC=CC=C1 KBJFYLLAMSZSOG-UHFFFAOYSA-N 0.000 description 1
- ILRLVKWBBFWKTN-UHFFFAOYSA-N n-benzyl-3-triethoxysilylpropan-1-amine Chemical compound CCO[Si](OCC)(OCC)CCCNCC1=CC=CC=C1 ILRLVKWBBFWKTN-UHFFFAOYSA-N 0.000 description 1
- CLYWMXVFAMGARU-UHFFFAOYSA-N n-benzyl-3-trimethoxysilylpropan-1-amine Chemical compound CO[Si](OC)(OC)CCCNCC1=CC=CC=C1 CLYWMXVFAMGARU-UHFFFAOYSA-N 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 238000007645 offset printing Methods 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 238000006068 polycondensation reaction Methods 0.000 description 1
- 238000000710 polymer precipitation Methods 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- FKRCODPIKNYEAC-UHFFFAOYSA-N propionic acid ethyl ester Natural products CCOC(=O)CC FKRCODPIKNYEAC-UHFFFAOYSA-N 0.000 description 1
- ILVGAIQLOCKNQA-UHFFFAOYSA-N propyl 2-hydroxypropanoate Chemical compound CCCOC(=O)C(C)O ILVGAIQLOCKNQA-UHFFFAOYSA-N 0.000 description 1
- JCMFJIHDWDKYIL-UHFFFAOYSA-N propyl 3-methoxypropanoate Chemical compound CCCOC(=O)CCOC JCMFJIHDWDKYIL-UHFFFAOYSA-N 0.000 description 1
- RUOJZAUFBMNUDX-UHFFFAOYSA-N propylene carbonate Chemical compound CC1COC(=O)O1 RUOJZAUFBMNUDX-UHFFFAOYSA-N 0.000 description 1
- 229940116423 propylene glycol diacetate Drugs 0.000 description 1
- LLHKCFNBLRBOGN-UHFFFAOYSA-N propylene glycol methyl ether acetate Chemical compound COCC(C)OC(C)=O LLHKCFNBLRBOGN-UHFFFAOYSA-N 0.000 description 1
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 1
- HDOUGSFASVGDCS-UHFFFAOYSA-N pyridin-3-ylmethanamine Chemical compound NCC1=CC=CN=C1 HDOUGSFASVGDCS-UHFFFAOYSA-N 0.000 description 1
- TXQWFIVRZNOPCK-UHFFFAOYSA-N pyridin-4-ylmethanamine Chemical compound NCC1=CC=NC=C1 TXQWFIVRZNOPCK-UHFFFAOYSA-N 0.000 description 1
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 description 1
- 239000002964 rayon Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000007142 ring opening reaction Methods 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000007650 screen-printing Methods 0.000 description 1
- 239000000565 sealant Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229910000077 silane Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 125000002345 steroid group Chemical group 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- 125000001302 tertiary amino group Chemical group 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- VLLMWSRANPNYQX-UHFFFAOYSA-N thiadiazole Chemical compound C1=CSN=N1.C1=CSN=N1 VLLMWSRANPNYQX-UHFFFAOYSA-N 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- IMFACGCPASFAPR-UHFFFAOYSA-N tributylamine Chemical compound CCCCN(CCCC)CCCC IMFACGCPASFAPR-UHFFFAOYSA-N 0.000 description 1
- SRPWOOOHEPICQU-UHFFFAOYSA-N trimellitic anhydride Chemical compound OC(=O)C1=CC=C2C(=O)OC(=O)C2=C1 SRPWOOOHEPICQU-UHFFFAOYSA-N 0.000 description 1
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 1
- KYWIYKKSMDLRDC-UHFFFAOYSA-N undecan-2-one Chemical compound CCCCCCCCCC(C)=O KYWIYKKSMDLRDC-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
- C08G73/06—Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
- C08G73/10—Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
- C08G73/1042—Copolyimides derived from at least two different tetracarboxylic compounds or two different diamino compounds
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
- C08G73/06—Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
- C08G73/10—Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
- C08G73/1075—Partially aromatic polyimides
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
- C08G73/06—Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
- C08G73/10—Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
- C08G73/1075—Partially aromatic polyimides
- C08G73/1078—Partially aromatic polyimides wholly aromatic in the diamino moiety
-
- G—PHYSICS
- G02—OPTICS
- G02F—OPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
- G02F1/00—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
- G02F1/01—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour
- G02F1/13—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour based on liquid crystals, e.g. single liquid crystal display cells
- G02F1/133—Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
- G02F1/1333—Constructional arrangements; Manufacturing methods
- G02F1/1337—Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers
- G02F1/133711—Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers by organic films, e.g. polymeric films
- G02F1/133723—Polyimide, polyamide-imide
-
- G—PHYSICS
- G02—OPTICS
- G02F—OPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
- G02F1/00—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
- G02F1/01—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour
- G02F1/13—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour based on liquid crystals, e.g. single liquid crystal display cells
- G02F1/137—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour based on liquid crystals, e.g. single liquid crystal display cells characterised by the electro-optical or magneto-optical effect, e.g. field-induced phase transition, orientation effect, guest-host interaction or dynamic scattering
- G02F1/139—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour based on liquid crystals, e.g. single liquid crystal display cells characterised by the electro-optical or magneto-optical effect, e.g. field-induced phase transition, orientation effect, guest-host interaction or dynamic scattering based on orientation effects in which the liquid crystal remains transparent
- G02F1/1393—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour based on liquid crystals, e.g. single liquid crystal display cells characterised by the electro-optical or magneto-optical effect, e.g. field-induced phase transition, orientation effect, guest-host interaction or dynamic scattering based on orientation effects in which the liquid crystal remains transparent the birefringence of the liquid crystal being electrically controlled, e.g. ECB-, DAP-, HAN-, PI-LC cells
Landscapes
- Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nonlinear Science (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Mathematical Physics (AREA)
- Crystallography & Structural Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Liquid Crystal (AREA)
Description
本発明は、液晶配向膜を作製する際に用いる液晶配向処理剤及びそれを用いた液晶表示素子に関するものである。 The present invention relates to a liquid crystal alignment treatment agent used when producing a liquid crystal alignment film and a liquid crystal display element using the same.
現在、液晶表示素子の液晶配向膜としては、ポリアミド酸などのポリイミド前駆体や可溶性ポリイミドの溶液を主成分とする液晶配向処理剤(液晶配向剤とも云う)を塗布し焼成した、いわゆるポリイミド系の液晶配向膜が主として用いられている。
液晶配向膜に求められる特性のひとつとして、基板面に対する液晶分子の配向傾斜角を任意の値に保つ、いわゆる液晶のプレチルト角制御がある。このプレチルト角の大きさは、液晶配向膜を構成しているポリイミドの構造を選択することで変更できることが知られている。At present, as a liquid crystal alignment film of a liquid crystal display element, a so-called polyimide type liquid crystal alignment treatment agent (also referred to as a liquid crystal alignment agent) mainly composed of a polyimide precursor such as polyamide acid or a solution of soluble polyimide is applied and baked. A liquid crystal alignment film is mainly used.
One of the characteristics required for the liquid crystal alignment film is so-called pre-tilt angle control of the liquid crystal in which the alignment tilt angle of the liquid crystal molecules with respect to the substrate surface is maintained at an arbitrary value. It is known that the magnitude of the pretilt angle can be changed by selecting the structure of the polyimide constituting the liquid crystal alignment film.
ポリイミドの構造によってプレチルト角を制御する技術の中でも、側鎖を有するジアミンをポリイミド原料の一部として用いる方法は、このジアミンの使用割合に応じてプレチルト角が大きくなるので、目的のプレチルト角に制御することが比較的容易であり、プレチルト角を大きくする手段として有用である。液晶のプレチルト角を大きくするジアミンの側鎖構造としては、ステロイド骨格(例えば特許文献1参照)、フェニル基やシクロヘキシル基などの環構造を含むものが提案されている(例えば特許文献2参照)。更には、このような環構造を側鎖に3個から4個有するジアミンも提案されている(例えば特許文献3参照)。 Among the technologies for controlling the pretilt angle depending on the polyimide structure, the method using a diamine having a side chain as a part of the polyimide raw material increases the pretilt angle depending on the proportion of the diamine used, so the target pretilt angle is controlled. This is relatively easy and is useful as a means for increasing the pretilt angle. As a side chain structure of a diamine that increases the pretilt angle of liquid crystal, a structure containing a steroid skeleton (see, for example, Patent Document 1) and a ring structure such as a phenyl group or a cyclohexyl group has been proposed (see, for example, Patent Document 2). Furthermore, a diamine having 3 to 4 such ring structures in the side chain has also been proposed (see, for example, Patent Document 3).
一方で、液晶配向膜作製の工程において、ポリアミド酸の溶液や溶媒可溶性ポリイミドの溶液を基板に塗布する場合、工業的にはフレキソ印刷などで行うことが一般的であり、塗布液の溶媒は、ポリマーの溶解性に優れるN−メチル−2−ピロリドンやγ−ブチロラクトンなどに加えて、均一で欠陥の無い薄膜を形成させる目的でブチルセロソルブなどが混合されている。しかしながら、ブチルセロソルブなどの溶媒は、ポリアミック酸やポリイミドを溶解させる能力に劣る為、多量に混合すると析出が発生するという問題を有している(例えば特許文献4参照)。特に、溶媒可溶性ポリイミドの溶液では、この問題が顕著に表れる。また、前記したような側鎖を有するジアミンを使用して得られたポリイミドは、溶液の塗布均一性が低下する傾向にあるため、ブチルセロソルブなどの塗布性改善溶媒の混合量を多くする必要があり、このような溶媒の混合許容量もポリイミドの重要な特性となる。 On the other hand, in the process of preparing the liquid crystal alignment film, when applying a solution of polyamic acid or a solvent-soluble polyimide to a substrate, it is generally industrially performed by flexographic printing, and the solvent of the coating liquid is In addition to N-methyl-2-pyrrolidone and γ-butyrolactone having excellent polymer solubility, butyl cellosolve and the like are mixed for the purpose of forming a uniform and defect-free thin film. However, since a solvent such as butyl cellosolve is inferior in the ability to dissolve polyamic acid or polyimide, it has a problem that precipitation occurs when mixed in a large amount (see, for example, Patent Document 4). In particular, this problem appears remarkably in a solvent-soluble polyimide solution. Moreover, since the polyimide obtained by using the diamine having a side chain as described above tends to reduce the coating uniformity of the solution, it is necessary to increase the mixing amount of the coating property improving solvent such as butyl cellosolve. Also, the mixing tolerance of such a solvent is an important characteristic of polyimide.
また、液晶表示素子の高精細化に伴い、液晶表示素子のコントラスト低下の抑制や残像現象の低減といった観点から、そこに使用される液晶配向膜においても電圧保持率が高いことや、直流電圧を印加した際の蓄積電荷が少なく、また、直流電圧により蓄積した残留電荷の緩和が早いといった特性が次第に重要となってきている。 In addition, as liquid crystal display elements are becoming higher in definition, liquid crystal alignment films used in the liquid crystal alignment films used in the liquid crystal display elements have a high voltage holding ratio and a direct current voltage from the viewpoint of suppressing contrast reduction and afterimage phenomenon. The characteristics that the accumulated charge when applied is small and the residual charge accumulated by the DC voltage is quickly relaxed are becoming increasingly important.
ポリイミド系の液晶配向膜において、直流電圧によって発生した残像が消えるまでの時間が短いものとして、ポリアミド酸やイミド基含有ポリアミド酸に加えて特定構造の3級アミンを含有する液晶配向剤を使用したもの(例えば特許文献5参照)や、ピリジン骨格などを有する特定ジアミンを原料に使用した可溶性ポリイミドを含有する液晶配向剤を使用したもの(例えば特許文献6参照)などが知られている。また、電圧保持率が高く、かつ直流電圧によって発生した残像が消えるまでの時間が短いものとして、ポリアミド酸やそのイミド化重合体などに加えて分子内に1個のカルボン酸基を含有する化合物、分子内に1個のカルボン酸無水物基を含有する化合物および分子内に1個の3級アミノ基を含有する化合物から選ばれる化合物を極少量含有する液晶配向剤を使用した液晶配向剤(例えば特許文献7参照)が知られている。 In a polyimide-based liquid crystal alignment film, a liquid crystal aligning agent containing a tertiary amine having a specific structure in addition to polyamic acid or an imide group-containing polyamic acid was used as a short time until the afterimage generated by direct current voltage disappears. There are known (for example, see Patent Document 5), and those using a liquid crystal aligning agent containing a soluble polyimide using a specific diamine having a pyridine skeleton or the like as a raw material (for example, see Patent Document 6). In addition to polyamic acid and its imidized polymer, a compound containing one carboxylic acid group in the molecule, assuming that the voltage holding ratio is high and the time until the afterimage generated by direct current voltage disappears is short A liquid crystal aligning agent using a liquid crystal aligning agent containing a very small amount of a compound selected from a compound containing one carboxylic anhydride group in the molecule and a compound containing one tertiary amino group in the molecule ( For example, see Patent Document 7).
しかしながら、近年では大画面で高精細の液晶テレビが広く実用化されており、このような用途における液晶表示素子では、それまでの文字や静止画を主として表示するディスプレイ用途と比較して、残像に対する要求はより厳しくなり、かつ過酷な使用環境での長期使用に耐えうる特性が要求されている。従って、そこに使用される液晶配向膜は従来よりも信頼性の高いものが必要となってきており、液晶配向膜の電気特性に関しても、初期特性が良好なだけでなく、例えば、高温下に長時間曝された後、さらにバックライトの紫外線に長時間曝された後であっても、良好な特性を維持することが求められている。 However, in recent years, large-screen, high-definition liquid crystal televisions have been widely put into practical use, and liquid crystal display elements in such applications are more effective against afterimages than conventional displays that mainly display characters and still images. The requirements are becoming stricter, and characteristics that can withstand long-term use in harsh usage environments are required. Therefore, the liquid crystal alignment film used there is required to have a higher reliability than before, and the electrical characteristics of the liquid crystal alignment film not only have good initial characteristics, but also, for example, at high temperatures. There is a demand for maintaining good characteristics even after long exposure to the ultraviolet light of the backlight.
本発明の目的は、液晶配向膜にした際に、液晶のプレチルト角を大きくする特性を有しており、少ない使用割合でも液晶を垂直に配向させることができ、また、液晶配向処理剤の塗布液に貧溶媒を混合したときにも析出が発生しにくい液晶配向処理剤を提供することにある。これらの特性に加え、電圧保持率が高く、更に高温下に長時間曝された後であっても、直流電圧により蓄積する残留電荷の緩和が速く、かつバックライトの紫外線に長時間曝された後でも電圧保持率の低下を抑制できる液晶配向膜が得られる液晶配向処理剤を提供することにある。更には過酷な使用環境での長期使用に耐えうる信頼性の高い液晶表示素子を提供することにある。 The object of the present invention is to have a property of increasing the pretilt angle of the liquid crystal when it is used as a liquid crystal alignment film, so that the liquid crystal can be vertically aligned even at a small usage rate, and the liquid crystal alignment treatment agent can be applied. An object of the present invention is to provide a liquid crystal aligning agent that hardly causes precipitation even when a poor solvent is mixed with the liquid. In addition to these characteristics, the voltage holding ratio is high, and even after being exposed to a high temperature for a long time, the residual charge accumulated by the DC voltage is quickly relaxed and exposed to the ultraviolet light of the backlight for a long time. An object of the present invention is to provide a liquid crystal alignment treatment agent capable of obtaining a liquid crystal alignment film capable of suppressing a decrease in voltage holding ratio even afterward. It is another object of the present invention to provide a highly reliable liquid crystal display element that can withstand long-term use in a harsh use environment.
本発明者は、上記の目的を達成するべく鋭意研究を進めたところ、これを達成する新規な液晶配向処理剤を見出した。本発明はかかる知見に基づくものであり、以下の要旨を有する。
(1)下記の(A)成分及び下記の(B)成分を含有することを特徴とする液晶配向処理剤。
(A)成分:下記の式[1]で表される繰り返し単位の構造式を有するポリアミド酸をイミド化させた重合体であり、該重合体中の分子内にカルボキシル基を有するポリイミド。
(B)成分:分子内に1級アミノ基を1個と窒素含有芳香族複素環とを有し、かつ前記1級アミノ基が脂肪族炭化水素基又は非芳香族環式炭化水素基に結合しているアミン化合物。The present inventor conducted intensive studies to achieve the above object, and found a novel liquid crystal aligning agent that achieves this. The present invention is based on such knowledge and has the following gist.
(1) A liquid crystal aligning agent comprising the following component (A) and the following component (B).
Component (A): A polyimide obtained by imidizing a polyamic acid having a structural formula of a repeating unit represented by the following formula [1], and having a carboxyl group in the molecule of the polymer.
Component (B): It has one primary amino group and a nitrogen-containing aromatic heterocyclic ring in the molecule, and the primary amino group is bonded to an aliphatic hydrocarbon group or a non-aromatic cyclic hydrocarbon group. Amine compound.
(2)式[2]のX2はシクロヘキシレン又はフェニレンであり、X4は炭素数3〜6のアルキル基、炭素数3〜6のアルコキシ基、炭素数3〜6のフルオロアルキル基、又は炭素数3〜6のフルオロアルコキシ基である上記(1)に記載の液晶配向処理剤。
(3)式[1]中のR2が下記の式[3]を含む2価の有機基である上記(1)に記載の液晶配向処理剤。
(2) X 2 in formula [2] is cyclohexylene or phenylene, and X 4 is an alkyl group having 3 to 6 carbon atoms, an alkoxy group having 3 to 6 carbon atoms, a fluoroalkyl group having 3 to 6 carbon atoms, or The liquid-crystal aligning agent as described in said (1) which is a C3-C6 fluoro alkoxy group.
(3) type liquid crystal alignment treating agent according to the above [1] R 2 in is a divalent organic group containing the formula [3] (1).
(4)式[1]中のR2が下記の式[4]を含む2価の有機基である上記1に記載の液晶配向処理剤。
(4) The liquid crystal aligning agent according to the above 1, wherein R 2 in the formula [1] is a divalent organic group containing the following formula [4].
(5)(A)成分が、式[1]で表される繰り返し単位の構造式を有するポリアミド酸をイミド化させた重合体であり、該重合体の有するカルボキシル基の量が、該重合体の繰り返し単位に対する平均値で0.1〜3個である上記(1)〜(4)のいずれかに記載の液晶配向処理剤。
(6)(A)成分が、前記の式[1]で表される繰り返し単位の構造式中、繰り返し単位の一部又は全てが下記の式[5]で表される単位を有する構造式を有するポリアミド酸をイミド化させた重合体であり、該重合体の有するカルボキシル基の量が、該重合体の繰り返し単位に対する平均値で0.1〜3個である上記(1)〜(5)のいずれかに記載の液晶配向処理剤。
(5) The component (A) is a polymer obtained by imidizing polyamic acid having the structural formula of the repeating unit represented by the formula [1], and the amount of the carboxyl group of the polymer is The liquid-crystal aligning agent in any one of said (1)-(4) which is 0.1-3 by the average value with respect to the repeating unit.
(6) In the structural formula of the repeating unit represented by the formula [1], the component (A) has a structural formula in which a part or all of the repeating units have a unit represented by the following formula [5]. (1) to (5) above, wherein the polymer has an imidized polyamic acid, and the amount of carboxyl groups of the polymer is 0.1 to 3 on average with respect to the repeating unit of the polymer. The liquid-crystal aligning agent in any one of.
(7)(B)成分が、下記の式[6]で表されるアミン化合物である上記(1)〜(6)のいずれかに記載の液晶配向処理剤。
(7) The liquid-crystal aligning agent in any one of said (1)-(6) whose (B) component is an amine compound represented by following formula [6].
(8)(B)成分が、下記の式[7]で表されるアミン化合物である上記(1)〜(6)のいずれかに記載の液晶配向処理剤。
(8) The liquid-crystal aligning agent in any one of said (1)-(6) whose (B) component is an amine compound represented by following formula [7].
(9)(B)成分が、式[7]におけるY3、Y4、及びY5がそれぞれ下記に記載の基又は環から選択される組み合わせからなるアミン化合物である上記(8)に記載の液晶配向処理剤。
(9) The component (B) is an amine compound comprising a combination in which Y 3 , Y 4 , and Y 5 in the formula [7] are each selected from the following groups or rings: Liquid crystal aligning agent.
但し、Y3は、炭素数1〜10の直鎖又は分岐アルキレン基、炭素数1〜10の不飽和アルキレン基、シクロプロパン環、シクロブタン環、シクロペンタン環、シクロヘキサン環、シクロヘプタン環、シクロオクタン環、シクロノナン環、シクロデカン環、シクロウンデカン環、シクロドデカン環、シクロトリデカン環、シクロテトラデカン環、シクロペンタデカン環、シクロヘキサデカン環、シクロヘプタデカン環、シクロオクタデカン環、シクロノナデカン環、シクロイコサン環、トリシクロエイコサン環、トリシクロデコサン環、ビシクロヘプタン環、デカヒドロナフタレン環、ノルボルネン環、及びアダマンタン環からなる群から選ばれる1種である;
Y4が、単結合、−O−、−NH−、−S−、−SO2−、炭素数1〜19の炭化水素基、−CO−O−、−O−CO−、−CO−NH−、−NH−CO−、−CO−、−CF2−、−C(CF3)2−、−CH(OH)−、−C(CH3)2−、−Si(CH3)2−、−O−Si(CH3)2−、−Si(CH3)2−O−、−O−Si(CH3)2−O−、シクロプロパン環、シクロブタン環、シクロペンタン環、シクロヘキサン環、シクロヘプタン環、シクロオクタン環、シクロノナン環、シクロデカン環、シクロウンデカン環、シクロドデカン環、シクロトリデカン環、シクロテトラデカン環、シクロペンタデカン環、シクロヘキサデカン環、シクロヘプタデカン環、シクロオクタデカン環、シクロノナデカン環、シクロイコサン環、トリシクロエイコサン環、トリシクロデコサン環、ビシクロヘプタン環、デカヒドロナフタレン環、ノルボルネン環、アダマンタン環、ベンゼン環、ナフタレン環、テトラヒドロナフタレン環、アズレン環、インデン環、フルオレン環、アントラセン環、フェナントレン環、フェナレン環、ピロール環、イミダゾール環、オキサゾール環、チアゾール環、ピラゾール環、ピリジン環、ピリミジン環、キノリン環、ピラゾリン環、イソキノリン環、カルバゾール環、プリン環、チアジアゾール環、ピリダジン環、トリアジン環、ピラゾリジン環、トリアゾール環、ピラジン環、ベンズイミダゾール環、ベンゾイミダゾール環、チノリン環、フェナントロリン環、インドール環、キノキサリン環、ベンゾチアゾール環、フェノチアジン環、オキサジアゾール環、アクリジン環、オキサゾール環、ピペラジン環、ピペリジン環、ジオキサン環、及びモルフォリン環からなる群から選ばれる1種である;
Y5が、ピロール環、イミダゾール環、オキサゾール環、チアゾール環、ピラゾール環、ピリジン環、ピリミジン環、キノリン環、ピラゾリン環、イソキノリン環、カルバゾール環、プリン環、チアジアゾール環、ピリダジン環、ピラゾリン環、トリアジン環、ピラゾリジン環、トリアゾール環、ピラジン環、ベンズイミダゾール環、ベンゾイミダゾール環、チノリン環、フェナントロリン環、インドール環、キノキサリン環、ベンゾチアゾール環、フェノチアジン環、オキサジアゾール環、及びアクリジン環からなる群から選ばれる1種である。
(10)(A)成分のポリイミドの有するカルボキシル基の1モル量に対して、(B)成分を0.01〜2モル倍量の割合で含有する上記(1)〜(9)のいずれかに記載の液晶配向処理剤。
(11)(A)成分のポリイミドと(B)成分のアミン化合物とを含有する有機溶媒を加熱下に混合して得られる上記(1)〜(10)のいずれかに記載の液晶配向処理剤。
(12)上記(1)〜(11)のいずれかに記載の液晶配向処理剤から得られる液晶配向膜。
(13)上記(12)に記載の液晶配向膜を有する液晶表示素子。However, Y 3 represents a linear or branched alkylene group having 1 to 10 carbon atoms, unsaturated alkylene group having 1 to 10 carbon atoms, cyclopropane ring, cyclobutane ring, cyclopentane ring, cyclohexane ring, cycloheptane ring, cyclooctane Ring, cyclononane ring, cyclodecane ring, cycloundecane ring, cyclododecane ring, cyclotridecane ring, cyclotetradecane ring, cyclopentadecane ring, cyclohexadecane ring, cycloheptadecane ring, cyclooctadecane ring, cyclononadecane ring, cycloicosane ring, tricyclo One selected from the group consisting of an eicosane ring, a tricyclodecosan ring, a bicycloheptane ring, a decahydronaphthalene ring, a norbornene ring, and an adamantane ring;
Y 4 is a single bond, —O—, —NH—, —S—, —SO 2 —, a hydrocarbon group having 1 to 19 carbon atoms, —CO—O—, —O—CO—, —CO—NH. -, - NH-CO -, - CO -, - CF 2 -, - C (CF 3) 2 -, - CH (OH) -, - C (CH 3) 2 -, - Si (CH 3) 2 - , —O—Si (CH 3 ) 2 —, —Si (CH 3 ) 2 —O—, —O—Si (CH 3 ) 2 —O—, cyclopropane ring, cyclobutane ring, cyclopentane ring, cyclohexane ring, Cycloheptane ring, cyclooctane ring, cyclononane ring, cyclodecane ring, cycloundecane ring, cyclododecane ring, cyclotridecane ring, cyclotetradecane ring, cyclopentadecane ring, cyclohexadecane ring, cycloheptadecane ring, cyclooctadecane ring, cyclononadecane Ring, cycloicosane ring, tricycloeicosane ring, tricyclodecosan ring, bicycloheptane ring, decahydronaphthalene ring, norbornene ring, adamantane ring, benzene ring, naphthalene ring, tetrahydronaphthalene ring, azulene ring, indene ring, fluorene ring , Anthracene ring, phenanthrene ring, phenalene ring, pyrrole ring, imidazole ring, oxazole ring, thiazole ring, pyrazole ring, pyridine ring, pyrimidine ring, quinoline ring, pyrazoline ring, isoquinoline ring, carbazole ring, purine ring, thiadiazole ring, pyridazine Ring, triazine ring, pyrazolidine ring, triazole ring, pyrazine ring, benzimidazole ring, benzimidazole ring, thionoline ring, phenanthroline ring, indole ring, quinoxaline ring, benzothiazole ring, One selected from the group consisting of an enothiazine ring, an oxadiazole ring, an acridine ring, an oxazole ring, a piperazine ring, a piperidine ring, a dioxane ring, and a morpholine ring;
Y 5 is a pyrrole ring, imidazole ring, oxazole ring, thiazole ring, pyrazole ring, pyridine ring, pyrimidine ring, quinoline ring, pyrazoline ring, isoquinoline ring, carbazole ring, purine ring, thiadiazole ring, pyridazine ring, pyrazoline ring, triazine From the group consisting of ring, pyrazolidine ring, triazole ring, pyrazine ring, benzimidazole ring, benzimidazole ring, thioline ring, phenanthroline ring, indole ring, quinoxaline ring, benzothiazole ring, phenothiazine ring, oxadiazole ring, and acridine ring One kind to be chosen.
(10) Any one of (1) to (9) above, wherein the component (B) is contained in an amount of 0.01 to 2 moles per 1 mole of the carboxyl group of the component (A) polyimide. Liquid crystal aligning agent as described in.
(11) Liquid crystal aligning agent in any one of said (1)-(10) obtained by mixing the organic solvent containing the polyimide of (A) component, and the amine compound of (B) component under a heating. .
(12) A liquid crystal alignment film obtained from the liquid crystal aligning agent according to any one of (1) to (11).
(13) A liquid crystal display device having the liquid crystal alignment film according to (12).
本発明の液晶配向処理剤は比較的簡便な方法で得ることができる。また、本発明の液晶配向処理剤は、液晶配向膜にした際に、液晶のプレチルト角を大きくする特性を有しており、少ない使用割合でも液晶を垂直に配向させることができる。また、液晶配向処理剤の塗布液に貧溶媒を混合したときにも析出が発生しにくい。さらに、電圧保持率が高く、かつ高温下に長時間曝された後であっても、直流電圧により蓄積する残留電荷の緩和が速い液晶配向膜を得ることができる。
また、本発明の液晶配向処理剤から得られた液晶配向膜を有する液晶表示素子は、信頼性に優れたものとなり、大画面で高精細の液晶テレビなどに好適に利用できる。The liquid crystal aligning agent of the present invention can be obtained by a relatively simple method. Moreover, the liquid crystal aligning agent of this invention has the characteristic which enlarges the pretilt angle of a liquid crystal, when it makes it a liquid crystal aligning film, and can align a liquid crystal vertically even with a small usage rate. Also, precipitation is unlikely to occur when a poor solvent is mixed in the liquid crystal aligning agent coating solution. Furthermore, it is possible to obtain a liquid crystal alignment film that has a high voltage holding ratio and can quickly relieve residual charges accumulated by a DC voltage even after being exposed to a high temperature for a long time.
Moreover, the liquid crystal display element which has the liquid crystal aligning film obtained from the liquid-crystal aligning agent of this invention becomes the thing excellent in reliability, and can be suitably utilized for a high-definition liquid crystal television etc. with a large screen.
本発明の液晶配向処理剤は、(A)成分である、前記の式[1]で表される繰り返し単位の構造式を有するポリアミド酸をイミド化させた重合体であり、該重合体の分子内にカルボキシル基を有するポリイミド(以下、特定ポリイミドと称することもある。)、及び(B)成分である、分子内にアミノ基を1個と窒素含有芳香族複素環とを有し、かつ前記アミノ基が脂肪族炭化水素基又は非芳香族系環式炭化水素基に結合しているアミン化合物(以下、特定アミン化合物と称することもある。)を含有する液晶配向処理剤である。なお、本明細書において、上記したアミノ基(−NH2)は1級アミノ基と同義であり、以下1級アミノ基とも言う。The liquid-crystal aligning agent of this invention is a polymer which imidated the polyamic acid which has structural formula of the repeating unit represented by said Formula [1] which is (A) component, and is a molecule | numerator of this polymer A polyimide having a carboxyl group therein (hereinafter also referred to as a specific polyimide), and (B) component having one amino group and a nitrogen-containing aromatic heterocyclic ring in the molecule, and It is a liquid crystal aligning agent containing an amine compound (hereinafter also referred to as a specific amine compound) in which an amino group is bonded to an aliphatic hydrocarbon group or a non-aromatic cyclic hydrocarbon group. In the present specification, the above-described amino group (—NH 2 ) is synonymous with a primary amino group, and is hereinafter also referred to as a primary amino group.
本発明の液晶配向処理剤における特定ポリイミドは、側鎖にプレチルト角を大きくする特性がある置換基を有する特定ジアミン(以下、特定ジアミンと称することもある。)を原料に用いる。そのため、この特定ジアミンを使用した場合、得られる液晶配向処理剤が、少ない使用割合でも液晶を垂直に配向させることができる。また、使用割合を少なくすることで、重合体の有機溶媒溶解性が高くなり、液晶配向処理剤の塗布液に貧溶媒を混合したときにも析出が発生しにくい。 The specific polyimide in the liquid crystal aligning agent of the present invention uses, as a raw material, a specific diamine having a substituent having a characteristic of increasing the pretilt angle in the side chain (hereinafter also referred to as a specific diamine). Therefore, when this specific diamine is used, the obtained liquid crystal aligning agent can align a liquid crystal vertically even with a small use ratio. Further, by reducing the use ratio, the solubility of the polymer in the organic solvent increases, and precipitation hardly occurs even when a poor solvent is mixed in the coating liquid for the liquid crystal alignment treatment agent.
本発明の液晶配向処理剤において、特定アミン化合物中のアミノ基は、特定ポリイミド中のカルボキシル基と塩形成をしているか、特定ポリイミド中のカルボキシル基やカルボキシエステル基に対して水又はアルコールの脱離を伴うアミド結合をしているか、特定ポリイミド中のイミド基に対してイミド基の開環を伴う結合反応をしていると考えられる。更に、液晶配向膜を作製する際の焼成工程によって、特定ポリイミド中のカルボキシル基と塩形成をしているアミノ基は、水の脱離によりアミド結合を形成すると考えられる。その結果、本発明の液晶配向処理剤は、有機溶媒中で混合するという簡便な手段にも係わらず、得られる液晶配向膜中では、特定アミン化合物と特定ポリイミドとが効率良く結合していると考える。 In the liquid crystal aligning agent of the present invention, the amino group in the specific amine compound forms a salt with the carboxyl group in the specific polyimide, or water or alcohol is removed from the carboxyl group or carboxy ester group in the specific polyimide. It is thought that it has an amide bond accompanied by separation or a bonding reaction involving ring opening of the imide group with respect to the imide group in the specific polyimide. Furthermore, it is considered that the amino group that forms a salt with the carboxyl group in the specific polyimide forms an amide bond by elimination of water in the baking step in producing the liquid crystal alignment film. As a result, the liquid crystal aligning agent of the present invention is efficiently combined with the specific amine compound and the specific polyimide in the obtained liquid crystal alignment film despite the simple means of mixing in an organic solvent. Think.
一方、特定アミン化合物中の窒素含有芳香族複素環は、その共役構造により電子のホッピングサイトとして機能するので、得られる液晶配向膜中の電荷の移動を促進する。また、液晶配向膜とした際に、窒素含有芳香族複素環と特定ポリイミド中のカルボキシル基とが塩形成や水素結合といった静電的相互作用で結ばれることで、特定ポリイミド中のカルボキシル基と特定アミン化合物中の窒素含有芳香族複素環との間で電荷の移動が起こる。更には、この特定アミン化合物は特定ポリイミドと化学結合しているため、窒素含有芳香族複素環部位に移動した電荷は、ポリイミド分子内や分子間を効率的に移動することができる。 On the other hand, the nitrogen-containing aromatic heterocycle in the specific amine compound functions as an electron hopping site due to its conjugated structure, and therefore promotes the movement of charges in the obtained liquid crystal alignment film. In addition, when the liquid crystal alignment film is used, the nitrogen-containing aromatic heterocycle and the carboxyl group in the specific polyimide are linked by an electrostatic interaction such as salt formation or hydrogen bond, so that the specific carboxyl group in the specific polyimide is identified. Charge transfer occurs between the nitrogen-containing aromatic heterocycle in the amine compound. Furthermore, since the specific amine compound is chemically bonded to the specific polyimide, the charge transferred to the nitrogen-containing aromatic heterocyclic moiety can efficiently move within and between the polyimide molecules.
以上のことにより、本発明の液晶配向処理剤は、液晶配向膜にした際、液晶のプレチルト角を大きくする特性を有しており、少ない使用割合でも液晶を垂直に配向させることができる。また、液晶配向処理剤の塗布液に貧溶媒を混合したときにも析出が発生しにくい。さらに、電圧保持率が高く、かつ高温下に長時間曝された後であっても、直流電圧により蓄積する残留電荷の緩和が速い液晶配向膜を得ることができる。 As described above, the liquid crystal aligning agent of the present invention has the property of increasing the pretilt angle of the liquid crystal when formed into a liquid crystal alignment film, and can align the liquid crystal vertically even with a small use ratio. In addition, precipitation is unlikely to occur when a poor solvent is mixed in the liquid crystal aligning agent coating solution. Furthermore, it is possible to obtain a liquid crystal alignment film that has a high voltage holding ratio and can quickly relieve residual charges accumulated by a DC voltage even after being exposed to a high temperature for a long time.
<(A)成分/特定ポリイミド>
本発明において、(A)成分である特定ポリイミドは、式[1]で表される繰り返し単位の構造式を有するポリアミド酸をイミド化させた重合体であり、該重合体の分子内にカルボキシル基を有するポリイミドであればその構造は特に限定されない。このポリイミドは、テトラカルボン酸二無水物とジアミンとを原料とすることで比較的簡便に得られるために、式[1]で表される繰り返し単位の構造式を有するポリアミド酸をイミド化させた重合体が好ましい。<(A) component / specific polyimide>
In the present invention, the specific polyimide as the component (A) is a polymer obtained by imidizing polyamic acid having the structural formula of the repeating unit represented by the formula [1], and a carboxyl group is present in the molecule of the polymer. The structure is not particularly limited as long as it has polyimide. Since this polyimide can be obtained relatively simply by using tetracarboxylic dianhydride and diamine as raw materials, a polyamic acid having a structural formula of a repeating unit represented by the formula [1] is imidized. Polymers are preferred.
式[2]中、X1はフェニレンであり、X2はシクロヘキシレン又はフェニレンであり、X3はシクロヘキシレンである。フェニレン又はシクロヘキシレンには、必要に応じて置換基を有していてもよい。X4は炭素数3〜12、好ましくは3〜6のアルキル基、炭素数3〜12、好ましくは3〜6のアルコキシ基、炭素数3〜12、好ましくは3〜6のフルオロアルキル基、又は炭素数3〜12、好ましくは3〜6のフルオロアルコキシ基である。アルキル基、フルオロアルキル基、アルコキシ基、及びフルオロアルコキシ基は直鎖状又は分岐状でもよいが、直鎖状が好ましく、また、適宜の置換基を有していてもよい。In the formula [2], X 1 is phenylene, X 2 is cyclohexylene or phenylene, and X 3 is cyclohexylene. Phenylene or cyclohexylene may have a substituent as necessary. X 4 is an alkyl group having 3 to 12 carbon atoms, preferably 3 to 6 carbon atoms, an alkoxy group having 3 to 12 carbon atoms, preferably 3 to 6 carbon atoms, a fluoroalkyl group having 3 to 12 carbon atoms, preferably 3 to 6 carbon atoms, or A fluoroalkoxy group having 3 to 12 carbon atoms, preferably 3 to 6 carbon atoms. The alkyl group, fluoroalkyl group, alkoxy group, and fluoroalkoxy group may be linear or branched, but are preferably linear, and may have an appropriate substituent.
式[2]中の主鎖のベンゼン環におけるアミノ基の結合位置は限定されない。具体例としては、下記の式[8]におけるZ1に対して、2,3の位置、2,4の位置、2,5の位置、2,6の位置、3,4の位置、3,5の位置が挙げられる。なかでも、ポリアミック酸を合成する際の反応性の観点から、2,4の位置、2,5の位置、3,5の位置が好ましい。ジアミン合成の容易性も加味すると、2,4の位置、又は2,5の位置が好ましい。The bonding position of the amino group in the benzene ring of the main chain in the formula [2] is not limited. As specific examples, with respect to Z 1 in the following formula [8], positions 2, 3; positions 2, 4; positions 2, 5; positions 2, 6; positions 3, 4; 5 positions. Among these, from the viewpoint of reactivity when synthesizing a polyamic acid, the positions 2, 4, 2, 5, and 3, 5 are preferable. Considering the ease of diamine synthesis, the positions 2, 4 or 2, 5 are preferred.
式[2]の中でも、X1が1,4−フェニレンが好ましい。また、X2は、1,4−フェニレン又は1,4−シクロへキシレンが好ましく、より好ましいのは、1,4−フェニレン又は1,4−トランス−シクロへキシレンであり、特には、1,4−トランス−シクロへキシレンが好ましい。また、X3は1,4−シクロへキシレンが好ましく、特には、1,4−トランス−シクロへキシレンが好ましい。Among the formulas [2], X 1 is preferably 1,4-phenylene. X 2 is preferably 1,4-phenylene or 1,4-cyclohexylene, more preferably 1,4-phenylene or 1,4-trans-cyclohexylene. 4-trans-cyclohexylene is preferred. X 3 is preferably 1,4-cyclohexylene, particularly 1,4-trans-cyclohexylene.
本発明の式[2]で表される構造の好ましい具体例は以下の通りである。なお、下記の式[9]〜[12]中のnは、それぞれ独立して2〜11の整数が好ましく、2〜6の整数が特に好ましい。また、式中の1,4−シクロへキシレンのシス−トランス異性は、それぞれトランス異性体である。 Preferred specific examples of the structure represented by the formula [2] of the present invention are as follows. In addition, n in the following formulas [9] to [12] is each independently preferably an integer of 2 to 11, particularly preferably an integer of 2 to 6. Moreover, the cis-trans isomerism of 1,4-cyclohexylene in the formula is a trans isomer.
式[13]で表されるジアミンを製造する方法は特に限定されないが、好ましい方法としては以下の方法が挙げられる。
Although the method of manufacturing diamine represented by Formula [13] is not specifically limited, The following method is mentioned as a preferable method.
式[14]のジニトロ化合物を合成し、通常の方法でニトロ基を還元してアミノ基に変換することで得られる。
式[14]のジニトロ化合物は、下記の式[15]で表わされる水酸基含有化合物とジニトロクロロベンゼンなどとの反応により得ることができる。
It is obtained by synthesizing a dinitro compound of the formula [14] and reducing the nitro group to convert it to an amino group by a usual method.
The dinitro compound of the formula [14] can be obtained by reacting a hydroxyl group-containing compound represented by the following formula [15] with dinitrochlorobenzene or the like.
式[3]、[4]、及び[9]〜[12]の構造を含む特定ポリイミドも、上記と同様の手法で得ることができる。
式[1]中においてR1及びR2はそれぞれ1種類であっても、それぞれ異なったR1及びR2を有し、繰り返し単位として異なった複数種を組み合わせたものでもよい。
液晶のプレチルト角を大きくするという目的では、式[2]の構造を1モル%以上用いることが好ましい。液晶を垂直に配向させるという目的では、10モル%以上用いることが好ましく、より好ましくは、15モル%以上である。式[3]、[4]、及び[9]〜[12]の構造を含む特定ポリイミドも同様である。
特定ポリイミドは、上記ポリアミド酸をイミド化させる際のイミド化率を通常は100%未満に制御することで得ることができる。
The specific polyimide containing the structures of the formulas [3], [4], and [9] to [12] can also be obtained by the same method as described above.
In the formula [1], R 1 and R 2 may be one type or may have different R 1 and R 2 and a combination of different types as repeating units.
For the purpose of increasing the pretilt angle of the liquid crystal, it is preferable to use 1 mol% or more of the structure of the formula [2]. For the purpose of aligning the liquid crystal vertically, it is preferably used in an amount of 10 mol% or more, more preferably 15 mol% or more. The same applies to the specific polyimide containing the structures of the formulas [3], [4], and [9] to [12].
The specific polyimide can be obtained by controlling the imidization ratio when imidating the polyamic acid to usually less than 100%.
また、特定ポリイミドは、式[1]で表される繰り返し単位の構造式中に、繰り返し単位に下記の式[5]で表される構造単位を含むポリアミド酸をイミド化することでも得ることができる。 The specific polyimide can also be obtained by imidizing a polyamic acid containing a structural unit represented by the following formula [5] in the repeating unit in the structural formula of the repeating unit represented by the formula [1]. it can.
その際、イミド化率は100%であってもよい。
特定ポリイミドのイミド化率は、高い電圧保持率が得られるという理由から20%以上であることが好ましく、より好ましくは40%以上である。
特定ポリイミド中のカルボキシル基の量は、本発明の効果が効率よく得られるという理由から、ポリイミドとしての構造式の繰り返し単位に対する平均値で0.1〜3個であることが好ましく、より好ましくは0.3〜2.0個であり、特に好ましくは0.5〜1.8個である。この場合の繰り返し単位とは、イミド化されていないアミド酸基を含んでいる単位も合わせたものである。例えば、式[1]で表される繰り返し単位からなるポリアミド酸をイミド化して得られるポリイミドの場合、イミド化率が100%未満では下記の式[16a]〜[16d]の構造の組合せから構成されることが考えられるが、上記でカルボキシル基の量を算出する場合の繰り返し単位には式[16a]〜[16d]の全てが含まれる。
At that time, the imidization ratio may be 100%.
The imidization ratio of the specific polyimide is preferably 20% or more, and more preferably 40% or more, because a high voltage holding ratio can be obtained.
The amount of the carboxyl group in the specific polyimide is preferably 0.1 to 3, more preferably an average value with respect to the repeating unit of the structural formula as a polyimide, because the effect of the present invention can be obtained efficiently. 0.3 to 2.0, and particularly preferably 0.5 to 1.8. The repeating unit in this case is a combination of units containing an imidized amic acid group. For example, in the case of a polyimide obtained by imidizing a polyamic acid composed of a repeating unit represented by the formula [1], when the imidization ratio is less than 100%, the composition is composed of a combination of the structures of the following formulas [16a] to [16d]. Although it is conceivable that the repeating unit for calculating the amount of carboxyl group as described above includes all of the formulas [16a] to [16d].
本発明において、特定ポリイミド中のカルボキシル基の量(以下、カルボキシル基の平均値ともいう。)は、下記(i)のPと、(ii)のQとの和として求められる。
(i)イミド化していないアミド酸由来のカルボキシル基の、ポリイミドとしての構造式の繰り返し単位に対する平均値:P
(ii)前記式[5]のR3、R4に含まれるカルボキシル基の、ポリイミドとしての構造式の繰り返し単位に対する平均値:Q
そして、上記(i)のPは、イミド化率(z)を用いて下記の式(1)から算出できる。なお、イミド化率(z)は、例えば、後記する<イミド化率の測定>から求められる。
P=2×(1−z/100) (1)
一方、上記(ii)のQは、式[5]のR3に含まれるカルボキシル基の、ポリイミドとしての構造式の繰り返し単位に対する平均値:Q1と、R4に含まれるカルボキシル基の、ポリイミドとしての構造式の繰り返し単位に対する平均値:Q2との和で求められる。
上記のR3、R4は、それぞれ、特定ポリイミドを得るために用いる原料の1部又は全部であるテトラカルボン酸二無水物残基(R3)、ジアミン残基(R4)である。
そのため、上記Q1は、特定ポリイミドを得るために用いるテトラカルボン酸二無水物の合計モル量中における下記の式[V1]で表されるテトラカルボン酸二無水物のモル分率を用いて、下記の式(2)から算出される。In the present invention, the amount of the carboxyl group in the specific polyimide (hereinafter also referred to as the average value of the carboxyl group) is determined as the sum of P in (i) below and Q in (ii).
(I) Average value of carboxyl group derived from unimided amide acid with respect to repeating unit of structural formula as polyimide: P
(Ii) Average value of the carboxyl groups contained in R 3 and R 4 of the formula [5] with respect to the repeating unit of the structural formula as polyimide: Q
And P of said (i) is computable from following formula (1) using imidation rate (z). In addition, the imidation rate (z) is calculated | required from <measurement of an imidation rate> mentioned later, for example.
P = 2 × (1−z / 100) (1)
On the other hand, Q in the above (ii) is an average value of the carboxyl group contained in R 3 of the formula [5] with respect to the repeating unit of the structural formula as polyimide: Q 1 and the polyimide of the carboxyl group contained in R 4 mean values for structural formula repeating units as: determined by the sum of the Q 2.
Said R < 3 >, R < 4 > is the tetracarboxylic dianhydride residue (R < 3 >) and the diamine residue (R < 4 >) which are 1 part or all of the raw material used in order to obtain a specific polyimide, respectively.
Therefore, the above Q 1 uses the molar fraction of the tetracarboxylic dianhydride represented by the following formula [V1] in the total molar amount of the tetracarboxylic dianhydride used to obtain the specific polyimide, It is calculated from the following equation (2).
Q1=β1×W1/W2 (2)
ここで、β1はR3に含有されるカルボキシル基の個数を表し、W1は式[V1]のテトラカルボン酸二無水物のモル量であり、W2はテトラカルボン酸二無水物の合計モル量を表す。
また、上記Q2は、特定ポリイミドを得るために用いるジアミンの合計モル量における下記の式[V2]で表されるジアミンのモル分率を用いて、下記の式(3)から算出される。
Q 1 = β 1 × W 1 / W 2 (2)
Here, β 1 represents the number of carboxyl groups contained in R 3 , W 1 is the molar amount of tetracarboxylic dianhydride of the formula [V1], and W 2 is the total of tetracarboxylic dianhydrides. Represents molar amount.
Further, the Q 2 are using the molar fraction of the diamine represented by the formula [V2] below in the total molar amount of the diamine used to obtain a specific polyimide, is calculated from the following equation (3).
Q2=β2×W3/W4 (3)
ここで、β2はR4に含有されるカルボキシル基の個数を表し、W3は式[V2]で表されるジアミンのモル量であり、W4はジアミンの合計モル量を表す。
かくして、カルボキシル基の量は下記の式(4)で求められる。
特定ポリイミド中のカルボキシル基の量
=P+Q1+Q2
=2×(1−z/100)+β1×W1/W2+β2×W3/W4 (4)
Q 2 = β 2 × W 3 / W 4 (3)
Here, β 2 represents the number of carboxyl groups contained in R 4 , W 3 represents the molar amount of the diamine represented by the formula [V2], and W 4 represents the total molar amount of the diamine.
Thus, the amount of the carboxyl group can be obtained by the following formula (4).
Amount of carboxyl group in specific polyimide = P + Q 1 + Q 2
= 2 × (1−z / 100) + β 1 × W 1 / W 2 + β 2 × W 3 / W 4 (4)
本発明において、特定ポリイミド中のカルボキシル基の量の調整は、
(1)イミド化率を制御することで調整する手段、
(2)式[5]のR3又はR4に含まれるカルボキシル基の数、及び式[1]で表される繰り返し単位の構造式中における式[5]の比率によって調整する手段、
のいずれであってもよい。更に、(1)と(2)の手段を併用することもできる。In the present invention, adjustment of the amount of carboxyl group in the specific polyimide,
(1) Means for adjusting by controlling the imidization rate,
(2) Means of adjusting by the number of carboxyl groups contained in R 3 or R 4 of formula [5] and the ratio of formula [5] in the structural formula of the repeating unit represented by formula [1],
Any of these may be used. Furthermore, the means (1) and (2) can be used in combination.
式[1]におけるR1およびR2の選択の自由度という観点から(1)の手段が好ましい。特定ポリイミドのイミド化率の選択の自由度という観点から(2)の手段が好ましい。また、液晶配向膜を作製する際の焼成工程によるイミド化反応によって、特定アミン化合物が脱離する又はポリイミド鎖が切断されるといった可能性が少ないという観点から(2)の手段が好ましい。From the viewpoint of the degree of freedom in selecting R 1 and R 2 in the formula [1], the means (1) is preferable. From the viewpoint of the degree of freedom in selecting the imidization ratio of the specific polyimide, the means (2) is preferable. The means (2) is preferred from the viewpoint that the specific amine compound is not likely to be detached or the polyimide chain is cleaved by the imidization reaction in the baking step when the liquid crystal alignment film is produced.
上記(1)の手段によって特定ポリイミド中のカルボキシル基の量を調整する場合は、式[1]におけるR1及びR2は特に限定されない。また、R1及びR2は式[1]中においてそれぞれ1種類であっても、それぞれ異なったR1及びR2の構造を有し、繰り返し単位として異なった複数種を組み合わせたものでもよい。
式[1]におけるR1の具体例を挙げるとすれば以下の通りである。When adjusting the amount of carboxyl groups in a particular polyimide by means of (1), R 1 and R 2 in the formula [1] is not particularly limited. In addition, R 1 and R 2 may each be one type in the formula [1], or may have different R 1 and R 2 structures, and a combination of different types as repeating units.
Specific examples of R 1 in the formula [1] are as follows.
また、R1の10モル%以上が、A−1〜A−25のように脂環式構造又は脂肪族構造を有する場合は電圧保持率が向上するので好ましい。特に、R1がA−1、A−16、A−19から選ばれる2種類を併用したものは、電荷の緩和がより速い液晶配向膜を得ることができるので好ましい。
式[1]において、R2は、式[2]で示される構造以外の有機基を含んでいてもよい。その具体例を挙げるとすれば以下の通りである。Moreover, more than 10 mole% of R 1 is, if having an alicyclic structure or aliphatic structure as A-1 to A-25 preferably improved voltage holding ratio. In particular, those in which R 1 is used in combination of two types selected from A-1, A-16, and A-19 are preferable because a liquid crystal alignment film with faster charge relaxation can be obtained.
In the formula [1], R 2 may contain an organic group other than the structure represented by the formula [2]. Specific examples are as follows.
(B−112及びB−113において、Qは−COO−,−OCO−,−CONH−,−NHCO−,−CH2−,−O−,−CO−,−NH−のいずれかを表す。)
前記(2)の手段によって特定ポリイミド中のカルボキシル基の量を調整する場合、R3又はR4のいずれかにカルボキシル基を有していればその構造は特に限定されない。また、カルボキシル基の数は、R3及びR4にそれぞれ0〜2個(ただし、R3又はR4のいずれか一方には少なくとも1個のカルボキシル基を有する。)が好ましい。(In B-112 and B-113, Q represents any of —COO—, —OCO—, —CONH—, —NHCO—, —CH 2 —, —O—, —CO—, —NH—. )
When the amount of the carboxyl group in the specific polyimide is adjusted by the means (2), the structure is not particularly limited as long as it has a carboxyl group in either R 3 or R 4 . The number of carboxyl groups is preferably 0 to 2 for R 3 and R 4 (however, either one of R 3 or R 4 has at least one carboxyl group).
ポリイミドの合成容易性、および原料の入手性の観点からはR4にカルボキシル基を有している方が好ましい。カルボキシル基を有するR4としては、B−102〜B−113が挙げられる。その際、カルボキシル基を有するR4は1種類であっても2種類以上を併用していてもよい。また、R4がカルボキシル基を有している場合にはR3の構造は特に限定されず、具体例としてはA−1〜A−45を挙げることができる。From the viewpoint of easy synthesis of polyimide and availability of raw materials, it is preferable that R 4 has a carboxyl group. Examples of R 4 having a carboxyl group include B-102 to B-113. At that time, R 4 may also be used in combination of two or more even one having a carboxyl group. Further, when R 4 has a carboxyl group, the structure of R 3 is not particularly limited, and specific examples include A-1 to A-45.
<特定ポリイミドの製造方法>
本発明に用いる(A)成分である特定ポリイミドの製造方法は特に限定されないが、一般的には、テトラカルボン酸及びその誘導体から選ばれる1種又は複数種からなるテトラカルボン酸成分と、1種又は複数種のジアミン化合物からなるジアミン成分とを反応して、式[1]で表される繰り返し単位の構造式を有するポリアミド酸を合成し、該ポリアミド酸をイミド化してポリイミドとする方法が用いられる。
その際、得られるポリアミド酸は、原料であるテトラカルボン酸成分とジアミン成分を適宜選択することによって単独重合体(ホモポリマー)又は共重合体(コポリマー)とすることができる。
ここで言うところのテトラカルボン酸及びその誘導体とは、テトラカルボン酸、テトラカルボン酸ジハライド又はテトラカルボン酸二無水物である。なかでも、テトラカルボン酸二無水物はジアミン化合物との反応性が高いので好ましい。<Production method of specific polyimide>
Although the manufacturing method of the specific polyimide which is (A) component used for this invention is not specifically limited, In general, the tetracarboxylic acid component which consists of 1 type or multiple types chosen from tetracarboxylic acid and its derivative (s), and 1 type Alternatively, a method is used in which a polyamic acid having a structural formula of a repeating unit represented by the formula [1] is synthesized by reacting with a diamine component composed of a plurality of types of diamine compounds, and the polyamic acid is imidized to form a polyimide. It is done.
In that case, the obtained polyamic acid can be made into a homopolymer (homopolymer) or a copolymer (copolymer) by appropriately selecting a tetracarboxylic acid component and a diamine component as raw materials.
The term “tetracarboxylic acid” and derivatives thereof as used herein refers to tetracarboxylic acid, tetracarboxylic acid dihalide, or tetracarboxylic dianhydride. Of these, tetracarboxylic dianhydrides are preferred because of their high reactivity with diamine compounds.
以下に、特定ポリイミドの製造方法の具体例を示す。
例えば、式[18]で表されるテトラカルボン酸二無水物から選ばれる少なくとも一種を含むテトラカルボン酸成分と、式[19]で表されるジアミン化合物から選ばれる少なくとも一種を含むジアミン成分とを、N−メチルピロリドン、N,N’−ジメチルアセトアミド、N,N’−ジメチルホルムアミド、γ-ブチロラクトンなどの有機溶媒中で重縮合反応させてポリアミド酸を得ることができる。Below, the specific example of the manufacturing method of specific polyimide is shown.
For example, a tetracarboxylic acid component containing at least one selected from tetracarboxylic dianhydrides represented by the formula [18] and a diamine component containing at least one selected from diamine compounds represented by the formula [19] Polyamide acid can be obtained by polycondensation reaction in an organic solvent such as N-methylpyrrolidone, N, N′-dimethylacetamide, N, N′-dimethylformamide, and γ-butyrolactone.
その際、反応温度は、−20℃から150℃の任意の温度を選択することができるが、好ましくは−5℃から100℃の範囲である。
テトラカルボン酸成分を構成する化合物の合計モル数と、ジアミン成分を構成するジアミン化合物の合計モル数との比は、好ましくは0.8:1〜1.2:1、特に好ましくは0.9:1〜1.1:1である。このモル比が1.0に近いほど生成する重合体の重合度は大きくなる。
In this case, the reaction temperature can be selected from -20 ° C to 150 ° C, preferably in the range of -5 ° C to 100 ° C.
The ratio between the total number of moles of the compound constituting the tetracarboxylic acid component and the total number of moles of the diamine compound constituting the diamine component is preferably 0.8: 1 to 1.2: 1, particularly preferably 0.9. : 1 to 1.1: 1. The closer this molar ratio is to 1.0, the greater the degree of polymerization of the polymer produced.
また、式[1]で表される繰り返し単位の構造式中に、繰り返し単位の一部又は全てに式[5]で表される単位を有するポリアミド酸を得るためには、R1にカルボキシル基を有するテトラカルボン酸二無水物及び/又はR2にカルボキシル基を有するジアミンを使用すればよい。
ポリアミド酸をイミド化させる方法としては、加熱による熱イミド化、触媒を使用する触媒イミド化が一般的であるが、比較的低温でイミド化反応が進行する触媒イミド化の方が、得られるポリイミドの分子量低下が起こりにくく好ましい。In addition, in order to obtain a polyamic acid having a unit represented by the formula [5] in a part or all of the repeating units in the structural formula of the repeating unit represented by the formula [1], a carboxyl group is added to R 1. A tetracarboxylic dianhydride having a diamine and / or a diamine having a carboxyl group at R 2 may be used.
As a method for imidizing polyamic acid, thermal imidization by heating and catalyst imidization using a catalyst are generally used, but the catalyst imidation in which the imidization reaction proceeds at a relatively low temperature is obtained. It is preferable that the molecular weight does not decrease.
触媒イミド化は、ポリアミド酸を有機溶媒中において、塩基性触媒と酸無水物の存在下で攪拌することにより行うことができる。このときの反応温度は−20〜250℃、好ましくは0〜180℃である。反応温度が高い方がイミド化は早く進行するが、高すぎるとポリイミドの分子量が低下する場合がある。塩基性触媒の量はアミド酸基の0.5〜30モル倍、好ましくは2〜20モル倍であり、酸無水物の量はアミド酸基の1〜50モル倍、好ましくは3〜30モル倍である。塩基性触媒や酸無水物の量が少ないと反応が十分に進行せず、また多すぎると反応終了後に完全に除去することが困難となる。この場合に用いる塩基性触媒としてはピリジン、トリエチルアミン、トリメチルアミン、トリブチルアミン、トリオクチルアミンなどを挙げることができ、中でもピリジンは反応を進行させるのに適度な塩基性を持つので好ましい。また、酸無水物としては無水酢酸、無水トリメリット酸、無水ピロメリット酸などを挙げることができ、中でも無水酢酸を用いると反応終了後の精製が容易となるので好ましい。有機溶媒としては、ポリアミド酸が溶解するものであれば限定されないが、その具体例を挙げるならば、N,N’−ジメチルホルムアミド、N,N’−ジメチルアセトアミド、N−メチル−2−ピロリドン、N−メチルカプロラクタム、ジメチルスルホキシド、テトラメチル尿素、ジメチルスルホン、ヘキサメチルスルホキシド、γ−ブチロラクトンなどを挙げることができる。触媒イミド化によるイミド化率は、触媒量と反応温度、反応時間を調節することにより制御することができる。 Catalytic imidation can be performed by stirring polyamic acid in an organic solvent in the presence of a basic catalyst and an acid anhydride. The reaction temperature at this time is -20-250 degreeC, Preferably it is 0-180 degreeC. The higher the reaction temperature, the faster the imidization proceeds, but if it is too high, the molecular weight of the polyimide may decrease. The amount of the basic catalyst is 0.5 to 30 mol times, preferably 2 to 20 mol times of the amidic acid group, and the amount of the acid anhydride is 1 to 50 mol times, preferably 3 to 30 mol of the amido acid group. Is double. If the amount of the basic catalyst or acid anhydride is small, the reaction does not proceed sufficiently. If the amount is too large, it becomes difficult to completely remove the reaction after completion of the reaction. Examples of the basic catalyst used in this case include pyridine, triethylamine, trimethylamine, tributylamine, trioctylamine and the like. Among them, pyridine is preferable because it has an appropriate basicity for proceeding with the reaction. Examples of the acid anhydride include acetic anhydride, trimellitic anhydride, pyromellitic anhydride, and the like. Among them, use of acetic anhydride is preferable because purification after completion of the reaction is facilitated. The organic solvent is not limited as long as the polyamic acid is soluble, and specific examples thereof include N, N′-dimethylformamide, N, N′-dimethylacetamide, N-methyl-2-pyrrolidone, Examples thereof include N-methylcaprolactam, dimethyl sulfoxide, tetramethyl urea, dimethyl sulfone, hexamethyl sulfoxide, and γ-butyrolactone. The imidization rate by catalytic imidation can be controlled by adjusting the amount of catalyst, reaction temperature, and reaction time.
生成したポリイミドは、上記反応溶液を貧溶媒に投入して生成した沈殿を回収することで得られる。その際、用いる貧溶媒は特に限定されないが、例えば、メタノール、アセトン、ヘキサン、ブチルセロソルブ、ヘプタン、メチルエチルケトン、メチルイソブチルケトン、エタノール、トルエン、ベンゼン、水などを挙げることができる。貧溶媒に投入して沈殿させたポリイミドは、濾過した後、常圧あるいは減圧下で、常温あるいは加熱乾燥して粉末とすることができる。そのポリイミド粉末を、更に有機溶媒に溶解して、再沈殿する操作を2〜10回繰り返すと、ポリイミドを精製することもできる。一度の沈殿回収操作では不純物が除ききれないときは、この精製工程を行うことが好ましい。 The produced polyimide can be obtained by collecting the reaction solution in a poor solvent and collecting the produced precipitate. In that case, the poor solvent to be used is not particularly limited, and examples thereof include methanol, acetone, hexane, butyl cellosolve, heptane, methyl ethyl ketone, methyl isobutyl ketone, ethanol, toluene, benzene, and water. The polyimide that has been poured into a poor solvent and precipitated is filtered, and then can be powdered by drying at normal temperature or under reduced pressure at normal temperature or under reduced pressure. The polyimide can also be refine | purified by repeating the operation which melt | dissolves the polyimide powder further in an organic solvent, and reprecipitates 2-10 times. When the impurities cannot be removed by a single precipitation recovery operation, it is preferable to perform this purification step.
本発明に用いる特定ポリイミドの分子量は特に制限されないが、取り扱いのしやすさと、膜形成した際の特性の安定性の観点から重量平均分子量で2,000〜200,000が好ましく、より好ましくは4,000〜50,000である。分子量は、GPC(ゲルパーミエッションクロマトグラフィ)により求めたものである。 The molecular weight of the specific polyimide used in the present invention is not particularly limited, but is preferably 2,000 to 200,000 in terms of weight average molecular weight, more preferably 4 from the viewpoint of easy handling and stability of characteristics when a film is formed. , 50,000 to 50,000. The molecular weight is determined by GPC (gel permeation chromatography).
<(B)成分/特定アミン化合物>
本発明に用いる(B)成分である特定アミン化合物は、分子内にアミノ基を1個と窒素含有芳香族複素環とを有し、かつ前記アミノ基が2価の脂肪族炭化水素基又は非芳香族環式炭化水素基に結合しているアミン化合物である。
この特定アミン化合物は、分子内に含まれるアミノ基が1個のみであるので、液晶配向処理剤を調製する際や液晶配向剤の保管中に、ポリマーの析出やゲル化といった問題が起こる可能性を回避できる。
特定アミン化合物に含まれる1級アミノ基は、特定ポリイミドとの塩形成や結合反応のしやすさの観点から、分子内において2価の脂肪族炭化水素基又は、芳香族炭化水素を含まない非芳香族環式炭化水素基に結合している必要がある。<(B) component / specific amine compound>
The specific amine compound as the component (B) used in the present invention has one amino group and a nitrogen-containing aromatic heterocyclic ring in the molecule, and the amino group is a divalent aliphatic hydrocarbon group or a non-valent group. It is an amine compound bonded to an aromatic cyclic hydrocarbon group.
Since this specific amine compound has only one amino group in the molecule, problems such as polymer precipitation and gelation may occur when preparing the liquid crystal aligning agent or during storage of the liquid crystal aligning agent. Can be avoided.
The primary amino group contained in the specific amine compound contains a divalent aliphatic hydrocarbon group or non-aromatic hydrocarbon in the molecule from the viewpoint of salt formation with the specific polyimide and the ease of the bonding reaction. It must be bonded to an aromatic cyclic hydrocarbon group.
脂肪族炭化水素基の具体例としては、直鎖状アルキレン基、分岐構造を有するアルキレン基、不飽和結合を有する2価の炭化水素基等を挙げることができる。脂肪族炭化水素基の炭素数は好ましくは1〜20であり、より好ましくは1〜15であり、更に好ましくは1〜10である。
2価の非芳香族環式炭化水素基の具体例としてはシクロプロパン環、シクロブタン環、シクロペンタン環、シクロヘキサン環、シクロヘプタン環、シクロオクタン環、シクロノナン環、シクロデカン環、シクロウンデカン環、シクロドデカン環、シクロトリデカン環、シクロテトラデカン環、シクロペンタデカン環、シクロヘキサデカン環、シクロヘプタデカン環、シクロオクタデカン環、シクロノナデカン環、シクロイコサン環、トリシクロエイコサン環、トリシクロデコサン環、ビシクロヘプタン環、デカヒドロナフタレン環、ノルボルネン環、アダマンタン環などが挙げられる。好ましくは炭素数が3〜20からなる環であり、より好ましくは炭素数が3〜15からなる環であり、更に好ましくは炭素数が3〜10からなる環の非芳香族環式炭化水素基である。
特定アミン化合物に含まれる窒素含有芳香族複素環は、下記の式[20a]、式[20b]及び式[20c]からなる群から選ばれる少なくとも1個の構造を含有する芳香族環式炭化水素であり、より好ましくは1個〜4個である。Specific examples of the aliphatic hydrocarbon group include a linear alkylene group, an alkylene group having a branched structure, and a divalent hydrocarbon group having an unsaturated bond. The number of carbon atoms of the aliphatic hydrocarbon group is preferably 1-20, more preferably 1-15, and still more preferably 1-10.
Specific examples of the divalent non-aromatic cyclic hydrocarbon group include cyclopropane ring, cyclobutane ring, cyclopentane ring, cyclohexane ring, cycloheptane ring, cyclooctane ring, cyclononane ring, cyclodecane ring, cycloundecane ring, cyclododecane Ring, cyclotridecane ring, cyclotetradecane ring, cyclopentadecane ring, cyclohexadecane ring, cycloheptadecane ring, cyclooctadecane ring, cyclononadecane ring, cycloicosane ring, tricycloeicosan ring, tricyclodecosan ring, bicycloheptane ring, Examples include a decahydronaphthalene ring, a norbornene ring, an adamantane ring, and the like. Preferably, it is a ring having 3 to 20 carbon atoms, more preferably a ring having 3 to 15 carbon atoms, and still more preferably a non-aromatic cyclic hydrocarbon group having 3 to 10 carbon atoms. It is.
The nitrogen-containing aromatic heterocyclic ring contained in the specific amine compound is an aromatic cyclic hydrocarbon containing at least one structure selected from the group consisting of the following formula [20a], formula [20b] and formula [20c]. And more preferably 1 to 4.
具体的には、ピロール環、イミダゾール環、オキサゾール環、チアゾール環、ピラゾール環、ピリジン環、ピリミジン環、キノリン環、ピラゾリン環、イソキノリン環、カルバゾール環、プリン環、チアジアゾール環、ピリダジン環、ピラゾリン環、トリアジン環、ピラゾリジン環、トリアゾール環、ピラジン環、ベンズイミダゾール環、ベンゾイミダゾール環、チノリン環、フェナントロリン環、インドール環、キノキサリン環、ベンゾチアゾール環、フェノチアジン環、オキサジアゾール環、アクリジン環などを挙げることができる。さらに、これら窒素含有芳香族複素環の炭素原子には、ヘテロ原子を含む置換基を有していてもよい。
より好ましい特定アミン化合物としては、下記の式[6]で表されるアミン化合物である。Specifically, pyrrole ring, imidazole ring, oxazole ring, thiazole ring, pyrazole ring, pyridine ring, pyrimidine ring, quinoline ring, pyrazoline ring, isoquinoline ring, carbazole ring, purine ring, thiadiazole ring, pyridazine ring, pyrazoline ring, List triazine ring, pyrazolidine ring, triazole ring, pyrazine ring, benzimidazole ring, benzimidazole ring, thionoline ring, phenanthroline ring, indole ring, quinoxaline ring, benzothiazole ring, phenothiazine ring, oxadiazole ring, acridine ring, etc. Can do. Furthermore, the carbon atom of these nitrogen-containing aromatic heterocycles may have a substituent containing a heteroatom.
A more preferred specific amine compound is an amine compound represented by the following formula [6].
式[6]において、Y1は脂肪族炭化水素基又は非芳香族環式炭化水素基を有する2価の有機基であれば特に限定されない。
In the formula [6], Y 1 is not particularly limited as long as Y 1 is a divalent organic group having an aliphatic hydrocarbon group or a non-aromatic cyclic hydrocarbon group.
式[6]における好ましいY1は、炭素数1〜20の脂肪族炭化水素基及び炭素数3〜20の非芳香族環式炭化水素基から選ばれる1種を有する2価の有機基である。非芳香族環式炭化水素基としては、上述した構造を挙げることができる。Y1は、より好ましくは炭素数1〜15の脂肪族炭化水素基、シクロプロパン環、シクロブタン環、シクロペンタン環、シクロヘキサン環、シクロヘプタン環、シクロオクタン環、シクロノナン環、シクロデカン環、シクロウンデカン環、シクロドデカン環、シクロトリデカン環、シクロテトラデカン環、ノルボルネン環、アダマンタン環などが挙げられる。Y1は、特に好ましくは炭素数1〜10の直鎖又は分岐アルキレン基である。Preferred Y 1 in the formula [6] is a divalent organic group having one kind selected from an aliphatic hydrocarbon group having 1 to 20 carbon atoms and a non-aromatic cyclic hydrocarbon group having 3 to 20 carbon atoms. . Examples of the non-aromatic cyclic hydrocarbon group include the structures described above. Y 1 is more preferably an aliphatic hydrocarbon group having 1 to 15 carbon atoms, cyclopropane ring, cyclobutane ring, cyclopentane ring, cyclohexane ring, cycloheptane ring, cyclooctane ring, cyclononane ring, cyclodecane ring, cycloundecane ring. , Cyclododecane ring, cyclotridecane ring, cyclotetradecane ring, norbornene ring, adamantane ring and the like. Y 1 is particularly preferably a linear or branched alkylene group having 1 to 10 carbon atoms.
また、Y1に含まれる、アミノ基に隣接しない任意の脂肪族炭化水素基又は非芳香族環式炭化水素基中の−CH2−は、−O−、−NH−、−CO−O−、−O−CO−、−CO−NH−、−NH−CO−、−CO−、−S−、−S(O)2−、−CF2−、−C(CF3)2−、−C(CH3)2−、−Si(CH3)2−、−O−Si(CH3)2−、−Si(CH3)2−O−、−O−Si(CH3)2−O−、2価の環状炭化水素基又は複素環で置き換えられてもよい。また、任意の炭素原子に結合している水素原子は、炭素数1〜20の直鎖又は分岐アルキレン基、環状炭化水素基、炭素数1〜10のフッ素含有アルキル基、複素環、フッ素原子、水酸基で置き換えられてもよい。In addition, —CH 2 — in any aliphatic hydrocarbon group or non-aromatic cyclic hydrocarbon group not adjacent to the amino group contained in Y 1 is —O—, —NH—, —CO—O—. , -O-CO -, - CO -NH -, - NH-CO -, - CO -, - S -, - S (O) 2 -, - CF 2 -, - C (CF 3) 2 -, - C (CH 3) 2 -, - Si (CH 3) 2 -, - O-Si (CH 3) 2 -, - Si (CH 3) 2 -O -, - O-Si (CH 3) 2 -O -It may be replaced by a divalent cyclic hydrocarbon group or a heterocyclic ring. Further, the hydrogen atom bonded to any carbon atom is a linear or branched alkylene group having 1 to 20 carbon atoms, a cyclic hydrocarbon group, a fluorine-containing alkyl group having 1 to 10 carbon atoms, a heterocyclic ring, a fluorine atom, It may be replaced with a hydroxyl group.
2価の環状炭化水素基の具体例としてはベンゼン環、ナフタレン環、テトラヒドロナフタレン環、アズレン環、インデン環、フルオレン環、アントラセン環、フェナントレン環、フェナレン環、シクロプロパン環、シクロブタン環、シクロペンタン環、シクロヘキサン環、シクロヘプタン環、シクロオクタン環、シクロノナン環、シクロデカン環、シクロウンデカン環、シクロドデカン環、シクロトリデカン環、シクロテトラデカン環、シクロペンタデカン環、シクロヘキサデカン環、シクロヘプタデカン環、シクロオクタデカン環、シクロノナデカン環、シクロイコサン環、トリシクロエイコサン環、トリシクロデコサン環、ビシクロヘプタン環、デカヒドロナフタレン環、ノルボルネン環、アダマンタン環などが挙げられる。 Specific examples of the divalent cyclic hydrocarbon group include a benzene ring, naphthalene ring, tetrahydronaphthalene ring, azulene ring, indene ring, fluorene ring, anthracene ring, phenanthrene ring, phenalene ring, cyclopropane ring, cyclobutane ring, cyclopentane ring. , Cyclohexane ring, cycloheptane ring, cyclooctane ring, cyclononane ring, cyclodecane ring, cycloundecane ring, cyclododecane ring, cyclotridecane ring, cyclotetradecane ring, cyclopentadecane ring, cyclohexadecane ring, cycloheptadecane ring, cyclooctadecane ring Ring, cyclononadecane ring, cycloicosane ring, tricycloeicosane ring, tricyclodecosan ring, bicycloheptane ring, decahydronaphthalene ring, norbornene ring, adamantane ring and the like.
また、2価の複素環の具体例としては、ピロール環、イミダゾール環、オキサゾール環、チアゾール環、ピラゾール環、ピリジン環、ピリミジン環、キノリン環、ピラゾリン環、イソキノリン環、カルバゾール環、プリン環、チアジアゾール環、ピリダジン環、ピラゾリン環、トリアジン環、ピラゾリジン環、トリアゾール環、ピラジン環、ベンズイミダゾール環、ベンゾイミダゾール環、チノリン環、フェナントロリン環、インドール環、キノキサリン環、ベンゾチアゾール環、フェノチアジン環、オキサジアゾール環、アクリジン環などを挙げることができる。 Specific examples of the divalent heterocyclic ring include pyrrole ring, imidazole ring, oxazole ring, thiazole ring, pyrazole ring, pyridine ring, pyrimidine ring, quinoline ring, pyrazoline ring, isoquinoline ring, carbazole ring, purine ring, thiadiazole. Ring, pyridazine ring, pyrazoline ring, triazine ring, pyrazolidine ring, triazole ring, pyrazine ring, benzimidazole ring, benzimidazole ring, tinoline ring, phenanthroline ring, indole ring, quinoxaline ring, benzothiazole ring, phenothiazine ring, oxadiazole Ring, acridine ring and the like.
式[6]におけるY2は、窒素含有芳香族複素環であり、上述したと同様に、式[20a]、式[20b]、及び式[20c]からなる群から選ばれる少なくとも1個の構造を含有する芳香族環式炭化水素である。その具体例としては、上述した構造を挙げることができる。これらのうち、ピロール環、イミダゾール環、ピラゾール環、ピリジン環、ピリミジン環、ピリダジン環、トリアジン環、トリアゾール環、ピラジン環、ベンズイミダゾール環、ベンゾイミダゾール環、キノキサリン環、アゼピン環、ジアゼピン環、ナフチリジン環、フェナジン環、フタラジン環が好ましい。Y 2 in the formula [6] is a nitrogen-containing aromatic heterocycle, and similarly to the above, at least one structure selected from the group consisting of the formula [20a], the formula [20b], and the formula [20c]. Is an aromatic cyclic hydrocarbon containing Specific examples thereof include the structure described above. Among these, pyrrole ring, imidazole ring, pyrazole ring, pyridine ring, pyrimidine ring, pyridazine ring, triazine ring, triazole ring, pyrazine ring, benzimidazole ring, benzimidazole ring, quinoxaline ring, azepine ring, diazepine ring, naphthyridine ring , A phenazine ring and a phthalazine ring are preferable.
また、窒素含有芳香族複素環と特定ポリイミド中のカルボキシル基との塩形成や水素結合といった静電的相互作用のしやすさの観点から、Y1はY2に含まれる式[20a]、式[20b]、及び式[20c]と隣り合わない置換基と結合していることが好ましい。
さらに、式[6]のY2である窒素含有芳香族複素環の炭素原子は、ハロゲン原子及び/又は有機基の置換基を有していてもよく、該有機基は酸素原子、硫黄原子、窒素原子等のヘテロ原子を含有してもよい。From the viewpoint of ease of electrostatic interaction such as salt formation and hydrogen bonding between the nitrogen-containing aromatic heterocycle and the carboxyl group in the specific polyimide, Y 1 is represented by the formula [20a] and formula contained in Y 2. It is preferably bonded to a substituent not adjacent to [20b] and formula [20c].
Furthermore, the carbon atom of the nitrogen-containing aromatic heterocyclic ring that is Y 2 in Formula [6] may have a halogen atom and / or a substituent of an organic group, and the organic group includes an oxygen atom, a sulfur atom, You may contain hetero atoms, such as a nitrogen atom.
式[6]における好ましいY1及びY2の組み合わせは、Y1が、炭素数1〜20の脂肪族炭化水素基及び炭素数3〜20の非芳香族環式炭化水素基からなる群から選ばれる1種を有する2価の有機基であり、Y2が、ピロール環、イミダゾール環、ピラゾール環、ピリジン環、ピリミジン環、ピリダジン環、トリアジン環、トリアゾール環、ピラジン環、ベンズイミダゾール環、ベンゾイミダゾール環、キノキサリン環、アゼピン環、ジアゼピン環、ナフチリジン環、フェナジン環、又はフタラジン環である。なお、Y2の窒素含有芳香族複素環の炭素原子は、ハロゲン原子及び/又は有機基の置換基を有していてもよく、該有機基は酸素原子、硫黄原子、窒素原子等のヘテロ原子を含有してもよい。
さらに好ましい特定アミン化合物としては、下記の式[7]で表されるアミン化合物である。A preferred combination of Y 1 and Y 2 in the formula [6], Y 1 is selected from the group consisting of non-aromatic cyclic hydrocarbon group having an aliphatic hydrocarbon group and having 3 to 20 carbon atoms having 1 to 20 carbon atoms Y 2 is a pyrrole ring, imidazole ring, pyrazole ring, pyridine ring, pyrimidine ring, pyridazine ring, triazine ring, triazole ring, pyrazine ring, benzimidazole ring, benzimidazole A ring, a quinoxaline ring, an azepine ring, a diazepine ring, a naphthyridine ring, a phenazine ring, or a phthalazine ring. The carbon atom of the nitrogen-containing aromatic heterocycle of Y 2 may have a halogen atom and / or a substituent of an organic group, and the organic group is a hetero atom such as an oxygen atom, a sulfur atom, or a nitrogen atom. It may contain.
A more preferred specific amine compound is an amine compound represented by the following formula [7].
式[7]におけるY3は、炭素数1〜10の2価の脂肪族炭化水素基又は非芳香族環式炭化水素基である。その具体例を挙げると、炭素数1〜10の直鎖又は分岐アルキレン基、炭素数1〜10の不飽和アルキレン基、シクロプロパン環、シクロブタン環、シクロペンタン環、シクロヘキサン環、シクロヘプタン環、シクロオクタン環、シクロノナン環、シクロデカン環、シクロウンデカン環、シクロドデカン環、シクロトリデカン環、シクロテトラデカン環、シクロペンタデカン環、シクロヘキサデカン環、シクロヘプタデカン環、シクロオクタデカン環、シクロノナデカン環、シクロイコサン環、トリシクロエイコサン環、トリシクロデコサン環、ビシクロヘプタン環、デカヒドロナフタレン環、ノルボルネン環、アダマンタン環などである。より好ましくは炭素数1〜10の直鎖又は分岐アルキレン基、シクロプロパン環、シクロブタン環、シクロペンタン環、シクロヘキサン環、シクロヘプタン環、シクロオクタン環、シクロノナン環、シクロデカン環、シクロウンデカン環、シクロドデカン環、シクロトリデカン環、シクロテトラデカン環、ノルボルネン環、アダマンタン環が挙げられる。特に好ましくは炭素数1〜10の直鎖又は分岐アルキレン基である。Y 3 in Formula [7] is a C 1-10 divalent aliphatic hydrocarbon group or non-aromatic cyclic hydrocarbon group. Specific examples thereof include a linear or branched alkylene group having 1 to 10 carbon atoms, an unsaturated alkylene group having 1 to 10 carbon atoms, a cyclopropane ring, a cyclobutane ring, a cyclopentane ring, a cyclohexane ring, a cycloheptane ring, a cyclo Octane ring, cyclononane ring, cyclodecane ring, cycloundecane ring, cyclododecane ring, cyclotridecane ring, cyclotetradecane ring, cyclopentadecane ring, cyclohexadecane ring, cycloheptadecane ring, cyclooctadecane ring, cyclononadecane ring, cycloicosane ring, trio A cycloeicosane ring, a tricyclodecosan ring, a bicycloheptane ring, a decahydronaphthalene ring, a norbornene ring, an adamantane ring, and the like. More preferably, a linear or branched alkylene group having 1 to 10 carbon atoms, cyclopropane ring, cyclobutane ring, cyclopentane ring, cyclohexane ring, cycloheptane ring, cyclooctane ring, cyclononane ring, cyclodecane ring, cycloundecane ring, cyclododecane And a ring, a cyclotridecane ring, a cyclotetradecane ring, a norbornene ring, and an adamantane ring. Particularly preferred is a linear or branched alkylene group having 1 to 10 carbon atoms.
Y3に含まれる、アミノ基に隣接しない任意の脂肪族炭化水素基又は非芳香族環式炭化水素基中の−CH2−は、−O−、−NH−、−CO−O−、−O−CO−、−CO−NH−、−NH−CO−、−CO−、−S−、−S(O)2−、−CF2−、−C(CF3)2−、−C(CH3)2−、−Si(CH3)2−、−O−Si(CH3)2−、−Si(CH3)2−O−、−O−Si(CH3)2−O−、2価の環状炭化水素基又は複素環で置き換えられてもよい。また、任意の炭素原子に結合している水素原子は、炭素数1〜20の直鎖又は分岐アルキル基、環状炭化水素基、炭素数1〜10のフッ素含有アルキル基、複素環、フッ素原子、水酸基で置き換えられてもよい。ここで言う環状炭化水素基及び複素環は、式[6]におけるY1で述べた定義と同意義である。
式[7]におけるY4は単結合、若しくは−O−、−NH−、−S−、−SO2−又は炭素数1〜19の2価の有機基である。この炭素数1〜19の2価の有機基は、炭素原子を1〜19個有する2価の有機基であり、酸素原子、窒素原子、硫黄原子、珪素原子などを含んでいてもよい。このようなY4の具体例を以下に挙げる。—CH 2 — in any aliphatic hydrocarbon group or non-aromatic cyclic hydrocarbon group not adjacent to the amino group contained in Y 3 is —O—, —NH—, —CO—O—, — O—CO—, —CO—NH—, —NH—CO—, —CO—, —S—, —S (O) 2 —, —CF 2 —, —C (CF 3 ) 2 —, —C ( CH 3) 2 -, - Si (CH 3) 2 -, - O-Si (CH 3) 2 -, - Si (CH 3) 2 -O -, - O-Si (CH 3) 2 -O-, It may be replaced with a divalent cyclic hydrocarbon group or a heterocyclic ring. Further, the hydrogen atom bonded to any carbon atom is a linear or branched alkyl group having 1 to 20 carbon atoms, a cyclic hydrocarbon group, a fluorine-containing alkyl group having 1 to 10 carbon atoms, a heterocyclic ring, a fluorine atom, It may be replaced with a hydroxyl group. The cyclic hydrocarbon group and the heterocyclic ring referred to here have the same meaning as defined for Y 1 in the formula [6].
Y 4 in Formula [7] is a single bond, —O—, —NH—, —S—, —SO 2 — or a divalent organic group having 1 to 19 carbon atoms. The divalent organic group having 1 to 19 carbon atoms is a divalent organic group having 1 to 19 carbon atoms, and may contain an oxygen atom, a nitrogen atom, a sulfur atom, a silicon atom, or the like. Specific examples of such Y 4 are given below.
例えば、単結合、−O−、−NH−、−S−、−SO2−、炭素数1〜19の炭化水素基、−CO−O−、−O−CO−、−CO−NH−、−NH−CO−、−CO−、−CF2−、−C(CF3)2−、−CH(OH)−、−C(CH3)2−、−Si(CH3)2−、−O−Si(CH3)2−、−Si(CH3)2−O−、−O−Si(CH3)2−O−、シクロプロパン環、シクロブタン環、シクロペンタン環、シクロヘキサン環、シクロヘプタン環、シクロオクタン環、シクロノナン環、シクロデカン環、シクロウンデカン環、シクロドデカン環、シクロトリデカン環、シクロテトラデカン環、シクロペンタデカン環、シクロヘキサデカン環、シクロヘプタデカン環、シクロオクタデカン環、シクロノナデカン環、シクロイコサン環、トリシクロエイコサン環、トリシクロデコサン環、ビシクロヘプタン環、デカヒドロナフタレン環、ノルボルネン環、アダマンタン環、ベンゼン環、ナフタレン環、テトラヒドロナフタレン環、アズレン環、インデン環、フルオレン環、アントラセン環、フェナントレン環、フェナレン環、ピロール環、イミダゾール環、オキサゾール環、チアゾール環、ピラゾール環、ピリジン環、ピリミジン環、キノリン環、ピラゾリン環、イソキノリン環、カルバゾール環、プリン環、チアジアゾール環、ピリダジン環、トリアジン環、ピラゾリジン環、トリアゾール環、ピラジン環、ベンズイミダゾール環、ベンゾイミダゾール環、チノリン環、フェナントロリン環、インドール環、キノキサリン環、ベンゾチアゾール環、フェノチアジン環、オキサジアゾール環、アクリジン環、オキサゾール環、ピペラジン環、ピペリジン環、ジオキサン環、モルフォリン環等が挙げられる。Y4として、これらを2種以上含んでいてもよい。For example, a single bond, —O—, —NH—, —S—, —SO 2 —, a hydrocarbon group having 1 to 19 carbon atoms, —CO—O—, —O—CO—, —CO—NH—, -NH-CO -, - CO - , - CF 2 -, - C (CF 3) 2 -, - CH (OH) -, - C (CH 3) 2 -, - Si (CH 3) 2 -, - O—Si (CH 3 ) 2 —, —Si (CH 3 ) 2 —O—, —O—Si (CH 3 ) 2 —O—, cyclopropane ring, cyclobutane ring, cyclopentane ring, cyclohexane ring, cycloheptane Ring, cyclooctane ring, cyclononane ring, cyclodecane ring, cycloundecane ring, cyclododecane ring, cyclotridecane ring, cyclotetradecane ring, cyclopentadecane ring, cyclohexadecane ring, cycloheptadecane ring, cyclooctadecane ring, cyclononadecane Ring, cycloicosane ring, tricycloeicosane ring, tricyclodecosan ring, bicycloheptane ring, decahydronaphthalene ring, norbornene ring, adamantane ring, benzene ring, naphthalene ring, tetrahydronaphthalene ring, azulene ring, indene ring, fluorene ring , Anthracene ring, phenanthrene ring, phenalene ring, pyrrole ring, imidazole ring, oxazole ring, thiazole ring, pyrazole ring, pyridine ring, pyrimidine ring, quinoline ring, pyrazoline ring, isoquinoline ring, carbazole ring, purine ring, thiadiazole ring, pyridazine Ring, triazine ring, pyrazolidine ring, triazole ring, pyrazine ring, benzimidazole ring, benzimidazole ring, thionoline ring, phenanthroline ring, indole ring, quinoxaline ring, benzothiazole ring, Phenothiazine ring, an oxadiazole ring, an acridine ring, an oxazole ring, piperazine ring, piperidine ring, dioxane ring, morpholine ring and the like. Y 4 may contain two or more of these.
かかる2種以上含んだ具体例としては、−NH−CH2−、−NH−C2H4−、−NH−C3H6−、−NH−C4H8−、−S−CH2−、−S−C2H4−、−S−C3H6−、−S−C4H8−、−O−CH2−、−O−C2H4−、−O−C3H6−、−O−C4H8−、−NH−CO−CH2−、−NH−CO−C2H4−、−NH−CO−C3H6−、−NH−CO−C4H8−、−CO−CH2−、−CO−C2H4−、−CO−C3H6−、−CO−C4H8−、−CO−NH−CH2−、−CO−NH−C2H4−、−CO−NH−C3H6−、−CO−NH−C4H8−、−NH−CH2−CH(CH3)−、−NH−C2H4−CH(CH3)−、−NH−C3H6−CH(CH3)−、−NH−C4H8−CH(CH3)−、−S−CH2−CH(CH3)−、−S−C2H4−CH(CH3)−、−S−C3H6−CH(CH3)−、−S−C4H8−CH(CH3)−、−O−CH3−CH(CH3)−、−O−C2H4−CH(CH3)−、−O−C3H6−CH(CH3)−、−O−C4H8−CH(CH3)−、−NH−CO−CH2−CH(CH3)−、−NH−CO−C2H4−CH(CH3)−、−NH−CO−C3H6−CH(CH3)−、−NH−CO−C4H8−CH(CH3)−、−CH(OH)−CH2−、−CH(OH)−C2H4−、−CH(OH)−C3H6−、−CH(OH)−C4H8−、−CH(CH2OH)−CH2−、−CH(CH2OH)−C2H4−、−CH(CH2OH)−C3H6−、−CH(CH2OH)−C4H8−、−NH−CH(CH2OH)−CH2−、−CO−NH−CH(CH2OH)−CH2−、−NH−CO−CH(CH2OH)−CH2−、−CO−CH(CH2OH)−CH2−、−S−CH(CH2OH)−CH2−、−O−CH(CH2OH)−CH2−、−CH(N(CH3)2)−、−C6H4−O−、−C6H4−NH−、−C6H4−CO−NH−、−C6H4−NH−CO−、−C6H4−CO−、−C6H4−CH2−、−C6H4−S−等が挙げられる。Specific examples including two or more of these include —NH—CH 2 —, —NH—C 2 H 4 —, —NH—C 3 H 6 —, —NH—C 4 H 8 —, —S—CH 2. -, - S-C 2 H 4 -, - S-C 3 H 6 -, - S-C 4 H 8 -, - O-CH 2 -, - O-C 2 H 4 -, - O-C 3 H 6 -, - O-C 4 H 8 -, - NH-CO-CH 2 -, - NH-CO-C 2 H 4 -, - NH-CO-C 3 H 6 -, - NH-CO-C 4 H 8 -, - CO- CH 2 -, - CO-C 2 H 4 -, - CO-C 3 H 6 -, - CO-C 4 H 8 -, - CO-NH-CH 2 -, - CO -NH-C 2 H 4 -, - CO-NH-C 3 H 6 -, - CO-NH-C 4 H 8 -, - NH-CH 2 -CH (CH 3) -, - NH-C 2 H 4 -CH (CH 3) - , —NH—C 3 H 6 —CH (CH 3 ) —, —NH—C 4 H 8 —CH (CH 3 ) —, —S—CH 2 —CH (CH 3 ) —, —S—C 2 H 4 -CH (CH 3) -, - S-C 3 H 6 -CH (CH 3) -, - S-C 4 H 8 -CH (CH 3) -, - O-CH 3 -CH (CH 3) -, - O-C 2 H 4 -CH (CH 3) -, - O-C 3 H 6 -CH (CH 3) -, - O-C 4 H 8 -CH (CH 3) -, - NH- CO-CH 2 -CH (CH 3 ) -, - NH-CO-C 2 H 4 -CH (CH 3) -, - NH-CO-C 3 H 6 -CH (CH 3) -, - NH-CO -C 4 H 8 -CH (CH 3 ) -, - CH (OH) -CH 2 -, - CH (OH) -C 2 H 4 -, - CH (OH) -C 3 H 6 -, - CH ( OH) -C 4 H 8 -, - CH ( CH 2 OH) -CH 2 -, - CH (CH 2 OH) -C 2 H 4 -, - CH (CH 2 OH) -C 3 H 6 -, - CH (CH 2 OH) -C 4 H 8 -, - NH-CH (CH 2 OH) -CH 2 -, - CO-NH-CH (CH 2 OH) -CH 2 -, - NH-CO-CH (CH 2 OH) -CH 2 -, - CO-CH (CH 2 OH) -CH 2 -, - S-CH (CH 2 OH) -CH 2 -, - O-CH (CH 2 OH) -CH 2 -, - CH ( N (CH 3) 2) - , - C 6 H 4 -O -, - C 6 H 4 -NH -, - C 6 H 4 -CO-NH -, - C 6 H 4 -NH-CO -, - C 6 H 4 —CO—, —C 6 H 4 —CH 2 —, —C 6 H 4 —S— and the like can be mentioned.
式[7]におけるY5は、窒素含有芳香族複素環であり、式[6]のおけるY2の定義と同じである。その具体例としては、上述したY2と同じ構造を挙げることができる。これらのうち、ピロール環、イミダゾール環、ピラゾール環、ピリジン環、ピリミジン環、ピリダジン環、トリアジン環、トリアゾール環、ピラジン環、ベンズイミダゾール環、ベンゾイミダゾール環、キノキサリン環、アゼピン環、ジアゼピン環、ナフチリジン環、フェナジン環、又はフタラジン環が好ましい。Y 5 in Formula [7] is a nitrogen-containing aromatic heterocyclic ring, and is the same as the definition of Y 2 in Formula [6]. Specific examples thereof include the same structure as Y 2 described above. Among these, pyrrole ring, imidazole ring, pyrazole ring, pyridine ring, pyrimidine ring, pyridazine ring, triazine ring, triazole ring, pyrazine ring, benzimidazole ring, benzimidazole ring, quinoxaline ring, azepine ring, diazepine ring, naphthyridine ring , A phenazine ring, or a phthalazine ring is preferable.
また、窒素含有芳香族複素環と特定ポリイミド中のカルボキシル基との塩形成や水素結合といった静電的相互作用のしやすさの観点から、Y4はY5に含まれる式[20a]、式[20b]又は式[20c]と隣り合わない炭素原子と結合していることが好ましい。
さらに、式[7]のY5である窒素含有芳香族複素環の炭素原子はハロゲン原子及び/又は有機基の置換基を有していてもよく、該有機基は酸素原子、硫黄原子、窒素原子等のヘテロ原子を含有してもよい。From the viewpoint of ease of electrostatic interaction such as salt formation or hydrogen bonding between the nitrogen-containing aromatic heterocycle and the carboxyl group in the specific polyimide, Y 4 is a formula [20a] or formula included in Y 5. It is preferably bonded to a carbon atom that is not adjacent to [20b] or formula [20c].
Further, the carbon atom of the nitrogen-containing aromatic heterocyclic ring represented by Y 5 in the formula [7] may have a halogen atom and / or a substituent of an organic group, and the organic group is an oxygen atom, a sulfur atom, nitrogen You may contain hetero atoms, such as an atom.
式[7]におけるY3、Y4及びY5の好ましい組み合わせは、Y3が、炭素数1〜10の直鎖又は分岐アルキレン基、シクロプロパン環、シクロブタン環、シクロペンタン環、シクロヘキサン環、シクロヘプタン環、シクロオクタン環、シクロノナン環、シクロデカン環、シクロウンデカン環、シクロドデカン環、シクロトリデカン環、シクロテトラデカン環、ノルボルネン環又はアダマンタン環であり、Y4が、単結合、炭素数1〜10の直鎖又は分岐アルキレン基、−O−、−NH−、−CO−O−、−O−CO−、−CO−NH−、−NH−CO−、−CO−、−S−、−SO2−、−CF2−、−C(CF3)2−、−Si(CH3)2−、−O−Si(CH3)2−、−Si(CH3)2−O−、−O−Si(CH3)2−O−、−CH(OH)−、−NH−CH2−、−NH−C2H4−、−NH−C3H6−、−NH−C4H8−、−S−CH2−、−S−C2H4−、−S−C3H6−、−S−C4H8−、−O−CH2−、−O−C2H4−、−O−C3H6−、−O−C4H8−、−NH−CO−CH2−、−NH−CO−C2H4−、−NH−CO−C3H6−、−NH−CO−C4H8−、−CO−CH2−、−CO−C2H4−、−CO−C3H6−、−CO−C4H8−、−CO−NH−CH2−、−CO−NH−C2H4−、−CO−NH−C3H6−、−CO−NH−C4H8−、−NH−CH2−CH(CH3)−、−NH−C2H4−CH(CH3)−、−NH−C3H6−CH(CH3)−、−NH−C4H8−CH(CH3)−、−S−CH2−CH(CH3)−、−S−C2H4−CH(CH3)−、−S−C3H6−CH(CH3)−、−S−C4H8−CH(CH3)−、−O−CH3−CH(CH3)−、−O−C2H4−CH(CH3)−、−O−C3H6−CH(CH3)−、−O−C4H8−CH(CH3)−、−NH−CO−CH2−CH(CH3)−、−NH−CO−C2H4−CH(CH3)−、−NH−CO−C3H6−CH(CH3)−、−NH−CO−C4H8−CH(CH3)−、−CH(OH)−CH2−、−CH(OH)−C2H4−、−CH(OH)−C3H6−、−CH(OH)−C4H8−、−CH(CH2OH)−CH2−、−CH(CH2OH)−C2H4−、−CH(CH2OH)−C3H6−、−CH(CH2OH)−C4H8−、−NH−CH(CH2OH)−CH2−、−CO−NH−CH(CH2OH)−CH2−、−NH−CO−CH(CH2OH)−CH2−、−CO−CH(CH2OH)−CH2−、−S−CH(CH2OH)−CH2−、−O−CH(CH2OH)−CH2−、−CH(N(CH3)2)−、−C6H4−O−、−C6H4−NH−、−C6H4−CO−NH−、−C6H4−NH−CO−、−C6H4−CO−、−C6H4−CH2−、−C6H4−S−、シクロプロパン環、シクロブタン環、シクロペンタン環、シクロヘキサン環、シクロヘプタン環、シクロオクタン環、シクロノナン環、シクロデカン環、シクロウンデカン環、シクロドデカン環、ノルボルネン環、アダマンタン環、ベンゼン環、ナフタレン環、テトラヒドロナフタレン環、アズレン環、インデン環、フルオレン環、アントラセン環、フェナントレン環、フェナレン環であり、Y5が、ピロール環、イミダゾール環、ピラゾール環、ピリジン環、ピリミジン環、ピリダジン環、トリアジン環、トリアゾール環、ピラジン環、ベンズイミダゾール環、ベンゾイミダゾール環、キノキサリン環、アゼピン環、ジアゼピン環、ナフチリジン環、フェナジン環、又はフタラジン環である。なお、Y5の窒素含有芳香族複素環の炭素原子は、ハロゲン原子及び/又は有機基の置換基を有していてもよく、該有機基は酸素原子、硫黄原子、窒素原子等のヘテロ原子を含有してもよい。In the preferable combination of Y 3 , Y 4 and Y 5 in the formula [7], Y 3 is a linear or branched alkylene group having 1 to 10 carbon atoms, a cyclopropane ring, a cyclobutane ring, a cyclopentane ring, a cyclohexane ring, a cyclo A heptane ring, a cyclooctane ring, a cyclononane ring, a cyclodecane ring, a cycloundecane ring, a cyclododecane ring, a cyclotridecane ring, a cyclotetradecane ring, a norbornene ring or an adamantane ring, and Y 4 is a single bond, having 1 to 10 carbon atoms. A linear or branched alkylene group, -O-, -NH-, -CO-O-, -O-CO-, -CO-NH-, -NH-CO-, -CO-, -S-, -SO 2 -, - CF 2 -, - C (CF 3) 2 -, - Si (CH 3) 2 -, - O-Si (CH 3) 2 -, - Si (CH 3) 2 -O -, - O -Si CH 3) 2 -O -, - CH (OH) -, - NH-CH 2 -, - NH-C 2 H 4 -, - NH-C 3 H 6 -, - NH-C 4 H 8 -, - S-CH 2 -, - S -C 2 H 4 -, - S-C 3 H 6 -, - S-C 4 H 8 -, - O-CH 2 -, - O-C 2 H 4 -, - O—C 3 H 6 —, —O—C 4 H 8 —, —NH—CO—CH 2 —, —NH—CO—C 2 H 4 —, —NH—CO—C 3 H 6 —, —NH -CO-C 4 H 8 -, - CO-CH 2 -, - CO-C 2 H 4 -, - CO-C 3 H 6 -, - CO-C 4 H 8 -, - CO-NH-CH 2 -, - CO-NH-C 2 H 4 -, - CO-NH-C 3 H 6 -, - CO-NH-C 4 H 8 -, - NH-CH 2 -CH (CH 3) -, - NH -C 2 H 4 -CH (CH 3 -, - NH-C 3 H 6 -CH (CH 3) -, - NH-C 4 H 8 -CH (CH 3) -, - S-CH 2 -CH (CH 3) -, - S-C 2 H 4 —CH (CH 3 ) —, —S—C 3 H 6 —CH (CH 3 ) —, —S—C 4 H 8 —CH (CH 3 ) —, —O—CH 3 —CH (CH 3) ) -, - O-C 2 H 4 -CH (CH 3) -, - O-C 3 H 6 -CH (CH 3) -, - O-C 4 H 8 -CH (CH 3) -, - NH -CO-CH 2 -CH (CH 3 ) -, - NH-CO-C 2 H 4 -CH (CH 3) -, - NH-CO-C 3 H 6 -CH (CH 3) -, - NH- CO-C 4 H 8 -CH ( CH 3) -, - CH (OH) -CH 2 -, - CH (OH) -C 2 H 4 -, - CH (OH) -C 3 H 6 -, - CH (OH) C 4 H 8 -, - CH (CH 2 OH) -CH 2 -, - CH (CH 2 OH) -C 2 H 4 -, - CH (CH 2 OH) -C 3 H 6 -, - CH (CH 2 OH) -C 4 H 8 - , - NH-CH (CH 2 OH) -CH 2 -, - CO-NH-CH (CH 2 OH) -CH 2 -, - NH-CO-CH (CH 2 OH ) -CH 2 -, - CO- CH (CH 2 OH) -CH 2 -, - S-CH (CH 2 OH) -CH 2 -, - O-CH (CH 2 OH) -CH 2 -, - CH (N (CH 3) 2) -, - C 6 H 4 -O -, - C 6 H 4 -NH -, - C 6 H 4 -CO-NH -, - C 6 H 4 -NH-CO-, -C 6 H 4 -CO -, - C 6 H 4 -CH 2 -, - C 6 H 4 -S-, cyclopropane ring, cyclobutane ring, cyclopentane , Cyclohexane ring, cycloheptane ring, cyclooctane ring, cyclononane ring, cyclodecane ring, cycloundecane ring, cyclododecane ring, norbornene ring, adamantane ring, benzene ring, naphthalene ring, tetrahydronaphthalene ring, azulene ring, indene ring, fluorene ring , Anthracene ring, phenanthrene ring, phenalene ring, and Y 5 is a pyrrole ring, imidazole ring, pyrazole ring, pyridine ring, pyrimidine ring, pyridazine ring, triazine ring, triazole ring, pyrazine ring, benzimidazole ring, benzimidazole ring Quinoxaline ring, azepine ring, diazepine ring, naphthyridine ring, phenazine ring, or phthalazine ring. The carbon atom of the nitrogen-containing aromatic heterocycle of Y 5 may have a halogen atom and / or a substituent of an organic group, and the organic group is a heteroatom such as an oxygen atom, a sulfur atom, or a nitrogen atom. It may contain.
式[7]におけるY3、Y4及びY5のより好ましい組み合わせは、Y3が、炭素数1〜5の直鎖又は分岐アルキレン基、シクロプロパン環、シクロブタン環、シクロペンタン環、シクロヘキサン環、シクロヘプタン環、ノルボルネン環、又はアダマンタン環であり、Y4が、単結合、炭素数1〜5の直鎖又は分岐アルキレン基、−O−、−NH−、−CO−O−、−O−CO−、−CO−NH−、−NH−CO−、−CO−、−S−、−S(O)2−、−CH(OH)−、−NH−CH2−、−S−CH2−、−O−CH2−、−O−C2H4−、−NH−CO−CH2−、−CO−CH2−、−CO−NH−CH2−、−NH−CH2−CH(CH3)−、−S−CH2−CH(CH3)−、−O−CH3−CH(CH3)−、−NH−CO−CH2−CH(CH3)−、−CH(OH)−CH2−、−CH(OH)−C2H4−、−CH(CH2OH)−CH2−、−NH−CH(CH2OH)−CH2−、−CO−NH−CH(CH2OH)−CH2−、−NH−CO−CH(CH2OH)−CH2−、−CO−CH(CH2OH)−CH2−、−S−CH(CH2OH)−CH2−、−O−CH(CH2OH)−CH2−、−CH(N(CH3)2)−、−C6H4−O−、−C6H4−NH−、−C6H4−CO−NH−、−C6H4−NH−CO−、−C6H4−CO−、−C6H4−CH2−、−C6H4−S−、シクロプロパン環、シクロブタン環、シクロペンタン環、シクロヘキサン環、シクロヘプタン環、ノルボルネン環、アダマンタン環、ベンゼン環、ナフタレン環、テトラヒドロナフタレン環、アズレン環、インデン環、フルオレン環、アントラセン環、フェナントレン環、又はフェナレン環であり、Y5が、ピロール環、イミダゾール環、ピラゾール環、ピリジン環、ピリミジン環、ピリダジン環、トリアジン環、トリアゾール環、ピラジン環、ベンズイミダゾール環、ベンゾイミダゾール環、キノキサリン環、アゼピン環、ジアゼピン環、ナフチリジン環、フェナジン環、又はフタラジン環である。なお、Y5の窒素含有芳香族複素環の炭素原子は、ハロゲン原子及び/又は有機基の置換基を有していてもよく、該有機基は酸素原子、硫黄原子、窒素原子等のヘテロ原子を含有してもよい。In a more preferable combination of Y 3 , Y 4 and Y 5 in the formula [7], Y 3 is a linear or branched alkylene group having 1 to 5 carbon atoms, a cyclopropane ring, a cyclobutane ring, a cyclopentane ring, a cyclohexane ring, A cycloheptane ring, a norbornene ring, or an adamantane ring, and Y 4 is a single bond, a linear or branched alkylene group having 1 to 5 carbon atoms, —O—, —NH—, —CO—O—, —O—. CO -, - CO-NH - , - NH-CO -, - CO -, - S -, - S (O) 2 -, - CH (OH) -, - NH-CH 2 -, - S-CH 2 -, - O-CH 2 - , - O-C 2 H 4 -, - NH-CO-CH 2 -, - CO-CH 2 -, - CO-NH-CH 2 -, - NH-CH 2 -CH (CH 3) -, - S -CH 2 -CH (CH 3) -, - O-CH 3 -CH (CH 3) -, - NH -CO-CH 2 -CH (CH 3) -, - CH (OH) -CH 2 -, - CH (OH) -C 2 H 4 -, - CH (CH 2 OH) -CH 2 -, - NH-CH (CH 2 OH) -CH 2 -, - CO-NH-CH (CH 2 OH) -CH 2 -, - NH-CO-CH (CH 2 OH) -CH 2 - , -CO-CH (CH 2 OH ) -CH 2 -, - S-CH (CH 2 OH) -CH 2 -, - O-CH (CH 2 OH) -CH 2 -, - CH (N (CH 3 ) 2) -, - C 6 H 4 -O -, - C 6 H 4 -NH -, - C 6 H 4 -CO-NH -, - C 6 H 4 -NH-CO -, - C 6 H 4 -CO -, - C 6 H 4 -CH2 -, - C 6 H 4 -S-, cyclopropane ring, cyclobutane ring, cyclopentane ring, cyclohex Ring, cycloheptane ring, a norbornene ring, adamantane ring, a benzene ring, a naphthalene ring, tetrahydronaphthalene ring, azulene ring, an indene ring, a fluorene ring, an anthracene ring, phenanthrene ring, or phenalene ring, Y 5, pyrrole ring, Imidazole ring, pyrazole ring, pyridine ring, pyrimidine ring, pyridazine ring, triazine ring, triazole ring, pyrazine ring, benzimidazole ring, benzimidazole ring, quinoxaline ring, azepine ring, diazepine ring, naphthyridine ring, phenazine ring, or phthalazine ring It is. The carbon atom of the nitrogen-containing aromatic heterocycle of Y 5 may have a halogen atom and / or a substituent of an organic group, and the organic group is a heteroatom such as an oxygen atom, a sulfur atom, or a nitrogen atom. It may contain.
式[7]におけるY3、Y4及びY5のさらに好ましい組み合わせは、Y3が、炭素数1〜5の直鎖又は分岐アルキレン基、シクロプロパン環、シクロブタン環、シクロペンタン環、又はシクロヘキサン環であり、Y4が、単結合、炭素数1〜5の直鎖又は分岐アルキレン基、−O−、−NH−、−CO−O−、−O−CO−、−CO−NH−、−NH−CO−、−CO−、−CH(OH)−、−NH−CH2−、−S−CH2−、−O−CH2−、−NH−CO−CH2−、−CO−CH2−、−CO−NH−CH2−、−NH−CH2−CH(CH3)−、−S−CH2−CH(CH3)−、−O−CH3−CH(CH3)−、−NH−CO−CH2−CH(CH3)−、−CH(OH)−CH2−、−CH(OH)−C2H4−、−CH(CH2OH)−CH2−、−NH−CH(CH2OH)−CH2−、−CO−NH−CH(CH2OH)−CH2−、−NH−CO−CH(CH2OH)−CH2−、−CO−CH(CH2OH)−CH2−、−S−CH(CH2OH)−CH2−、−O−CH(CH2OH)−CH2−、−CH(N(CH3)2)−、−C6H4−O−、−C6H4−NH−、−C6H4−CO−NH−、−C6H4−NH−CO−、−C6H4−CO−、−C6H4−CH2−、−C6H4−S−、シクロプロパン環、シクロブタン環、シクロペンタン環、シクロヘキサン環、シクロヘプタン環、ノルボルネン環、アダマンタン環、ベンゼン環、ナフタレン環、テトラヒドロナフタレン環、フルオレン環、又はアントラセン環であり、Y5が、ピロール環、イミダゾール環、ピラゾール環、ピリジン環、ピリミジン環、ピリダジン環、トリアジン環、トリアゾール環、ピラジン環、ベンズイミダゾール環、又はベンゾイミダゾール環である。なお、Y5の窒素含有芳香族複素環の炭素原子は、ハロゲン原子及び/又は有機基の置換基を有していてもよく、該有機基は酸素原子、硫黄原子、窒素原子等のヘテロ原子を含有してもよい。In a more preferable combination of Y 3 , Y 4 and Y 5 in the formula [7], Y 3 is a linear or branched alkylene group having 1 to 5 carbon atoms, a cyclopropane ring, a cyclobutane ring, a cyclopentane ring, or a cyclohexane ring. Y 4 is a single bond, a linear or branched alkylene group having 1 to 5 carbon atoms, —O—, —NH—, —CO—O—, —O—CO—, —CO—NH—, — NH—CO—, —CO—, —CH (OH) —, —NH—CH 2 —, —S—CH 2 —, —O—CH 2 —, —NH—CO—CH 2 —, —CO—CH 2 -, - CO-NH- CH 2 -, - NH-CH 2 -CH (CH 3) -, - S-CH 2 -CH (CH 3) -, - O-CH 3 -CH (CH 3) - , -NH-CO-CH 2 -CH (CH 3) -, - CH (OH) -CH 2 -, - CH ( H) -C 2 H 4 -, - CH (CH 2 OH) -CH 2 -, - NH-CH (CH 2 OH) -CH 2 -, - CO-NH-CH (CH 2 OH) -CH 2 - , -NH-CO-CH (CH 2 OH) -CH 2 -, - CO-CH (CH 2 OH) -CH 2 -, - S-CH (CH 2 OH) -CH 2 -, - O-CH ( CH 2 OH) -CH 2 -, - CH (N (CH 3) 2) -, - C 6 H 4 -O -, - C 6 H 4 -NH -, - C 6 H 4 -CO-NH-, -C 6 H 4 -NH-CO - , - C 6 H 4 -CO -, - C 6 H 4 -CH2 -, - C 6 H 4 -S-, cyclopropane ring, cyclobutane ring, cyclopentane ring, cyclohexane Ring, cycloheptane ring, norbornene ring, adamantane ring, benzene ring, naphthalene ring, tetrahydro A Futaren ring, fluorene ring, or an anthracene ring, Y 5 is a pyrrole ring, an imidazole ring, a pyrazole ring, a pyridine ring, a pyrimidine ring, a pyridazine ring, a triazine ring, a triazole ring, a pyrazine ring, a benzimidazole ring, or benzimidazole It is a ring. The carbon atom of the nitrogen-containing aromatic heterocycle of Y 5 may have a halogen atom and / or a substituent of an organic group, and the organic group is a heteroatom such as an oxygen atom, a sulfur atom, or a nitrogen atom. It may contain.
式[7]におけるY3、Y4及びY5の特に好ましい組み合わせは、Y3が、炭素数1〜5の直鎖又は分岐アルキレン基、シクロブタン環、又はシクロヘキサン環であり、Y4が、単結合、−O−、−CO−O−、−O−CO−、−CO−NH−、−NH−CO−、−CH(OH)−、ベンゼン環、ナフタレン環、フルオレン環、又はアントラセン環であり、Y5が、ピロール環、イミダゾール環、ピラゾール環、ピリジン環、又はピリミジン環である。なお、Y5の窒素含有芳香族複素環の炭素原子は、ハロゲン原子及び/又は有機基の置換基を有していてもよく、該有機基は酸素原子、硫黄原子、窒素原子等のヘテロ原子を含有してもよい。
本発明に用いる特定アミン化合物の具体例としては、M1〜M156の化合物が挙げられる。A particularly preferred combination of Y 3 , Y 4 and Y 5 in the formula [7] is that Y 3 is a linear or branched alkylene group having 1 to 5 carbon atoms, a cyclobutane ring, or a cyclohexane ring, and Y 4 is a simple group. A bond, —O—, —CO—O—, —O—CO—, —CO—NH—, —NH—CO—, —CH (OH) —, a benzene ring, a naphthalene ring, a fluorene ring, or an anthracene ring. Y 5 is a pyrrole ring, an imidazole ring, a pyrazole ring, a pyridine ring, or a pyrimidine ring. The carbon atom of the nitrogen-containing aromatic heterocycle of Y 5 may have a halogen atom and / or a substituent of an organic group, and the organic group is a heteroatom such as an oxygen atom, a sulfur atom, or a nitrogen atom. It may contain.
Specific examples of the specific amine compound used in the present invention include M1 to M156 compounds.
より好ましい化合物としては、M6〜M8、M10、M16〜M21、M31〜M36、M40〜M45、M47〜M57、M59〜M63、M68、M69、M72〜M82、M95〜M98、M100〜M103、M108〜M125、M128〜M137、M139〜M143、M149〜M156が挙げられる。さらに好ましいのは、M6〜M8、M16〜M20、M32〜M36、M40、M41、M44、M49〜M54、M59〜M62、M68、M69、M75〜M82、M100〜M103、M108〜M112、M114〜M116、M118〜M121、M125、M134〜M136、M139、M140、M143、M150、M152〜M156である。 More preferable compounds include M6 to M8, M10, M16 to M21, M31 to M36, M40 to M45, M47 to M57, M59 to M63, M68, M69, M72 to M82, M95 to M98, M100 to M103, M108 to M125, M128-M137, M139-M143, M149-M156 are mentioned. More preferable are M6 to M8, M16 to M20, M32 to M36, M40, M41, M44, M49 to M54, M59 to M62, M68, M69, M75 to M82, M100 to M103, M108 to M112, M114 to M116. M118 to M121, M125, M134 to M136, M139, M140, M143, M150, and M152 to M156.
<液晶配向処理剤>
本発明の液晶配向処理剤は、通常、上記した(A)成分である特定ポリイミドと(B)成分である特定アミン化合物とを有機溶媒中で混合して得られる。混合する特定ポリイミド及び特性アミン化合物は、それぞれ、1種類でもよく、複数種類を併用してもよい。<Liquid crystal alignment agent>
The liquid-crystal aligning agent of this invention is normally obtained by mixing the above-mentioned specific polyimide which is (A) component, and the specific amine compound which is (B) component in an organic solvent. Each of the specific polyimide and the characteristic amine compound to be mixed may be one kind or a plurality of kinds may be used in combination.
混合方法としては、特定ポリイミドの前駆体であるポリアミド酸をイミド化した反応溶液(特定ポリイミドの溶液)を用いてもよいが、好ましくは、精製して得られた特定ポリイミドの粉体を有機溶媒に溶解させた溶液に、特定アミン化合物を添加する方法が挙げられる。その際に用いる有機溶媒は、特定ポリイミドを溶解させる溶媒であれば特に限定されない。かかる有機溶媒の具体例を以下に挙げる。 As a mixing method, a reaction solution (specific polyimide solution) obtained by imidizing polyamic acid, which is a precursor of the specific polyimide, may be used. Preferably, the powder of the specific polyimide obtained by purification is used as an organic solvent. The method of adding a specific amine compound to the solution dissolved in (1) is mentioned. The organic solvent used in that case will not be specifically limited if it is a solvent which dissolves specific polyimide. Specific examples of such organic solvents are given below.
例えば、N,N’−ジメチルホルムアミド、N,N’−ジメチルアセトアミド、N−メチル−2−ピロリドン、N−メチルカプロラクタム、2−ピロリドン、N−エチルピロリドン、N−ビニルピロリドン、ジメチルスルホキシド、テトラメチル尿素、ピリジン、ジメチルスルホン、ヘキサメチルスルホキシド、γ−ブチロラクトン、1,3−ジメチル−イミダゾリジノン、ジペンテン、エチルアミルケトン、メチルノニルケトン、メチルエチルケトン、メチルイソアミルケトン、メチルイソプロピルケトン、シクロヘキサノン、エチレンカーボネート、プロピレンカーボネート、ジグライム、4−ヒドロキシ−4−メチル−2−ペンタノンなどが挙げられる。これらの溶媒は2種類以上を混合して用いてもよい。 For example, N, N′-dimethylformamide, N, N′-dimethylacetamide, N-methyl-2-pyrrolidone, N-methylcaprolactam, 2-pyrrolidone, N-ethylpyrrolidone, N-vinylpyrrolidone, dimethyl sulfoxide, tetramethyl Urea, pyridine, dimethyl sulfone, hexamethyl sulfoxide, γ-butyrolactone, 1,3-dimethyl-imidazolidinone, dipentene, ethyl amyl ketone, methyl nonyl ketone, methyl ethyl ketone, methyl isoamyl ketone, methyl isopropyl ketone, cyclohexanone, ethylene carbonate, Examples include propylene carbonate, diglyme and 4-hydroxy-4-methyl-2-pentanone. Two or more kinds of these solvents may be mixed and used.
特定ポリイミドを有機溶媒に溶解させる際に、特定ポリイミドの溶解を促進する目的で、加熱してもよい。加熱する温度が高すぎるとポリイミドの分子量が低下する場合があるので、温度30〜100℃が好ましい。特定ポリイミドの溶液の濃度は特に限定されないが、特定アミン化合物と均一に混合し易いので、溶液中の特定ポリイミド濃度として1〜20質量%が好ましく、より好ましくは3〜15質量%であり、特に好ましくは3〜10質量%である。
特定アミン化合物は、上記の特定ポリイミドの溶液に直接添加しても構わないが、適当な溶媒で好ましくは濃度0.1〜10質量%の溶液にしてから添加することが好ましい。この溶媒としては、上記した特定ポリイミドの溶媒が挙げられる。When the specific polyimide is dissolved in the organic solvent, the specific polyimide may be heated for the purpose of promoting the dissolution of the specific polyimide. Since the molecular weight of a polyimide may fall when the temperature to heat is too high, the temperature of 30-100 degreeC is preferable. The concentration of the specific polyimide solution is not particularly limited. However, since it is easy to uniformly mix with the specific amine compound, the specific polyimide concentration in the solution is preferably 1 to 20% by mass, more preferably 3 to 15% by mass. Preferably it is 3-10 mass%.
The specific amine compound may be added directly to the solution of the specific polyimide, but it is preferable to add the specific amine compound after forming a solution having a concentration of 0.1 to 10% by mass with an appropriate solvent. As this solvent, the solvent of the specific polyimide mentioned above is mentioned.
特定ポリイミドと特定アミン化合物とを有機溶媒中で混合した後に加熱することは好ましい。加熱することで、液晶配向処理剤の状態で既に結合している特定アミン化合物と特定ポリイミドの比率が増加し、液晶配向膜としたときにより効率的に電荷の移動が可能となる。混合後に加熱する場合の温度は10〜100℃が好ましく、より好ましくは20〜80℃である。 It is preferable to heat after mixing a specific polyimide and a specific amine compound in an organic solvent. By heating, the ratio of the specific amine compound and the specific polyimide that are already bonded in the state of the liquid crystal alignment treatment agent is increased, and the charge can be transferred more efficiently when the liquid crystal alignment film is formed. The temperature in the case of heating after mixing is preferably 10 to 100 ° C, more preferably 20 to 80 ° C.
本発明の液晶配向処理剤における特定アミン化合物の含有量は、本発明の効果が効率よく得られ、かつ液晶配向処理剤の安定性を損なわないという理由から、特定ポリイミドに含まれるカルボキシル基の1モル量に対して0.01〜2モル倍が好ましく、より好ましくは0.05〜1モル倍であり、特に好ましくは0.08〜0.8モル倍である。 The content of the specific amine compound in the liquid crystal aligning agent of the present invention is one of the carboxyl groups contained in the specific polyimide because the effects of the present invention can be obtained efficiently and the stability of the liquid crystal aligning agent is not impaired. 0.01-2 mol times is preferable with respect to molar amount, More preferably, it is 0.05-1 mol times, Especially preferably, it is 0.08-0.8 mol times.
本発明の液晶配向処理剤は、特定ポリイミド、特定アミン化合物以外に、その他の成分として、液晶配向処理剤を塗布した際の膜厚均一性や表面平滑性を向上させる溶媒や化合物、液晶配向膜と基板との密着性を向上させる化合物などを含有してもよい。その他の成分は、特定ポリイミドと特定アミン化合物を混合する途中に添加してもよいし、これらの混合溶液に後から添加してもよい。 In addition to the specific polyimide and specific amine compound, the liquid crystal alignment treatment agent of the present invention is a solvent or compound that improves the film thickness uniformity and surface smoothness when the liquid crystal alignment treatment agent is applied as other components, a liquid crystal alignment film A compound that improves the adhesion between the substrate and the substrate may be contained. Other components may be added during the mixing of the specific polyimide and the specific amine compound, or may be added later to these mixed solutions.
膜厚の均一性や表面平滑性を向上させる溶媒の具体例としては次のものが挙げられる。
例えば、イソプロピルアルコール、メトキシメチルペンタノール、メチルセロソルブ、エチルセロソルブ、ブチルセロソルブ、メチルセロソルブアセテート、エチルセロソルブアセテート、ブチルカルビトール、エチルカルビトール、エチルカルビトールアセテート、エチレングリコール、エチレングリコールモノアセテート、エチレングリコールモノイソプロピルエーテル、エチレングリコールモノブチルエーテル、プロピレングリコール、プロピレングリコールモノアセテート、プロピレングリコールモノメチルエーテル、プロピレングリコール−tert−ブチルエーテル、ジプロピレングリコールモノメチルエーテル、ジエチレングリコール、ジエチレングリコールモノアセテート、ジエチレングリコールジメチルエーテル、ジプロピレングリコールモノアセテートモノメチルエーテル、ジプロピレングリコールモノメチルエーテル、ジプロピレングリコールモノエチルエーテル、ジプロピレングリコールモノアセテートモノエチルエーテル、ジプロピレングリコールモノプロピルエーテル、ジプロピレングリコールモノアセテートモノプロピルエーテル、3−メチル−3−メトキシブチルアセテート、トリプロピレングリコールメチルエーテル、3−メチル−3−メトキシブタノール、ジイソプロピルエーテル、エチルイソブチルエーテル、ジイソブチレン、アミルアセテート、ブチルブチレート、ブチルエーテル、ジイソブチルケトン、メチルシクロへキセン、プロピルエーテル、ジヘキシルエーテル、n−へキサン、n−ペンタン、n−オクタン、ジエチルエーテル、乳酸メチル、乳酸エチル、酢酸メチル、酢酸エチル、酢酸n−ブチル、酢酸プロピレングリコールモノエチルエーテル、ピルビン酸メチル、ピルビン酸エチル、3−メトキシプロピオン酸メチル、3−エトキシプロピオン酸メチルエチル、3−メトキシプロピオン酸エチル、3−エトキシプロピオン酸、3−メトキシプロピオン酸、3−メトキシプロピオン酸プロピル、3−メトキシプロピオン酸ブチル、1−メトキシ−2−プロパノール、1−エトキシ−2−プロパノール、1−ブトキシ−2−プロパノール、1−フェノキシ−2−プロパノール、プロピレングリコールモノアセテート、プロピレングリコールジアセテート、プロピレングリコール−1−モノメチルエーテル−2−アセテート、プロピレングリコール−1−モノエチルエーテル−2−アセテート、ジプロピレングリコール、2−(2−エトキシプロポキシ)プロパノール、乳酸メチルエステル、乳酸エチルエステル、乳酸n−プロピルエステル、乳酸n−ブチルエステル、乳酸イソアミルエステルなどの低表面張力を有する溶媒などが挙げられる。Specific examples of the solvent for improving the film thickness uniformity and surface smoothness include the following.
For example, isopropyl alcohol, methoxymethylpentanol, methyl cellosolve, ethyl cellosolve, butyl cellosolve, methyl cellosolve acetate, ethyl cellosolve acetate, butyl carbitol, ethyl carbitol, ethyl carbitol acetate, ethylene glycol, ethylene glycol monoacetate, ethylene glycol monoacetate Isopropyl ether, ethylene glycol monobutyl ether, propylene glycol, propylene glycol monoacetate, propylene glycol monomethyl ether, propylene glycol-tert-butyl ether, dipropylene glycol monomethyl ether, diethylene glycol, diethylene glycol monoacetate, diethylene glycol dimethyl ether, dipro Lenglycol monoacetate monomethyl ether, dipropylene glycol monomethyl ether, dipropylene glycol monoethyl ether, dipropylene glycol monoacetate monoethyl ether, dipropylene glycol monopropyl ether, dipropylene glycol monoacetate monopropyl ether, 3-methyl-3 -Methoxybutyl acetate, tripropylene glycol methyl ether, 3-methyl-3-methoxybutanol, diisopropyl ether, ethyl isobutyl ether, diisobutylene, amyl acetate, butyl butyrate, butyl ether, diisobutyl ketone, methylcyclohexene, propyl ether, dihexyl Ether, n-hexane, n-pentane, n-octane, diethyl ether Methyl lactate, ethyl lactate, methyl acetate, ethyl acetate, n-butyl acetate, propylene glycol monoethyl ether, methyl pyruvate, ethyl pyruvate, methyl 3-methoxypropionate, methyl ethyl 3-ethoxypropionate, 3-methoxy Ethyl propionate, 3-ethoxypropionic acid, 3-methoxypropionic acid, propyl 3-methoxypropionate, butyl 3-methoxypropionate, 1-methoxy-2-propanol, 1-ethoxy-2-propanol, 1-butoxy- 2-propanol, 1-phenoxy-2-propanol, propylene glycol monoacetate, propylene glycol diacetate, propylene glycol-1-monomethyl ether-2-acetate, propylene glycol-1-monoethyl acetate Low surface tension such as lu-2-acetate, dipropylene glycol, 2- (2-ethoxypropoxy) propanol, lactate methyl ester, lactate ethyl ester, lactate n-propyl ester, lactate n-butyl ester, lactyl isoamyl ester A solvent etc. are mentioned.
これらの溶媒は1種類でも複数種類を混合して用いてもよい。上記のような溶媒を用いる場合は、液晶配向処理剤に含まれる溶媒全体の5〜80質量%であることが好ましく、より好ましくは20〜60質量%である。 These solvents may be used alone or in combination. When using the above solvent, it is preferable that it is 5-80 mass% of the whole solvent contained in a liquid-crystal aligning agent, More preferably, it is 20-60 mass%.
膜厚均一性や表面平滑性を向上させる化合物としては、フッ素系界面活性剤、シリコーン系界面活性剤、ノ二オン系界面活性剤などが挙げられる。
より具体的には、例えば、エフトップEF301、EF303、EF352(トーケムプロダクツ社製))、メガファックF171、F173、R−30(大日本インキ社製)、フロラードFC430、FC431(住友スリーエム社製)、アサヒガードAG710、サーフロンS−382、SC101、SC102、SC103、SC104、SC105、SC106(旭硝子社製)などが挙げられる。これらの界面活性剤の使用割合は、液晶配向処理剤に含有される(A)成分の100質量部に対して、好ましくは0.01〜2質量部、より好ましくは0.01〜1質量部である。Examples of compounds that improve film thickness uniformity and surface smoothness include fluorine-based surfactants, silicone-based surfactants, and nonionic surfactants.
More specifically, for example, EFTOP EF301, EF303, EF352 (manufactured by Tochem Products), MegaFuck F171, F173, R-30 (manufactured by Dainippon Ink), Florard FC430, FC431 (manufactured by Sumitomo 3M) Asahi Guard AG710, Surflon S-382, SC101, SC102, SC103, SC104, SC105, SC106 (manufactured by Asahi Glass Co., Ltd.). The use ratio of these surfactants is preferably 0.01 to 2 parts by mass, more preferably 0.01 to 1 part by mass with respect to 100 parts by mass of the component (A) contained in the liquid crystal aligning agent. It is.
液晶配向膜と基板との密着性を向上させる化合物の具体例としては、次に示す官能性シラン含有化合物やエポキシ基含有化合物であるものが挙げられる。 Specific examples of the compound that improves the adhesion between the liquid crystal alignment film and the substrate include the following functional silane-containing compounds and epoxy group-containing compounds.
例えば、3−アミノプロピルトリメトキシシラン、3−アミノプロピルトリエトキシシラン、2−アミノプロピルトリメトキシシラン、2−アミノプロピルトリエトキシシラン、N−(2−アミノエチル)−3−アミノプロピルトリメトキシシラン、N−(2−アミノエチル)−3−アミノプロピルメチルジメトキシシラン、3−ウレイドプロピルトリメトキシシラン、3−ウレイドプロピルトリエトキシシラン、N−エトキシカルボニル−3−アミノプロピルトリメトキシシラン、N−エトキシカルボニル−3−アミノプロピルトリエトキシシラン、N−トリエトキシシリルプロピルトリエチレントリアミン、N−トリメトキシシリルプロピルトリエチレントリアミン、10−トリメトキシシリル−1,4,7−トリアザデカン、10−トリエトキシシリル−1,4,7−トリアザデカン、9−トリメトキシシリル−3,6−ジアザノニルアセテート、9−トリエトキシシリル−3,6−ジアザノニルアセテート、N−ベンジル−3−アミノプロピルトリメトキシシラン、N−ベンジル−3−アミノプロピルトリエトキシシラン、N−フェニル−3−アミノプロピルトリメトキシシラン、N−フェニル−3−アミノプロピルトリエトキシシラン、N−ビス(オキシエチレン)−3−アミノプロピルトリメトキシシラン、N−ビス(オキシエチレン)−3−アミノプロピルトリエトキシシラン、エチレングリコールジグリシジルエーテル、ポリエチレングリコールジグリシジルエーテル、プロピレングリコールジグリシジルエーテル、トリプロピレングリコールジグリシジルエーテル、ポリプロピレングリコールジグリシジルエーテル、ネオペンチルグリコールジグリシジルエーテル、1,6−ヘキサンジオールジグリシジルエーテル、グリセリンジグリシジルエーテル、2,2−ジブロモネオペンチルグリコールジグリシジルエーテル、1,3,5,6−テトラグリシジル−2,4−ヘキサンジオール、N,N,N’,N’,−テトラグリシジル−m−キシレンジアミン、1,3−ビス(N,N−ジグリシジルアミノメチル)シクロヘキサン、N,N,N’,N’,−テトラグリシジル−4、4’−ジアミノジフェニルメタンなどが挙げられる。 For example, 3-aminopropyltrimethoxysilane, 3-aminopropyltriethoxysilane, 2-aminopropyltrimethoxysilane, 2-aminopropyltriethoxysilane, N- (2-aminoethyl) -3-aminopropyltrimethoxysilane N- (2-aminoethyl) -3-aminopropylmethyldimethoxysilane, 3-ureidopropyltrimethoxysilane, 3-ureidopropyltriethoxysilane, N-ethoxycarbonyl-3-aminopropyltrimethoxysilane, N-ethoxy Carbonyl-3-aminopropyltriethoxysilane, N-triethoxysilylpropyltriethylenetriamine, N-trimethoxysilylpropyltriethylenetriamine, 10-trimethoxysilyl-1,4,7-triazadecane, 10-tri Toxisilyl-1,4,7-triazadecane, 9-trimethoxysilyl-3,6-diazanonyl acetate, 9-triethoxysilyl-3,6-diazanonyl acetate, N-benzyl-3-aminopropyltrimethoxy Silane, N-benzyl-3-aminopropyltriethoxysilane, N-phenyl-3-aminopropyltrimethoxysilane, N-phenyl-3-aminopropyltriethoxysilane, N-bis (oxyethylene) -3-aminopropyl Trimethoxysilane, N-bis (oxyethylene) -3-aminopropyltriethoxysilane, ethylene glycol diglycidyl ether, polyethylene glycol diglycidyl ether, propylene glycol diglycidyl ether, tripropylene glycol diglycidyl ether, poly Lopylene glycol diglycidyl ether, neopentyl glycol diglycidyl ether, 1,6-hexanediol diglycidyl ether, glycerin diglycidyl ether, 2,2-dibromoneopentyl glycol diglycidyl ether, 1,3,5,6-tetraglycidyl -2,4-hexanediol, N, N, N ′, N ′,-tetraglycidyl-m-xylenediamine, 1,3-bis (N, N-diglycidylaminomethyl) cyclohexane, N, N, N ′ , N ′,-tetraglycidyl-4,4′-diaminodiphenylmethane and the like.
これら基板との密着性を向上させる化合物の使用量は、液晶配向処理剤に含有される特定ポリイミド成分の100質量部に対して0.1〜30質量部であることが好ましく、より好ましくは1〜20質量部である。0.1質量部未満であると密着性向上の効果は期待できず、30質量部よりも多くなると液晶の配向性が悪くなる場合がある。 It is preferable that the usage-amount of the compound which improves the adhesiveness with these board | substrates is 0.1-30 mass parts with respect to 100 mass parts of the specific polyimide component contained in a liquid-crystal aligning agent, More preferably, 1 ˜20 parts by mass. If the amount is less than 0.1 part by mass, the effect of improving the adhesion cannot be expected, and if it exceeds 30 parts by mass, the orientation of the liquid crystal may deteriorate.
本発明の液晶配向処理剤には、上記の他、本発明の効果が損なわれない範囲であれば、特定ポリイミド以外のポリマー成分や、液晶配向膜の誘電率や導電性などの電気特性を変化させる目的の誘電体や導電物質、さらには、液晶配向膜にした際の膜の硬度や緻密度を高める目的の架橋性化合物を添加してもよい。
本発明の液晶配向処理剤における固形分の濃度は、目的とする液晶配向膜の膜厚によって適宜変更することができるが、欠陥のない塗膜を形成させ、且つ液晶配向膜として適切な膜厚を得ることができるという理由から1〜20質量%とすることが好ましく、より好ましくは2〜10質量%である。In addition to the above, the liquid crystal alignment treatment agent of the present invention changes the polymer components other than the specific polyimide, and the electrical characteristics such as the dielectric constant and conductivity of the liquid crystal alignment film, as long as the effects of the present invention are not impaired. It is also possible to add a target dielectric material or conductive material, and a crosslinkable compound for the purpose of increasing the hardness and density of the film when the liquid crystal alignment film is formed.
The concentration of the solid content in the liquid crystal alignment treatment agent of the present invention can be appropriately changed depending on the film thickness of the target liquid crystal alignment film, but a film having no defect is formed, and the film thickness is suitable as a liquid crystal alignment film. It is preferable to set it as 1-20 mass% from the reason that can be obtained, More preferably, it is 2-10 mass%.
<液晶配向膜・液晶表示素子>
本発明の液晶配向処理剤は、基板上に塗布、焼成した後、ラビング処理や光照射などで配向処理をして、又は垂直配向用途などでは配向処理無しで液晶配向膜として用いることができる。この際、用いる基板としては透明性の高い基板であれば特に限定されず、ガラス基板、アクリル基板やポリカーボネート基板などのプラスチック基板などを用いることができる。また、液晶駆動のためのITO電極などが形成された基板を用いることがプロセスの簡素化の観点から好ましい。また、反射型の液晶表示素子では片側の基板のみにならばシリコンウエハー等の不透明な物でも使用でき、この場合の電極はアルミ等の光を反射する材料も使用できる。<Liquid crystal alignment film and liquid crystal display element>
The liquid crystal aligning agent of the present invention can be used as a liquid crystal aligning film without applying an alignment treatment after being applied and baked on a substrate and then subjected to an alignment treatment by rubbing treatment, light irradiation, or the like. In this case, the substrate to be used is not particularly limited as long as it is a highly transparent substrate, and a glass substrate, a plastic substrate such as an acrylic substrate or a polycarbonate substrate, or the like can be used. In addition, it is preferable to use a substrate on which an ITO electrode or the like for driving liquid crystal is formed from the viewpoint of simplifying the process. Further, in the reflection type liquid crystal display element, an opaque material such as a silicon wafer can be used as long as the substrate is only on one side, and in this case, a material that reflects light such as aluminum can be used.
液晶配向処理剤の塗布方法は特に限定されないが、工業的には、スクリーン印刷、オフセット印刷、フレキソ印刷、インクジェットなどで行う方法が一般的である。その他の塗布方法としては、ディップ、ロールコーター、スリットコーター、スピンナーなどがあり、目的に応じてこれらを用いてもよい。 A method for applying the liquid crystal alignment treatment agent is not particularly limited, but industrially, a method of performing screen printing, offset printing, flexographic printing, ink jet, or the like is common. Other coating methods include dip, roll coater, slit coater, spinner and the like, and these may be used depending on the purpose.
液晶配向処理剤を基板上に塗布した後の焼成は、ホットプレートなどの加熱手段により50〜300℃、好ましくは80〜250℃で溶媒を蒸発させて、塗膜を形成させることができる。焼成後の塗膜の厚みは、厚すぎると液晶表示素子の消費電力の面で不利となり、薄すぎると液晶表示素子の信頼性が低下する場合があるので、好ましくは5〜300nm、より好ましくは10〜100nmである。液晶を水平配向や傾斜配向させる場合は、焼成後の塗膜をラビング又は偏光紫外線照射などで処理する。
本発明の液晶表示素子は、上記した手法により本発明の液晶配向剤から液晶配向膜付き基板を得た後、公知の方法で液晶セルを作成し、液晶表示素子としたものである。Firing after applying the liquid crystal aligning agent on the substrate can form a coating film by evaporating the solvent at 50 to 300 ° C., preferably 80 to 250 ° C., by a heating means such as a hot plate. If the thickness of the coating film after baking is too thick, it is disadvantageous in terms of power consumption of the liquid crystal display element, and if it is too thin, the reliability of the liquid crystal display element may be lowered, so it is preferably 5 to 300 nm, more preferably 10-100 nm. When the liquid crystal is aligned horizontally or tilted, the fired coating film is treated by rubbing or irradiation with polarized ultraviolet rays.
The liquid crystal display element of the present invention is a liquid crystal display element obtained by obtaining a substrate with a liquid crystal alignment film from the liquid crystal aligning agent of the present invention by the method described above, and then preparing a liquid crystal cell by a known method.
液晶セル作成の一例を挙げるならば、液晶配向膜の形成された1対の基板を用意し、片方の基板の液晶配向膜上にスペーサーを散布し、液晶配向膜面が内側になるようにして、もう片方の基板を貼り合わせ、液晶を減圧注入して封止する方法、又は、スペーサーを散布した液晶配向膜面に液晶を滴下した後に基板を貼り合わせて封止を行う方法などが例示できる。このときのスペーサーの厚みは、好ましくは1〜30μm、より好ましくは2〜10μmである。
以上のようにして、本発明の液晶配向処理剤を用いて作製された液晶表示素子は、信頼性に優れたものとなり、大画面で高精細の液晶テレビなどに好適に利用できる。To give an example of creating a liquid crystal cell, prepare a pair of substrates on which a liquid crystal alignment film is formed, and spray spacers on the liquid crystal alignment film on one substrate so that the liquid crystal alignment film surface is on the inside. Examples include a method of bonding the other substrate and injecting the liquid crystal under reduced pressure, or a method of sealing the liquid crystal after dropping the liquid crystal on the liquid crystal alignment film surface on which the spacers are dispersed, and the like. . The thickness of the spacer at this time is preferably 1 to 30 μm, more preferably 2 to 10 μm.
As described above, the liquid crystal display device manufactured using the liquid crystal aligning agent of the present invention has excellent reliability and can be suitably used for a large-screen, high-definition liquid crystal television.
以下に実施例及び比較例を挙げ、本発明を更に詳しく説明するが、本発明の解釈はこれらの実施例に限定されるものではない。
本実施例で使用する略号の説明は、以下の通りである。
(テトラカルボン酸二無水物)
CBDA:1,2,3,4−シクロブタンテトラカルボン酸二無水物
BODA:ビシクロ[3,3,0]オクタン−2,4,6,8−テトラカルボン酸二無水物EXAMPLES The present invention will be described in more detail below with reference to examples and comparative examples, but the interpretation of the present invention is not limited to these examples.
The explanation of the abbreviations used in this example is as follows.
(Tetracarboxylic dianhydride)
CBDA: 1,2,3,4-cyclobutanetetracarboxylic dianhydride BODA: bicyclo [3,3,0] octane-2,4,6,8-tetracarboxylic dianhydride
(ジアミン)
DBA:3,5−ジアミノ安息香酸
m−PBCH5DABz:1,3−ジアミノ−5−{4−〔トランス−4−(トランス−4−n−ペンチルシクロへキシル)シクロへキシル〕フェノキシメチル}ベンゼン
m−BPCH5DABz:1,3−ジアミノ−5−{4−〔4−(トランス−4−n−ペンチルシクロへキシル)フェニル〕フェノキシメチル}ベンゼン
p−PBCH5DABz:1,4−ジアミノ−5−{4−〔トランス−4−(トランス−4−n−ペンチルシクロへキシル)シクロへキシル〕フェノキシメチル}ベンゼン
PCH7DAB:1,3−ジアミノ−4−〔4−(トランス−4−n−ヘプチルシクロへキシル)フェノキシ〕ベンゼン(Diamine)
DBA: 3,5-diaminobenzoic acid m-PBCH5DABz: 1,3-diamino-5- {4- [trans-4- (trans-4-n-pentylcyclohexyl) cyclohexyl] phenoxymethyl} benzene m -BPCH5DABz: 1,3-diamino-5- {4- [4- (trans-4-n-pentylcyclohexyl) phenyl] phenoxymethyl} benzene p-PBCH5DABz: 1,4-diamino-5- {4- [Trans-4- (trans-4-n-pentylcyclohexyl) cyclohexyl] phenoxymethyl} benzene PCH7DAB: 1,3-diamino-4- [4- (trans-4-n-heptylcyclohexyl) Phenoxy] benzene
3−AMP:3−アミノメチルピリジン
4−AMP:4−アミノメチルピリジン
AEP:4−(2−アミノエチル)ピリジン
API:1−(3−アミノプロピル)イミダゾール
2−AMMP:2−(アミノメチル)−5−メチルピラジン
3-AMP: 3-aminomethylpyridine 4-AMP: 4-aminomethylpyridine AEP: 4- (2-aminoethyl) pyridine API: 1- (3-aminopropyl) imidazole 2-AMMP: 2- (aminomethyl) -5-methylpyrazine
Py:ピリジン
AP:3−アミノピリジン
HA:へキシルアミン
Py: pyridine AP: 3-aminopyridine HA: hexylamine
NMP:N−メチル−2−ピロリドン
BCS:ブチルセロソルブ
NMP: N-methyl-2-pyrrolidone BCS: Butyl cellosolve
<ポリイミドの分子量測定>
合成例におけるポリイミドの分子量は、センシュー科学社製 常温ゲル浸透クロマトグラフィー(GPC)装置(SSC−7200)、Shodex社製カラム(KD−803、KD−805)を用い以下のようにして測定した。
カラム温度:50℃
溶離液:N,N’−ジメチルホルムアミド(添加剤として、臭化リチウム−水和物(LiBr・H2O)が30mmol/L、リン酸・無水結晶(o−リン酸)が30mmol/L、テトラヒドロフラン(THF)が10ml/L)
流速:1.0ml/分
検量線作成用標準サンプル:東ソー社製 TSK 標準ポリエチレンオキサイド(分子量 約9000,000、150,000、100,000、30,000)、および、ポリマーラボラトリー社製 ポリエチレングリコール(分子量 約12,000、4,000、1,000)。<Measurement of molecular weight of polyimide>
The molecular weight of the polyimide in the synthesis example was measured as follows using a room temperature gel permeation chromatography (GPC) apparatus (SSC-7200) manufactured by Senshu Science Co., Ltd. and a column (KD-803, KD-805) manufactured by Shodex.
Column temperature: 50 ° C
Eluent: N, N′-dimethylformamide (as additives, lithium bromide-hydrate (LiBr · H 2 O) 30 mmol / L, phosphoric acid / anhydrous crystal (o-phosphoric acid) 30 mmol / L, tetrahydrofuran ( THF) is 10 ml / L)
Flow rate: 1.0 ml / standard sample for preparing a calibration curve: TSK standard polyethylene oxide (molecular weight of about 9,000,150,000, 100,000, 30,000) manufactured by Tosoh Corporation, and polyethylene glycol (manufactured by Polymer Laboratories) Molecular weight about 12,000, 4,000, 1,000).
<イミド化率の測定>
合成例におけるポリイミドのイミド化率は次のようにして測定した。ポリイミド粉末20mgをNMRサンプル管(草野科学社製 NMRサンプリングチューブスタンダード φ5)に入れ、重水素化ジメチルスルホキシド(DMSO−d6、0.05%TMS混合品)0.53mlを添加し、超音波をかけて完全に溶解させた。この溶液を日本電子データム(株)製NMR測定器(JNW−ECA500)にて500MHzのプロトンNMRを測定した。イミド化率は、イミド化前後で変化しない構造に由来するプロトンを基準プロトンとして決め、このプロトンのピーク積算値と、9.5〜10.0ppm付近に現れるアミック酸のNH基に由来するプロトンピーク積算値とを用い以下の式によって求めた。
イミド化率(%)=(1−α・x/y)×100
上記式において、xはアミック酸のNH基由来のプロトンピーク積算値、yは基準プロトンのピーク積算値、αはポリアミック酸(イミド化率が0%)の場合におけるアミック酸のNH基プロトン1個に対する基準プロトンの個数割合である。
<カルボキシル基量の算出方法>
先に記載した方法により算出した。<Measurement of imidization ratio>
The imidation ratio of polyimide in the synthesis example was measured as follows. Add 20 mg of polyimide powder to an NMR sample tube (NMR sampling tube standard φ5 by Kusano Kagaku Co., Ltd.), add 0.53 ml of deuterated dimethyl sulfoxide (DMSO-d 6 , 0.05% TMS mixture), and apply ultrasonic waves. To dissolve completely. 500 MHz proton NMR was measured for this solution with the NMR measuring device (JNW-ECA500) by JEOL datum. The imidation rate is determined based on protons derived from structures that do not change before and after imidation as reference protons, and the peak integrated value of these protons and proton peaks derived from NH groups of amic acid appearing in the vicinity of 9.5 to 10.0 ppm. It calculated | required by the following formula | equation using the integrated value.
Imidation ratio (%) = (1−α · x / y) × 100
In the above formula, x is the proton peak integrated value derived from the NH group of the amic acid, y is the peak integrated value of the reference proton, α is one NH group proton of the amic acid in the case of polyamic acid (imidation rate is 0%) Is the number ratio of the reference proton to.
<Calculation method of carboxyl group amount>
It was calculated by the method described above.
<合成例1>
BODA(4.41g,17.6mmol)、DBA(2.86g,18.8mmol)、及び側鎖ジアミンとしてm−PBCH5DABz(2.11g,4.70mmol)をNMP(23.0g)中で混合し、80℃で5時間反応させた後、CBDA(1.01g,5.15mmol)とNMP(18.0)gを加え、40℃で6時間反応させポリアミド酸溶液を得た。
このポリアミド酸溶液(20.0g)にNMPを加え6質量%に希釈した後、イミド化触媒として無水酢酸(2.53g)、及びピリジン(1.96g)を加え、80℃で3時間反応させた。この反応溶液をメタノール(270ml)中に投入し、得られた沈殿物を濾別した。この沈殿物をメタノールで洗浄し、100℃で減圧乾燥しポリイミド粉末(A)を得た。このポリイミドのイミド化率は40%であり、数平均分子量は17,300、重量平均分子量は46,800であった。このポリイミドにおけるカルボキシル基の量は、繰り返し単位に対して2.0個である。<Synthesis Example 1>
BODA (4.41 g, 17.6 mmol), DBA (2.86 g, 18.8 mmol) and m-PBCH5DABz (2.11 g, 4.70 mmol) as side chain diamine were mixed in NMP (23.0 g). After reacting at 80 ° C. for 5 hours, CBDA (1.01 g, 5.15 mmol) and NMP (18.0) g were added and reacted at 40 ° C. for 6 hours to obtain a polyamic acid solution.
After adding NMP to this polyamic acid solution (20.0 g) and diluting to 6% by mass, acetic anhydride (2.53 g) and pyridine (1.96 g) were added as an imidization catalyst and reacted at 80 ° C. for 3 hours. It was. This reaction solution was put into methanol (270 ml), and the resulting precipitate was separated by filtration. This deposit was wash | cleaned with methanol, and it dried under reduced pressure at 100 degreeC, and obtained the polyimide powder (A). The imidation ratio of this polyimide was 40%, the number average molecular weight was 17,300, and the weight average molecular weight was 46,800. The amount of carboxyl groups in this polyimide is 2.0 with respect to the repeating unit.
<合成例2>
BODA(32.28g,129.2mmol)、DBA(18.32g,120.4mmol)、及び側鎖ジアミンとしてm−PBCH5DABz(23.16g,51.6mmol)をNMP(172.1g)中で混合し、80℃で5時間反応させた後、CBDA(8.20g,42.0mmol)とNMP(152.0)gを加え、40℃で6時間反応させポリアミド酸溶液を得た。
このポリアミド酸溶液(150.0g)にNMPを加え6質量%に希釈した後、イミド化触媒として無水酢酸(16.13g)、及びピリジン(12.45g)を加え、80℃で3時間反応させた。この反応溶液をメタノール(1900ml)中に投入し、得られた沈殿物を濾別した。この沈殿物をメタノールで洗浄し、100℃で減圧乾燥しポリイミド粉末(B)を得た。このポリイミドのイミド化率は80%であり、数平均分子量は19,700、重量平均分子量は52,200であった。このポリイミドにおけるカルボキシル基の量は、繰り返し単位に対して1.1個である。<Synthesis Example 2>
BODA (32.28 g, 129.2 mmol), DBA (18.32 g, 120.4 mmol), and m-PBCH5DABz (23.16 g, 51.6 mmol) as side chain diamine were mixed in NMP (172.1 g). After reacting at 80 ° C. for 5 hours, CBDA (8.20 g, 42.0 mmol) and NMP (152.0) g were added and reacted at 40 ° C. for 6 hours to obtain a polyamic acid solution.
After adding NMP to this polyamic acid solution (150.0 g) and diluting to 6% by mass, acetic anhydride (16.13 g) and pyridine (12.45 g) are added as an imidization catalyst and reacted at 80 ° C. for 3 hours. It was. This reaction solution was poured into methanol (1900 ml), and the resulting precipitate was filtered off. This deposit was wash | cleaned with methanol, and it dried under reduced pressure at 100 degreeC, and obtained the polyimide powder (B). The imidation ratio of this polyimide was 80%, the number average molecular weight was 19,700, and the weight average molecular weight was 52,200. The amount of carboxyl groups in this polyimide is 1.1 with respect to the repeating unit.
<合成例3>
合成例2で得たポリアミド酸溶液(30.2g)にNMPを加え6質量%に希釈した後、イミド化触媒として無水酢酸(6.41g)、及びトリエチルアミン(2.27g)を加え、100℃で4時間反応させた。この反応溶液に蓚酸(2.82g)を加え中和した後、メタノール(350ml)中に投入し、得られた沈殿物を濾別した。この沈殿物をメタノールで洗浄し、100℃で減圧乾燥しポリイミド粉末(C)を得た。このポリイミドのイミド化率は98%であり、数平均分子量は19,200、重量平均分子量は51,200であった。このポリイミドにおけるカルボキシル基の量は、繰り返し単位に対して0.74個である。<Synthesis Example 3>
After adding NMP to the polyamic acid solution (30.2 g) obtained in Synthesis Example 2 and diluting to 6% by mass, acetic anhydride (6.41 g) and triethylamine (2.27 g) were added as an imidization catalyst, and 100 ° C. For 4 hours. The reaction solution was neutralized by adding oxalic acid (2.82 g), and then poured into methanol (350 ml), and the resulting precipitate was separated by filtration. This deposit was wash | cleaned with methanol, and it dried under reduced pressure at 100 degreeC, and obtained the polyimide powder (C). The imidation ratio of this polyimide was 98%, the number average molecular weight was 19,200, and the weight average molecular weight was 51,200. The amount of carboxyl groups in this polyimide is 0.74 with respect to the repeating unit.
<合成例4>
BODA(3.90g,15.6mmol)、DBA(2.16g,14.2mmol)、及び側鎖ジアミンとしてm−BPCH5DABz(2.65g,6.10mmol)をNMP(18.0g)中で混合し、80℃で5時間反応させた後、CBDA(0.93g,4.74mmol)とNMP(14.4g)を加え、40℃で6時間反応させポリアミド酸溶液を得た。
このポリアミド酸溶液(30.0g)にNMPを加え6質量%に希釈した後、イミド化触媒として無水酢酸(3.23g)、及びピリジン(2.49g)を加え、80℃で3時間反応させた。この反応溶液をメタノール(380ml)中に投入し、得られた沈殿物を濾別した。この沈殿物をメタノールで洗浄し、100℃で減圧乾燥しポリイミド粉末(D)を得た。このポリイミドのイミド化率は82%であり、数平均分子量は17,100、重量平均分子量は48,400であった。このポリイミドにおけるカルボキシル基の量は、繰り返し単位に対して1.06個である。<Synthesis Example 4>
BODA (3.90 g, 15.6 mmol), DBA (2.16 g, 14.2 mmol) and m-BPCH5DABz (2.65 g, 6.10 mmol) as side chain diamine were mixed in NMP (18.0 g). After reacting at 80 ° C. for 5 hours, CBDA (0.93 g, 4.74 mmol) and NMP (14.4 g) were added and reacted at 40 ° C. for 6 hours to obtain a polyamic acid solution.
After adding NMP to this polyamic acid solution (30.0 g) and diluting to 6% by mass, acetic anhydride (3.23 g) and pyridine (2.49 g) were added as an imidization catalyst and reacted at 80 ° C. for 3 hours. It was. This reaction solution was poured into methanol (380 ml), and the resulting precipitate was filtered off. This deposit was wash | cleaned with methanol, and it dried under reduced pressure at 100 degreeC, and obtained the polyimide powder (D). The imidation ratio of this polyimide was 82%, the number average molecular weight was 17,100, and the weight average molecular weight was 48,400. The amount of carboxyl groups in this polyimide is 1.06 with respect to the repeating unit.
<合成例5>
BODA(3.28g,13.1mmol)、DBA(2.42g,15.9mmol)、及び側鎖ジアミンとしてp−PBCH5DABz(2.26g,5.03mmol)をNMP(14.0g)中で混合し、80℃で5時間反応させた後、CBDA(0.72g,3.68mmol)とNMP(11.3g)を加え、40℃で6時間反応させポリアミド酸溶液を得た。
このポリアミド酸溶液(30.1g)にNMPを加え6質量%に希釈した後、イミド化触媒として無水酢酸(3.22g)、及びピリジン(2.51g)を加え、80℃で3時間反応させた。この反応溶液をメタノール(380ml)中に投入し、得られた沈殿物を濾別した。この沈殿物をメタノールで洗浄し、100℃で減圧乾燥しポリイミド粉末(E)を得た。このポリイミドのイミド化率は80%であり、数平均分子量は18,400、重量平均分子量は49,900であった。このポリイミドにおけるカルボキシル基の量は、繰り返し単位に対して1.1個である。<Synthesis Example 5>
BODA (3.28 g, 13.1 mmol), DBA (2.42 g, 15.9 mmol), and p-PBCH5DABz (2.26 g, 5.03 mmol) as side chain diamine were mixed in NMP (14.0 g). After reacting at 80 ° C. for 5 hours, CBDA (0.72 g, 3.68 mmol) and NMP (11.3 g) were added and reacted at 40 ° C. for 6 hours to obtain a polyamic acid solution.
After adding NMP to this polyamic acid solution (30.1 g) and diluting to 6% by mass, acetic anhydride (3.22 g) and pyridine (2.51 g) were added as an imidization catalyst and reacted at 80 ° C. for 3 hours. It was. This reaction solution was poured into methanol (380 ml), and the resulting precipitate was filtered off. This deposit was wash | cleaned with methanol, and it dried under reduced pressure at 100 degreeC, and obtained the polyimide powder (E). The imidation ratio of this polyimide was 80%, the number average molecular weight was 18,400, and the weight average molecular weight was 49,900. The amount of carboxyl groups in this polyimide is 1.1 with respect to the repeating unit.
<合成例6>
BODA(15.0g,60.0mmol)、DBA(9.74g,64.0mmol)、及び側鎖ジアミンとしてPCH7DAB(6.09g,16.0mmol)をNMP(131g)中で混合し、80℃で5時間反応させた後、CBDA(3.88g,19.8mmol)とNMP(30g)を加え、40℃で3時間反応させポリアミド酸溶液を得た。
このポリアミド酸溶液(10.0g)にNMPを加え6質量%に希釈した後、イミド化触媒として無水酢酸(1.27g)、及びピリジン(0.98g)を加え、80℃で3時間反応させた。この反応溶液をメタノール(140ml)中に投入し、得られた沈殿物を濾別した。この沈殿物をメタノールで洗浄し、100℃で減圧乾燥しポリイミド粉末(F)を得た。このポリイミドのイミド化率は46%であり、数平均分子量は20,200、重量平均分子量は62,500であった。このポリイミドにおけるカルボキシル基の量は、繰り返し単位に対して1.88個である。<Synthesis Example 6>
BODA (15.0 g, 60.0 mmol), DBA (9.74 g, 64.0 mmol) and PCH7DAB (6.09 g, 16.0 mmol) as side chain diamine were mixed in NMP (131 g) at 80 ° C. After reacting for 5 hours, CBDA (3.88 g, 19.8 mmol) and NMP (30 g) were added and reacted at 40 ° C. for 3 hours to obtain a polyamic acid solution.
After adding NMP to this polyamic acid solution (10.0 g) and diluting to 6% by mass, acetic anhydride (1.27 g) and pyridine (0.98 g) were added as an imidization catalyst and reacted at 80 ° C. for 3 hours. It was. This reaction solution was poured into methanol (140 ml), and the resulting precipitate was filtered off. This deposit was wash | cleaned with methanol, and it dried under reduced pressure at 100 degreeC, and obtained the polyimide powder (F). The imidation ratio of this polyimide was 46%, the number average molecular weight was 20,200, and the weight average molecular weight was 62,500. The amount of carboxyl groups in this polyimide is 1.88 with respect to the repeating unit.
<合成例7>
BODA(150.1g,600mmol)、DBA(60.9g,400mmol)、及び側鎖ジアミンとしてPCH7DAB(152.2g,400mmol)をNMP(1290g)中で混合し、80℃で5時間反応させた後、CBDA(38.8g,198mmol)とNMP(320g)を加え、40℃で3時間反応させポリアミド酸溶液を得た。
このポリアミド酸溶液(101.2g)にNMPを加え6質量%に希釈した後、イミド化触媒として無水酢酸(21.3g)、及びピリジン(16.5g)を加え、90℃で3時間反応させた。この反応溶液をメタノール(1300ml)中に投入し、得られた沈殿物を濾別した。この沈殿物をメタノールで洗浄し、100℃で減圧乾燥しポリイミド粉末(G)を得た。このポリイミドのイミド化率は81%であり、数平均分子量は20,400、重量平均分子量は63,000であった。このポリイミドにおけるカルボキシル基の量は、繰り返し単位に対して0.88個である。<Synthesis Example 7>
BODA (150.1 g, 600 mmol), DBA (60.9 g, 400 mmol) and PCH7DAB (152.2 g, 400 mmol) as side chain diamine were mixed in NMP (1290 g) and reacted at 80 ° C. for 5 hours. CBDA (38.8 g, 198 mmol) and NMP (320 g) were added and reacted at 40 ° C. for 3 hours to obtain a polyamic acid solution.
After adding NMP to this polyamic acid solution (101.2 g) and diluting to 6% by mass, acetic anhydride (21.3 g) and pyridine (16.5 g) were added as an imidization catalyst and reacted at 90 ° C. for 3 hours. It was. This reaction solution was put into methanol (1300 ml), and the resulting precipitate was separated by filtration. This deposit was wash | cleaned with methanol, and it dried under reduced pressure at 100 degreeC, and obtained the polyimide powder (G). The imidation ratio of this polyimide was 81%, the number average molecular weight was 20,400, and the weight average molecular weight was 63,000. The amount of carboxyl groups in this polyimide is 0.88 with respect to the repeating unit.
<実施例1>
合成例1で得たポリイミド粉末(A)(1.65g)にNMP(9.34g)を加え、70℃にて40時間攪拌して溶解させた。この溶液に3−AMPの10質量%NMP溶液(0.50g)(3−AMPとして0.050g)、NMP(3.43g)、及びBCS(12.5g)を加え、50℃にて15時間攪拌することで、液晶配向処理剤[1]を得た。この液晶配向処理剤に濁りや析出などの異常は見られず、樹脂成分は均一に溶解していることが確認された。<Example 1>
NMP (9.34 g) was added to the polyimide powder (A) (1.65 g) obtained in Synthesis Example 1, and dissolved by stirring at 70 ° C. for 40 hours. To this solution was added 10 mass% NMP solution (0.50 g) of 3-AMP (0.050 g as 3-AMP), NMP (3.43 g), and BCS (12.5 g), and 15 hours at 50 ° C. The liquid crystal aligning agent [1] was obtained by stirring. Abnormalities such as turbidity and precipitation were not observed in this liquid crystal alignment treatment agent, and it was confirmed that the resin component was uniformly dissolved.
<液晶セルの作製>
上記で得た液晶配向処理剤[1]を3cm×4cmITO電極付き基板のITO面にスピンコートし、80℃で5分間、210℃の熱風循環式オーブンで1時間焼成を行い、膜厚100nmのポリイミド塗膜を作製した。
この液晶配向膜付き基板を、ロール径120mm、レーヨン布のラビング装置にて、回転数300rpm、ロール進行速度20mm/sec、押し込み量0.3mmの条件にてラビング処理をし、液晶配向膜付き基板を得た。
この液晶配向膜付き基板を2枚用意し、その1枚の液晶配向膜面上に6μmのビーズスペーサーを散布した後、その上からシール剤を印刷した。もう1枚の基板を液晶配向膜面を内側にし、ラビング方向が逆向きになるようにして張り合わせた後、シール剤を硬化させて空セルを作製した。この空セルに減圧注入法によって、アンチパラレル配向のネマチック液晶セルを得た。<Production of liquid crystal cell>
The liquid crystal aligning agent [1] obtained above was spin-coated on the ITO surface of the substrate with 3 cm × 4 cm ITO electrode, and baked at 80 ° C. for 5 minutes and in a 210 ° C. hot air circulating oven for 1 hour. A polyimide coating was prepared.
This substrate with a liquid crystal alignment film is subjected to a rubbing treatment with a roll diameter 120 mm, a rayon cloth rubbing device under the conditions of a rotation speed of 300 rpm, a roll traveling speed of 20 mm / sec, and an indentation amount of 0.3 mm. Got.
Two substrates with this liquid crystal alignment film were prepared, and a 6 μm bead spacer was sprayed on the surface of one liquid crystal alignment film, and then a sealant was printed thereon. Another substrate was bonded so that the liquid crystal alignment film surface was inside and the rubbing direction was reversed, and then the sealing agent was cured to produce an empty cell. An antiparallel aligned nematic liquid crystal cell was obtained by vacuum injection into this empty cell.
<プレチルト角の評価>
上記で作製した液晶セルのプレチルト角を、プレチルト角測定装置(ELSICON社製 モデル:PAS−301)を用いて室温でのプレチルト角を測定した。結果は、後述する表2に示す。
また、ラビング処理をしなかった以外は上記と同様に作製した液晶セルを偏光顕微鏡で観察したところ、液晶は均一に垂直配向していることが確認された。<Evaluation of pretilt angle>
The pretilt angle of the liquid crystal cell produced above was measured at room temperature using a pretilt angle measuring device (ELSICON model: PAS-301). The results are shown in Table 2 described later.
Moreover, when the liquid crystal cell produced similarly to the above except having not rubbed was observed with the polarization microscope, it was confirmed that the liquid crystal was uniformly vertically aligned.
<電圧保持率の評価>
プレチルト角測定後の液晶セルに、80℃の温度下で4Vの電圧を60μs印加し、16.67ms後及び1667ms後の電圧を測定し、電圧がどのくらい保持できているかを電圧保持率として計算した。結果は、後述する表3に示す。
<残留電荷の緩和の評価>
電圧保持率測定後の液晶セルに、直流電圧10Vを30分印加し、1秒間短絡させた後、液晶セル内に発生している電位を1800秒間測定した。そして、50秒後及び1000秒後の残留電荷を測定した。なお、測定には東陽テクニカ社製6254型液晶物性評価装置を用いた。結果は、後述する表4に示す。<Evaluation of voltage holding ratio>
A voltage of 4 V was applied to the liquid crystal cell after the pretilt angle measurement at a temperature of 80 ° C. for 60 μs, the voltage after 16.67 ms and 1667 ms was measured, and the voltage holding ratio was calculated as the voltage holding ratio. . The results are shown in Table 3 described later.
<Evaluation of residual charge relaxation>
A DC voltage of 10 V was applied to the liquid crystal cell after measuring the voltage holding ratio for 30 minutes and short-circuited for 1 second, and then the potential generated in the liquid crystal cell was measured for 1800 seconds. The residual charges after 50 seconds and 1000 seconds were measured. For measurement, a 6254 type liquid crystal physical property evaluation apparatus manufactured by Toyo Technica Co., Ltd. was used. The results are shown in Table 4 described later.
<高温放置後の評価>
残留電荷測定後の液晶セルを、100℃に設定した高温槽に7日間放置した後、電圧保持率及び残留電荷の測定を行った。結果は、後述する表3及び表4に示す。
<紫外線照射後の電圧保持率の評価>
上記で作製した液晶セルに、80℃の温度下で4Vの電圧を60μs印加し、16.67ms後及び1667ms後の電圧を測定し、電圧がどのくらい保持できているかを電圧保持率として計算した。さらに、測定後、卓上型UV硬化装置(HCT3 B28 HEX−1(セン特殊光源社製))により、365nmにおける照射量が10J/cm2の紫外線を液晶セルに照射し、同様の条件で電圧保持率を測定した。結果は、後述する表5に示す。<Evaluation after leaving at high temperature>
The liquid crystal cell after the residual charge measurement was left in a high-temperature bath set at 100 ° C. for 7 days, and then the voltage holding ratio and the residual charge were measured. The results are shown in Tables 3 and 4 below.
<Evaluation of voltage holding ratio after UV irradiation>
A voltage of 4 V was applied to the liquid crystal cell produced above at a temperature of 80 ° C. for 60 μs, the voltage after 16.67 ms and after 1667 ms was measured, and the voltage holding ratio was calculated as the voltage holding ratio. Furthermore, after the measurement, the liquid crystal cell was irradiated with ultraviolet rays having a dose of 10 J / cm 2 at 365 nm by a desktop UV curing device (HCT3 B28 HEX-1 (manufactured by Sen Special Light Source)), and the voltage was maintained under the same conditions. The rate was measured. The results are shown in Table 5 described later.
<実施例2>
合成例2で得たポリイミド粉末(B)(1.67g)にNMP(9.46g)を加え、70℃にて40時間攪拌して溶解させた。この溶液に3−AMPの10質量%NMP溶液(0.50g)(3−AMPとして0.050g)、NMP(3.47g)、及びBCS(12.5g)を加え、50℃にて15時間攪拌することで、液晶配向処理剤[2]を得た。この液晶配向処理剤に濁りや析出などの異常は見られず、樹脂成分は均一に溶解していることが確認された。
得られた液晶配向処理剤[2]を用い、実施例1と同様に液晶セルを作製し、プレチルト角の評価を行った。結果は、後述する表2に示す。なお、ラビング処理をしなかった以外は実施例1と同様に作製した液晶セルを偏光顕微鏡で観察したところ、液晶は均一に垂直配向していることが確認された。
また、実施例1と同様に作製した液晶セルを用いて、電圧保持率の評価、残留電荷の緩和の評価、高温放置後の評価及び紫外線照射後の電圧保持率の評価を行った。結果は、後述する表3、表4及び表5に示す。<Example 2>
NMP (9.46 g) was added to the polyimide powder (B) (1.67 g) obtained in Synthesis Example 2, and dissolved by stirring at 70 ° C. for 40 hours. To this solution was added 10 mass% NMP solution (0.50 g) of 3-AMP (0.050 g as 3-AMP), NMP (3.47 g), and BCS (12.5 g), and the mixture was stirred at 50 ° C. for 15 hours. The liquid crystal aligning agent [2] was obtained by stirring. Abnormalities such as turbidity and precipitation were not observed in this liquid crystal alignment treatment agent, and it was confirmed that the resin component was uniformly dissolved.
Using the obtained liquid crystal aligning agent [2], a liquid crystal cell was produced in the same manner as in Example 1, and the pretilt angle was evaluated. The results are shown in Table 2 described later. In addition, when the liquid crystal cell produced similarly to Example 1 was observed with the polarization microscope except having not rubbed, it was confirmed that the liquid crystal was uniformly vertically aligned.
Further, using the liquid crystal cell produced in the same manner as in Example 1, evaluation of voltage holding ratio, evaluation of relaxation of residual charge, evaluation after standing at high temperature, and evaluation of voltage holding ratio after ultraviolet irradiation were performed. The results are shown in Table 3, Table 4 and Table 5 described later.
<実施例3>
合成例2で得たポリイミド粉末(B)(1.65g)にNMP(9.34g)を加え、70℃にて40時間攪拌して溶解させた。この溶液に3−AMPの10質量%NMP溶液(0.83g)(3−AMPとして0.083g)、NMP(3.14g)、及びBCS(12.4g)を加え、50℃にて15時間攪拌することで、液晶配向処理剤[3]を得た。この液晶配向処理剤に濁りや析出などの異常は見られず、樹脂成分は均一に溶解していることが確認された。
得られた液晶配向処理剤[3]を用い、実施例1と同様に液晶セルを作製し、プレチルト角の評価を行った。結果は、後述する表2に示す。なお、ラビング処理をしなかった以外は実施例1と同様に作製した液晶セルを偏光顕微鏡で観察したところ、液晶は均一に垂直配向していることが確認された。
また、実施例1と同様に作製した液晶セルを用いて、電圧保持率の評価、残留電荷の緩和の評価、高温放置後の評価及び紫外線照射後の電圧保持率の評価を行った。結果は、後述する表3、表4及び表5に示す。<Example 3>
NMP (9.34 g) was added to the polyimide powder (B) (1.65 g) obtained in Synthesis Example 2 and dissolved by stirring at 70 ° C. for 40 hours. To this solution was added 10 mass% NMP solution (0.83 g) of 3-AMP (0.083 g as 3-AMP), NMP (3.14 g), and BCS (12.4 g), and the mixture was stirred at 50 ° C. for 15 hours. The liquid crystal aligning agent [3] was obtained by stirring. Abnormalities such as turbidity and precipitation were not observed in this liquid crystal alignment treatment agent, and it was confirmed that the resin component was uniformly dissolved.
Using the obtained liquid crystal aligning agent [3], a liquid crystal cell was produced in the same manner as in Example 1, and the pretilt angle was evaluated. The results are shown in Table 2 described later. In addition, when the liquid crystal cell produced similarly to Example 1 was observed with the polarization microscope except having not rubbed, it was confirmed that the liquid crystal was uniformly vertically aligned.
Further, using the liquid crystal cell produced in the same manner as in Example 1, evaluation of voltage holding ratio, evaluation of relaxation of residual charge, evaluation after standing at high temperature, and evaluation of voltage holding ratio after ultraviolet irradiation were performed. The results are shown in Table 3, Table 4 and Table 5 described later.
<実施例4>
合成例2で得たポリイミド粉末(B)(1.65g)にNMP(9.34g)を加え、70℃にて40時間攪拌して溶解させた。この溶液に3−AMPの10質量%NMP溶液(1.16g)(3−AMPとして0.116g)、NMP(2.84g)、及びBCS(12.4g)を加え、50℃にて15時間攪拌することで、液晶配向処理剤[4]を得た。この液晶配向処理剤に濁りや析出などの異常は見られず、樹脂成分は均一に溶解していることが確認された。
得られた液晶配向処理剤[4]を用い、実施例1と同様に液晶セルを作製し、プレチルト角の評価を行った。結果は、後述する表2に示す。なお、ラビング処理をしなかった以外は実施例1と同様に作製した液晶セルを偏光顕微鏡で観察したところ、液晶は均一に垂直配向していることが確認された。
また、実施例1と同様に作製した液晶セルを用いて、電圧保持率の評価、残留電荷の緩和の評価、高温放置後の評価及び紫外線照射後の電圧保持率の評価を行った。結果は、後述する表3、表4及び表5に示す。<Example 4>
NMP (9.34 g) was added to the polyimide powder (B) (1.65 g) obtained in Synthesis Example 2 and dissolved by stirring at 70 ° C. for 40 hours. To this solution was added 10 mass% NMP solution (1.16 g) of 3-AMP (0.116 g as 3-AMP), NMP (2.84 g), and BCS (12.4 g), and 15 hours at 50 ° C. The liquid crystal aligning agent [4] was obtained by stirring. Abnormalities such as turbidity and precipitation were not observed in this liquid crystal alignment treatment agent, and it was confirmed that the resin component was uniformly dissolved.
Using the obtained liquid crystal aligning agent [4], a liquid crystal cell was produced in the same manner as in Example 1, and the pretilt angle was evaluated. The results are shown in Table 2 described later. In addition, when the liquid crystal cell produced similarly to Example 1 was observed with the polarization microscope except having not rubbed, it was confirmed that the liquid crystal was uniformly vertically aligned.
Further, using the liquid crystal cell produced in the same manner as in Example 1, evaluation of voltage holding ratio, evaluation of relaxation of residual charge, evaluation after standing at high temperature, and evaluation of voltage holding ratio after ultraviolet irradiation were performed. The results are shown in Table 3, Table 4 and Table 5 described later.
<実施例5>
合成例2で得たポリイミド粉末(B)(1.64g)にNMP(9.29g)を加え、70℃にて40時間攪拌して溶解させた。この溶液に3−AMPの10質量%NMP溶液(1.64g)(3−AMPとして0.164g)、NMP(2.38g)、及びBCS(12.3g)を加え、50℃にて15時間攪拌することで、液晶配向処理剤[5]を得た。この液晶配向処理剤に濁りや析出などの異常は見られず、樹脂成分は均一に溶解していることが確認された。
得られた液晶配向処理剤[5]を用い、実施例1と同様に液晶セルを作製し、プレチルト角の評価を行った。結果は、後述する表2に示す。なお、ラビング処理をしなかった以外は実施例1と同様に作製した液晶セルを偏光顕微鏡で観察したところ、液晶は均一に垂直配向していることが確認された。
また、実施例1と同様に作製した液晶セルを用いて、電圧保持率の評価、残留電荷の緩和の評価、高温放置後の評価及び紫外線照射後の電圧保持率の評価を行った。結果は、後述する表3、表4及び表5に示す。<Example 5>
NMP (9.29 g) was added to the polyimide powder (B) (1.64 g) obtained in Synthesis Example 2, and dissolved by stirring at 70 ° C. for 40 hours. To this solution was added 10 mass% NMP solution (1.64 g) of 3-AMP (0.164 g as 3-AMP), NMP (2.38 g), and BCS (12.3 g), and 15 hours at 50 ° C. The liquid crystal aligning agent [5] was obtained by stirring. Abnormalities such as turbidity and precipitation were not observed in this liquid crystal alignment treatment agent, and it was confirmed that the resin component was uniformly dissolved.
Using the obtained liquid crystal aligning agent [5], a liquid crystal cell was produced in the same manner as in Example 1, and the pretilt angle was evaluated. The results are shown in Table 2 described later. In addition, when the liquid crystal cell produced similarly to Example 1 was observed with the polarization microscope except having not rubbed, it was confirmed that the liquid crystal was uniformly vertically aligned.
Further, using the liquid crystal cell produced in the same manner as in Example 1, evaluation of voltage holding ratio, evaluation of relaxation of residual charge, evaluation after standing at high temperature, and evaluation of voltage holding ratio after ultraviolet irradiation were performed. The results are shown in Table 3, Table 4 and Table 5 described later.
<実施例6>
合成例2で得たポリイミド粉末(B)(1.65g)にNMP(9.34g)を加え、70℃にて40時間攪拌して溶解させた。この溶液に4−AMPの10質量%NMP溶液(1.16g)(4−AMPとして0.116g)、NMP(2.84g)、及びBCS(12.4g)を加え、50℃にて15時間攪拌することで、液晶配向処理剤[6]を得た。この液晶配向処理剤に濁りや析出などの異常は見られず、樹脂成分は均一に溶解していることが確認された。
得られた液晶配向処理剤[6]を用い、実施例1と同様に液晶セルを作製し、プレチルト角の評価を行った。結果は、後述する表2に示す。なお、ラビング処理をしなかった以外は実施例1と同様に作製した液晶セルを偏光顕微鏡で観察したところ、液晶は均一に垂直配向していることが確認された。
また、実施例1と同様に作製した液晶セルを用いて、電圧保持率の評価、残留電荷の緩和の評価、高温放置後の評価及び紫外線照射後の電圧保持率の評価を行った。結果は、後述する表3、表4及び表5に示す。<Example 6>
NMP (9.34 g) was added to the polyimide powder (B) (1.65 g) obtained in Synthesis Example 2 and dissolved by stirring at 70 ° C. for 40 hours. To this solution was added a 10 wt% NMP solution (1.16 g) of 4-AMP (0.116 g as 4-AMP), NMP (2.84 g), and BCS (12.4 g), and 15 hours at 50 ° C. By stirring, a liquid crystal aligning agent [6] was obtained. Abnormalities such as turbidity and precipitation were not observed in this liquid crystal alignment treatment agent, and it was confirmed that the resin component was uniformly dissolved.
Using the obtained liquid crystal aligning agent [6], a liquid crystal cell was produced in the same manner as in Example 1, and the pretilt angle was evaluated. The results are shown in Table 2 described later. In addition, when the liquid crystal cell produced similarly to Example 1 was observed with the polarization microscope except having not rubbed, it was confirmed that the liquid crystal was uniformly vertically aligned.
Further, using the liquid crystal cell produced in the same manner as in Example 1, evaluation of voltage holding ratio, evaluation of relaxation of residual charge, evaluation after standing at high temperature, and evaluation of voltage holding ratio after ultraviolet irradiation were performed. The results are shown in Table 3, Table 4 and Table 5 described later.
<実施例7>
合成例2で得たポリイミド粉末(B)(1.66g)にNMP(9.41g)を加え、70℃にて40時間攪拌して溶解させた。この溶液にAEPの10質量%NMP溶液(1.16g)(AEPとして0.116g)、NMP(2.86g)、及びBCS(12.5g)を加え、50℃にて15時間攪拌することで、液晶配向処理剤[7]を得た。この液晶配向処理剤に濁りや析出などの異常は見られず、樹脂成分は均一に溶解していることが確認された。
得られた液晶配向処理剤[7]を用い、実施例1と同様に液晶セルを作製し、プレチルト角の評価を行った。結果は、後述する表2に示す。なお、ラビング処理をしなかった以外は実施例1と同様に作製した液晶セルを偏光顕微鏡で観察したところ、液晶は均一に垂直配向していることが確認された。
また、実施例1と同様に作製した液晶セルを用いて、電圧保持率の評価、残留電荷の緩和の評価、高温放置後の評価及び紫外線照射後の電圧保持率の評価を行った。結果は、後述する表3、表4及び表5に示す。<Example 7>
NMP (9.41 g) was added to the polyimide powder (B) (1.66 g) obtained in Synthesis Example 2, and dissolved by stirring at 70 ° C. for 40 hours. A 10 mass% NMP solution (1.16 g) of AEP (0.116 g as AEP), NMP (2.86 g), and BCS (12.5 g) were added to this solution, and the mixture was stirred at 50 ° C. for 15 hours. A liquid crystal aligning agent [7] was obtained. Abnormalities such as turbidity and precipitation were not observed in this liquid crystal alignment treatment agent, and it was confirmed that the resin component was uniformly dissolved.
Using the obtained liquid crystal aligning agent [7], a liquid crystal cell was produced in the same manner as in Example 1, and the pretilt angle was evaluated. The results are shown in Table 2 described later. In addition, when the liquid crystal cell produced similarly to Example 1 was observed with the polarization microscope except having not rubbed, it was confirmed that the liquid crystal was uniformly vertically aligned.
Further, using the liquid crystal cell produced in the same manner as in Example 1, evaluation of voltage holding ratio, evaluation of relaxation of residual charge, evaluation after standing at high temperature, and evaluation of voltage holding ratio after ultraviolet irradiation were performed. The results are shown in Table 3, Table 4 and Table 5 described later.
<実施例8>
合成例2で得たポリイミド粉末(B)(1.65g)にNMP(9.34g)を加え、70℃にて40時間攪拌して溶解させた。この溶液にAPIの10質量%NMP溶液(1.16g)(APIとして0.116g)、NMP(2.84g)、及びBCS(12.4g)を加え、50℃にて15時間攪拌することで、液晶配向処理剤[8]を得た。この液晶配向処理剤に濁りや析出などの異常は見られず、樹脂成分は均一に溶解していることが確認された。
得られた液晶配向処理剤[8]を用い、実施例1と同様に液晶セルを作製し、プレチルト角の評価を行った。結果は、後述する表2に示す。なお、ラビング処理をしなかった以外は実施例1と同様に作製した液晶セルを偏光顕微鏡で観察したところ、液晶は均一に垂直配向していることが確認された。
また、実施例1と同様に作製した液晶セルを用いて、電圧保持率の評価、残留電荷の緩和の評価、高温放置後の評価及び紫外線照射後の電圧保持率の評価を行った。結果は、後述する表3、表4及び表5に示す。<Example 8>
NMP (9.34 g) was added to the polyimide powder (B) (1.65 g) obtained in Synthesis Example 2 and dissolved by stirring at 70 ° C. for 40 hours. A 10% by mass NMP solution (1.16 g) of API (0.116 g as API), NMP (2.84 g), and BCS (12.4 g) were added to this solution, and the mixture was stirred at 50 ° C. for 15 hours. A liquid crystal aligning agent [8] was obtained. Abnormalities such as turbidity and precipitation were not observed in this liquid crystal alignment treatment agent, and it was confirmed that the resin component was uniformly dissolved.
Using the obtained liquid crystal aligning agent [8], a liquid crystal cell was produced in the same manner as in Example 1, and the pretilt angle was evaluated. The results are shown in Table 2 described later. In addition, when the liquid crystal cell produced similarly to Example 1 was observed with the polarization microscope except having not rubbed, it was confirmed that the liquid crystal was uniformly vertically aligned.
Further, using the liquid crystal cell produced in the same manner as in Example 1, evaluation of voltage holding ratio, evaluation of relaxation of residual charge, evaluation after standing at high temperature, and evaluation of voltage holding ratio after ultraviolet irradiation were performed. The results are shown in Table 3, Table 4 and Table 5 described later.
<実施例9>
合成例2で得たポリイミド粉末(B)(1.65g)にNMP(9.34g)を加え、70℃にて40時間攪拌して溶解させた。この溶液に2−AMMPの10質量%NMP溶液(1.16g)(2−AMMPとして0.116g)、NMP(2.84g)、及びBCS(12.4g)を加え、50℃にて15時間攪拌することで、液晶配向処理剤[9]を得た。この液晶配向処理剤に濁りや析出などの異常は見られず、樹脂成分は均一に溶解していることが確認された。
得られた液晶配向処理剤[9]を用い、実施例1と同様に液晶セルを作製し、プレチルト角の評価を行った。結果は、後述する表2に示す。なお、ラビング処理をしなかった以外は実施例1と同様に作製した液晶セルを偏光顕微鏡で観察したところ、液晶は均一に垂直配向していることが確認された。
また、実施例1と同様に作製した液晶セルを用いて、電圧保持率の評価、残留電荷の緩和の評価、高温放置後の評価及び紫外線照射後の電圧保持率の評価を行った。結果は、後述する表3、表4及び表5に示す。<Example 9>
NMP (9.34 g) was added to the polyimide powder (B) (1.65 g) obtained in Synthesis Example 2 and dissolved by stirring at 70 ° C. for 40 hours. To this solution, a 10% by mass NMP solution (1.16 g) of 2-AMMP (0.116 g as 2-AMMP), NMP (2.84 g), and BCS (12.4 g) were added, and the mixture was stirred at 50 ° C. for 15 hours. The liquid crystal aligning agent [9] was obtained by stirring. Abnormalities such as turbidity and precipitation were not observed in this liquid crystal alignment treatment agent, and it was confirmed that the resin component was uniformly dissolved.
Using the obtained liquid crystal aligning agent [9], a liquid crystal cell was produced in the same manner as in Example 1, and the pretilt angle was evaluated. The results are shown in Table 2 described later. In addition, when the liquid crystal cell produced similarly to Example 1 was observed with the polarization microscope except having not rubbed, it was confirmed that the liquid crystal was uniformly vertically aligned.
Further, using the liquid crystal cell produced in the same manner as in Example 1, evaluation of voltage holding ratio, evaluation of relaxation of residual charge, evaluation after standing at high temperature, and evaluation of voltage holding ratio after ultraviolet irradiation were performed. The results are shown in Table 3, Table 4 and Table 5 described later.
<実施例10>
合成例3で得たポリイミド粉末(C)(1.64g)にNMP(9.29g)を加え、70℃にて40時間攪拌して溶解させた。この溶液に3−AMPの10質量%NMP溶液(1.64g)(3−AMPとして0.164g)、NMP(2.38g)、及びBCS(12.3g)を加え、50℃にて15時間攪拌することで、液晶配向処理剤[10]を得た。この液晶配向処理剤に濁りや析出などの異常は見られず、樹脂成分は均一に溶解していることが確認された。
得られた液晶配向処理剤[10]を用い、実施例1と同様に液晶セルを作製し、プレチルト角の評価を行った。結果は、後述する表2に示す。なお、ラビング処理をしなかった以外は実施例1と同様に作製した液晶セルを偏光顕微鏡で観察したところ、液晶は均一に垂直配向していることが確認された。
また、実施例1と同様に作製した液晶セルを用いて、電圧保持率の評価、残留電荷の緩和の評価、高温放置後の評価及び紫外線照射後の電圧保持率の評価を行った。結果は、後述する表3、表4及び表5に示す。<Example 10>
NMP (9.29 g) was added to the polyimide powder (C) (1.64 g) obtained in Synthesis Example 3, and dissolved by stirring at 70 ° C. for 40 hours. To this solution was added 10 mass% NMP solution (1.64 g) of 3-AMP (0.164 g as 3-AMP), NMP (2.38 g), and BCS (12.3 g), and 15 hours at 50 ° C. By stirring, a liquid crystal aligning agent [10] was obtained. Abnormalities such as turbidity and precipitation were not observed in this liquid crystal alignment treatment agent, and it was confirmed that the resin component was uniformly dissolved.
Using the obtained liquid crystal aligning agent [10], a liquid crystal cell was produced in the same manner as in Example 1, and the pretilt angle was evaluated. The results are shown in Table 2 described later. In addition, when the liquid crystal cell produced similarly to Example 1 was observed with the polarization microscope except having not rubbed, it was confirmed that the liquid crystal was uniformly vertically aligned.
Further, using the liquid crystal cell produced in the same manner as in Example 1, evaluation of voltage holding ratio, evaluation of relaxation of residual charge, evaluation after standing at high temperature, and evaluation of voltage holding ratio after ultraviolet irradiation were performed. The results are shown in Table 3, Table 4 and Table 5 described later.
<実施例11>
合成例4で得たポリイミド粉末(D)(1.65g)にNMP(9.34g)を加え、70℃にて40時間攪拌して溶解させた。この溶液に3−AMPの10質量%NMP溶液(1.16g)(3−AMPとして0.116g)、NMP(2.85g)、及びBCS(12.4g)を加え、50℃にて15時間攪拌することで、液晶配向処理剤[11]を得た。この液晶配向処理剤に濁りや析出などの異常は見られず、樹脂成分は均一に溶解していることが確認された。
得られた液晶配向処理剤[11]を用い、実施例1と同様に液晶セルを作製し、プレチルト角の評価を行った。結果は、後述する表2に示す。なお、ラビング処理をしなかった以外は実施例1と同様に作製した液晶セルを偏光顕微鏡で観察したところ、液晶は均一に垂直配向していることが確認された。
また、実施例1と同様に作製した液晶セルを用いて、電圧保持率の評価、残留電荷の緩和の評価、高温放置後の評価及び紫外線照射後の電圧保持率の評価を行った。結果は、後述する表3、表4及び表5に示す。<Example 11>
NMP (9.34 g) was added to the polyimide powder (D) (1.65 g) obtained in Synthesis Example 4, and dissolved by stirring at 70 ° C. for 40 hours. To this solution was added 10 mass% NMP solution (1.16 g) of 3-AMP (0.116 g as 3-AMP), NMP (2.85 g), and BCS (12.4 g), and 15 hours at 50 ° C. By stirring, a liquid crystal aligning agent [11] was obtained. Abnormalities such as turbidity and precipitation were not observed in this liquid crystal alignment treatment agent, and it was confirmed that the resin component was uniformly dissolved.
Using the obtained liquid crystal aligning agent [11], a liquid crystal cell was produced in the same manner as in Example 1, and the pretilt angle was evaluated. The results are shown in Table 2 described later. In addition, when the liquid crystal cell produced similarly to Example 1 was observed with the polarization microscope except having not rubbed, it was confirmed that the liquid crystal was uniformly vertically aligned.
Further, using the liquid crystal cell produced in the same manner as in Example 1, evaluation of voltage holding ratio, evaluation of relaxation of residual charge, evaluation after standing at high temperature, and evaluation of voltage holding ratio after ultraviolet irradiation were performed. The results are shown in Table 3, Table 4 and Table 5 described later.
<実施例12>
合成例5で得たポリイミド粉末(E)(1.65g)にNMP(9.34g)を加え、70℃にて40時間攪拌して溶解させた。この溶液に3−AMPの10質量%NMP溶液(1.16g)(3−AMPとして0.116g)、NMP(2.84g)、及びBCS(12.5g)を加え、50℃にて15時間攪拌することで、液晶配向処理剤[12]を得た。この液晶配向処理剤に濁りや析出などの異常は見られず、樹脂成分は均一に溶解していることが確認された。
得られた液晶配向処理剤[12]を用い、実施例1と同様に液晶セルを作製し、プレチルト角の評価を行った。結果は、後述する表2に示す。なお、ラビング処理をしなかった以外は実施例1と同様に作製した液晶セルを偏光顕微鏡で観察したところ、液晶は均一に垂直配向していることが確認された。
また、実施例1と同様に作製した液晶セルを用いて、電圧保持率の評価、残留電荷の緩和の評価、高温放置後の評価及び紫外線照射後の電圧保持率の評価を行った。結果は、後述する表3、表4及び表5に示す。<Example 12>
NMP (9.34 g) was added to the polyimide powder (E) obtained in Synthesis Example 5 (1.65 g), and dissolved by stirring at 70 ° C. for 40 hours. To this solution was added 10 mass% NMP solution (1.16 g) of 3-AMP (0.116 g as 3-AMP), NMP (2.84 g), and BCS (12.5 g), and 15 hours at 50 ° C. By stirring, a liquid crystal aligning agent [12] was obtained. Abnormalities such as turbidity and precipitation were not observed in this liquid crystal alignment treatment agent, and it was confirmed that the resin component was uniformly dissolved.
Using the obtained liquid crystal aligning agent [12], a liquid crystal cell was produced in the same manner as in Example 1, and the pretilt angle was evaluated. The results are shown in Table 2 described later. In addition, when the liquid crystal cell produced similarly to Example 1 was observed with the polarization microscope except having not rubbed, it was confirmed that the liquid crystal was uniformly vertically aligned.
Further, using the liquid crystal cell produced in the same manner as in Example 1, evaluation of voltage holding ratio, evaluation of relaxation of residual charge, evaluation after standing at high temperature, and evaluation of voltage holding ratio after ultraviolet irradiation were performed. The results are shown in Table 3, Table 4 and Table 5 described later.
<比較例1>
合成例2で得たポリイミド粉末(B)(1.65g)にNMP(9.34g)を加え、70℃にて40時間攪拌して溶解させた。この溶液にNMP(3.88g)、及びBCS(12.4g)を加え、50℃にて15時間攪拌することで、液晶配向処理剤[13]を得た。この液晶配向処理剤に濁りや析出などの異常は見られず、樹脂成分は均一に溶解していることが確認された。
得られた液晶配向処理剤[13]を用い、実施例1と同様に液晶セルを作製し、プレチルト角の評価を行った。結果は、後述する表2に示す。なお、ラビング処理をしなかった以外は実施例1と同様に作製した液晶セルを偏光顕微鏡で観察したところ、液晶は均一に垂直配向していることが確認された。
また、実施例1と同様に作製した液晶セルを用いて、電圧保持率の評価、残留電荷の緩和の評価、高温放置後の評価及び紫外線照射後の電圧保持率の評価を行った。結果は、後述する表3、表4及び表5に示す。<Comparative Example 1>
NMP (9.34 g) was added to the polyimide powder (B) (1.65 g) obtained in Synthesis Example 2 and dissolved by stirring at 70 ° C. for 40 hours. NMP (3.88g) and BCS (12.4g) were added to this solution, and the liquid-crystal aligning agent [13] was obtained by stirring at 50 degreeC for 15 hours. Abnormalities such as turbidity and precipitation were not observed in this liquid crystal alignment treatment agent, and it was confirmed that the resin component was uniformly dissolved.
Using the obtained liquid crystal aligning agent [13], a liquid crystal cell was produced in the same manner as in Example 1, and the pretilt angle was evaluated. The results are shown in Table 2 described later. In addition, when the liquid crystal cell produced similarly to Example 1 was observed with the polarization microscope except having not rubbed, it was confirmed that the liquid crystal was uniformly vertically aligned.
Further, using the liquid crystal cell produced in the same manner as in Example 1, evaluation of voltage holding ratio, evaluation of relaxation of residual charge, evaluation after standing at high temperature, and evaluation of voltage holding ratio after ultraviolet irradiation were performed. The results are shown in Table 3, Table 4 and Table 5 described later.
<比較例2>
合成例3で得たポリイミド粉末(C)(1.63g)にNMP(9.24g)を加え、70℃にて40時間攪拌して溶解させた。この溶液にNMP(3.83g)、及びBCS(12.2g)を加え、50℃にて15時間攪拌することで、液晶配向処理剤[14]を得た。この液晶配向処理剤に濁りや析出などの異常は見られず、樹脂成分は均一に溶解していることが確認された。
得られた液晶配向処理剤[14]を用い、実施例1と同様に液晶セルを作製し、プレチルト角の評価を行った。結果は、後述する表2に示す。なお、ラビング処理をしなかった以外は実施例1と同様に作製した液晶セルを偏光顕微鏡で観察したところ、液晶は均一に垂直配向していることが確認された。
また、実施例1と同様に作製した液晶セルを用いて、電圧保持率の評価、残留電荷の緩和の評価、高温放置後の評価及び紫外線照射後の電圧保持率の評価を行った。結果は、後述する表3、表4及び表5に示す。<Comparative example 2>
NMP (9.24 g) was added to the polyimide powder (C) (1.63 g) obtained in Synthesis Example 3, and dissolved by stirring at 70 ° C. for 40 hours. NMP (3.83g) and BCS (12.2g) were added to this solution, and it stirred at 50 degreeC for 15 hours, and obtained liquid-crystal aligning agent [14]. Abnormalities such as turbidity and precipitation were not observed in this liquid crystal alignment treatment agent, and it was confirmed that the resin component was uniformly dissolved.
Using the obtained liquid crystal aligning agent [14], a liquid crystal cell was produced in the same manner as in Example 1, and the pretilt angle was evaluated. The results are shown in Table 2 described later. In addition, when the liquid crystal cell produced similarly to Example 1 was observed with the polarization microscope except having not rubbed, it was confirmed that the liquid crystal was uniformly vertically aligned.
Further, using the liquid crystal cell produced in the same manner as in Example 1, evaluation of voltage holding ratio, evaluation of relaxation of residual charge, evaluation after standing at high temperature, and evaluation of voltage holding ratio after ultraviolet irradiation were performed. The results are shown in Table 3, Table 4 and Table 5 described later.
<比較例3>
合成例4で得たポリイミド粉末(D)(1.65g)にNMP(9.34g)を加え、70℃にて40時間攪拌して溶解させた。この溶液にNMP(3.88g)、及びBCS(12.3g)を加え、50℃にて15時間攪拌することで、液晶配向処理剤[15]を得た。この液晶配向処理剤に濁りや析出などの異常は見られず、樹脂成分は均一に溶解していることが確認された。
得られた液晶配向処理剤[15]を用い、実施例1と同様に液晶セルを作製し、プレチルト角の評価を行った。結果は、後述する表2に示す。なお、ラビング処理をしなかった以外は実施例1と同様に作製した液晶セルを偏光顕微鏡で観察したところ、液晶は均一に垂直配向していることが確認された。
また、実施例1と同様に作製した液晶セルを用いて、電圧保持率の評価、残留電荷の緩和の評価、高温放置後の評価及び紫外線照射後の電圧保持率の評価を行った。結果は、後述する表3、表4及び表5に示す。<Comparative Example 3>
NMP (9.34 g) was added to the polyimide powder (D) (1.65 g) obtained in Synthesis Example 4, and dissolved by stirring at 70 ° C. for 40 hours. NMP (3.88g) and BCS (12.3g) were added to this solution, and it stirred at 50 degreeC for 15 hours, and obtained liquid-crystal aligning agent [15]. Abnormalities such as turbidity and precipitation were not observed in this liquid crystal alignment treatment agent, and it was confirmed that the resin component was uniformly dissolved.
Using the obtained liquid crystal aligning agent [15], a liquid crystal cell was produced in the same manner as in Example 1, and the pretilt angle was evaluated. The results are shown in Table 2 described later. In addition, when the liquid crystal cell produced similarly to Example 1 was observed with the polarization microscope except having not rubbed, it was confirmed that the liquid crystal was uniformly vertically aligned.
Further, using the liquid crystal cell produced in the same manner as in Example 1, evaluation of voltage holding ratio, evaluation of relaxation of residual charge, evaluation after standing at high temperature, and evaluation of voltage holding ratio after ultraviolet irradiation were performed. The results are shown in Table 3, Table 4 and Table 5 described later.
<比較例4>
合成例5で得たポリイミド粉末(E)(1.65g)にNMP(9.31g)を加え、70℃にて40時間攪拌して溶解させた。この溶液にNMP(3.88g)、及びBCS(12.4g)を加え、50℃にて15時間攪拌することで、液晶配向処理剤[16]を得た。この液晶配向処理剤に濁りや析出などの異常は見られず、樹脂成分は均一に溶解していることが確認された。
得られた液晶配向処理剤[16]を用い、実施例1と同様に液晶セルを作製し、プレチルト角の評価を行った。結果は、後述する表2に示す。なお、ラビング処理をしなかった以外は実施例1と同様に作製した液晶セルを偏光顕微鏡で観察したところ、液晶は均一に垂直配向していることが確認された。
また、実施例1と同様に作製した液晶セルを用いて、電圧保持率の評価、残留電荷の緩和の評価、高温放置後の評価及び紫外線照射後の電圧保持率の評価を行った。結果は、後述する表3、表4及び表5に示す。<Comparative example 4>
NMP (9.31 g) was added to the polyimide powder (E) (1.65 g) obtained in Synthesis Example 5, and dissolved by stirring at 70 ° C. for 40 hours. NMP (3.88g) and BCS (12.4g) were added to this solution, and it stirred at 50 degreeC for 15 hours, and obtained liquid-crystal aligning agent [16]. Abnormalities such as turbidity and precipitation were not observed in this liquid crystal alignment treatment agent, and it was confirmed that the resin component was uniformly dissolved.
Using the obtained liquid crystal aligning agent [16], a liquid crystal cell was produced in the same manner as in Example 1, and the pretilt angle was evaluated. The results are shown in Table 2 described later. In addition, when the liquid crystal cell produced similarly to Example 1 was observed with the polarization microscope except having not rubbed, it was confirmed that the liquid crystal was uniformly vertically aligned.
Further, using the liquid crystal cell produced in the same manner as in Example 1, evaluation of voltage holding ratio, evaluation of relaxation of residual charge, evaluation after standing at high temperature, and evaluation of voltage holding ratio after ultraviolet irradiation were performed. The results are shown in Table 3, Table 4 and Table 5 described later.
<比較例5>
合成例6で得たポリイミド粉末(F)(1.63g)にNMP(9.23g)を加え、70℃にて40時間攪拌して溶解させた。この溶液にNMP(3.83g)、及びBCS(12.2g)を加え、50℃にて15時間攪拌することで、液晶配向処理剤[17]を得た。この液晶配向処理剤に濁りや析出などの異常は見られず、樹脂成分は均一に溶解していることが確認された。
得られた液晶配向処理剤[17]を用い、実施例1と同様に液晶セルを作製し、プレチルト角の評価を行った。結果は、後述する表2に示す。なお、ラビング処理をしなかった以外は実施例1と同様に作製した液晶セルを偏光顕微鏡で観察したところ、液晶は均一に垂直配向していることが確認された。
また、実施例1と同様に作製した液晶セルを用いて、電圧保持率の評価、残留電荷の緩和の評価、高温放置後の評価及び紫外線照射後の電圧保持率の評価を行った。結果は、後述する表3、表4及び表5に示す。<Comparative Example 5>
NMP (9.23 g) was added to the polyimide powder (F) (1.63 g) obtained in Synthesis Example 6, and dissolved by stirring at 70 ° C. for 40 hours. NMP (3.83g) and BCS (12.2g) were added to this solution, and it stirred at 50 degreeC for 15 hours, and obtained liquid-crystal aligning agent [17]. Abnormalities such as turbidity and precipitation were not observed in this liquid crystal alignment treatment agent, and it was confirmed that the resin component was uniformly dissolved.
Using the obtained liquid crystal aligning agent [17], a liquid crystal cell was produced in the same manner as in Example 1, and the pretilt angle was evaluated. The results are shown in Table 2 described later. In addition, when the liquid crystal cell produced similarly to Example 1 was observed with the polarization microscope except having not rubbed, it was confirmed that the liquid crystal was uniformly vertically aligned.
Further, using the liquid crystal cell produced in the same manner as in Example 1, evaluation of voltage holding ratio, evaluation of relaxation of residual charge, evaluation after standing at high temperature, and evaluation of voltage holding ratio after ultraviolet irradiation were performed. The results are shown in Table 3, Table 4 and Table 5 described later.
<比較例6>
合成例2で得たポリイミド粉末(B)(1.63g)にNMP(9.23g)を加え、70℃にて40時間攪拌して溶解させた。この溶液にPyの10質量%NMP溶液(1.14g)(Pyとして0.114g)、NMP(2.80g)、及びBCS(12.3g)を加え、50℃にて15時間攪拌することで、液晶配向処理剤[18]を得た。この液晶配向処理剤に濁りや析出などの異常は見られず、樹脂成分は均一に溶解していることが確認された。
得られた液晶配向処理剤[18]を用い、実施例1と同様に液晶セルを作製し、プレチルト角の評価を行った。結果は、後述する表2に示す。なお、ラビング処理をしなかった以外は実施例1と同様に作製した液晶セルを偏光顕微鏡で観察したところ、液晶は均一に垂直配向していることが確認された。
また、実施例1と同様に作製した液晶セルを用いて、電圧保持率の評価、残留電荷の緩和の評価、高温放置後の評価及び紫外線照射後の電圧保持率の評価を行った。結果は、後述する表3、表4及び表5に示す。<Comparative Example 6>
NMP (9.23 g) was added to the polyimide powder (B) (1.63 g) obtained in Synthesis Example 2, and dissolved by stirring at 70 ° C. for 40 hours. By adding 10 mass% PMP of NMP solution (1.14 g) (0.114 g as Py), NMP (2.80 g), and BCS (12.3 g) to this solution, and stirring at 50 ° C. for 15 hours. A liquid crystal aligning agent [18] was obtained. Abnormalities such as turbidity and precipitation were not observed in this liquid crystal alignment treatment agent, and it was confirmed that the resin component was uniformly dissolved.
Using the obtained liquid crystal aligning agent [18], a liquid crystal cell was produced in the same manner as in Example 1, and the pretilt angle was evaluated. The results are shown in Table 2 described later. In addition, when the liquid crystal cell produced similarly to Example 1 was observed with the polarization microscope except having not rubbed, it was confirmed that the liquid crystal was uniformly vertically aligned.
Further, using the liquid crystal cell produced in the same manner as in Example 1, evaluation of voltage holding ratio, evaluation of relaxation of residual charge, evaluation after standing at high temperature, and evaluation of voltage holding ratio after ultraviolet irradiation were performed. The results are shown in Table 3, Table 4 and Table 5 described later.
<比較例7>
合成例2で得たポリイミド粉末(B)(1.65g)にNMP(9.33g)を加え、70℃にて40時間攪拌して溶解させた。この溶液にAPの10質量%NMP溶液(1.16g)(APとして0.116g)、NMP(2.83g)、及びBCS(12.3g)を加え、50℃にて15時間攪拌することで、液晶配向処理剤[19]を得た。この液晶配向処理剤に濁りや析出などの異常は見られず、樹脂成分は均一に溶解していることが確認された。
得られた液晶配向処理剤[19]を用い、実施例1と同様に液晶セルを作製し、プレチルト角の評価を行った。結果は、後述する表2に示す。なお、ラビング処理をしなかった以外は実施例1と同様に作製した液晶セルを偏光顕微鏡で観察したところ、液晶は均一に垂直配向していることが確認された。
また、実施例1と同様に作製した液晶セルを用いて、電圧保持率の評価、残留電荷の緩和の評価、高温放置後の評価及び紫外線照射後の電圧保持率の評価を行った。結果は、後述する表3、表4及び表5に示す。<Comparative Example 7>
NMP (9.33 g) was added to the polyimide powder (B) (1.65 g) obtained in Synthesis Example 2, and dissolved by stirring at 70 ° C. for 40 hours. A 10 mass% NMP solution (1.16 g) of AP (0.116 g as AP), NMP (2.83 g), and BCS (12.3 g) were added to this solution, and the mixture was stirred at 50 ° C. for 15 hours. A liquid crystal aligning agent [19] was obtained. Abnormalities such as turbidity and precipitation were not observed in this liquid crystal alignment treatment agent, and it was confirmed that the resin component was uniformly dissolved.
Using the obtained liquid crystal aligning agent [19], a liquid crystal cell was produced in the same manner as in Example 1, and the pretilt angle was evaluated. The results are shown in Table 2 described later. In addition, when the liquid crystal cell produced similarly to Example 1 was observed with the polarization microscope except having not rubbed, it was confirmed that the liquid crystal was uniformly vertically aligned.
Further, using the liquid crystal cell produced in the same manner as in Example 1, evaluation of voltage holding ratio, evaluation of relaxation of residual charge, evaluation after standing at high temperature, and evaluation of voltage holding ratio after ultraviolet irradiation were performed. The results are shown in Table 3, Table 4 and Table 5 described later.
<比較例8>
合成例2で得たポリイミド粉末(B)(1.63g)にNMP(9.23g)を加え、70℃にて40時間攪拌して溶解させた。この溶液にHAの10質量%NMP溶液(1.14g)(HAとして0.114g)、NMP(2.78g)、及びBCS(12.3g)を加え、50℃にて15時間攪拌することで、液晶配向処理剤[20]を得た。この液晶配向処理剤に濁りや析出などの異常は見られず、樹脂成分は均一に溶解していることが確認された。
得られた液晶配向処理剤[20]を用い、実施例1と同様に液晶セルを作製し、プレチルト角の評価を行った。結果は、後述する表2に示す。なお、ラビング処理をしなかった以外は実施例1と同様に作製した液晶セルを偏光顕微鏡で観察したところ、液晶は均一に垂直配向していることが確認された。
また、実施例1と同様に作製した液晶セルを用いて、電圧保持率の評価、残留電荷の緩和の評価、高温放置後の評価及び紫外線照射後の電圧保持率の評価を行った。結果は、後述する表3、表4及び表5に示す。<Comparative Example 8>
NMP (9.23 g) was added to the polyimide powder (B) (1.63 g) obtained in Synthesis Example 2, and dissolved by stirring at 70 ° C. for 40 hours. A 10 mass% NMP solution (1.14 g) of HA (0.114 g as HA), NMP (2.78 g), and BCS (12.3 g) were added to this solution, and the mixture was stirred at 50 ° C. for 15 hours. A liquid crystal aligning agent [20] was obtained. Abnormalities such as turbidity and precipitation were not observed in this liquid crystal alignment treatment agent, and it was confirmed that the resin component was uniformly dissolved.
Using the obtained liquid crystal aligning agent [20], a liquid crystal cell was produced in the same manner as in Example 1, and the pretilt angle was evaluated. The results are shown in Table 2 described later. In addition, when the liquid crystal cell produced similarly to Example 1 was observed with the polarization microscope except having not rubbed, it was confirmed that the liquid crystal was uniformly vertically aligned.
Further, using the liquid crystal cell produced in the same manner as in Example 1, evaluation of voltage holding ratio, evaluation of relaxation of residual charge, evaluation after standing at high temperature, and evaluation of voltage holding ratio after ultraviolet irradiation were performed. The results are shown in Table 3, Table 4 and Table 5 described later.
<比較例9>
合成例6で得たポリイミド粉末(F)(1.65g)にNMP(9.34g)を加え、70℃にて40時間攪拌して溶解させた。この溶液に3−AMPの10質量%NMP溶液(0.50g)(3−AMPとして0.05g)、NMP(3.43g)、及びBCS(12.4g)を加え、50℃にて15時間攪拌することで、液晶配向処理剤[21]を得た。この液晶配向処理剤に濁りや析出などの異常は見られず、樹脂成分は均一に溶解していることが確認された。
得られた液晶配向処理剤[21]を用い、実施例1と同様に液晶セルを作製し、プレチルト角の評価を行った。結果は、後述する表2に示す。なお、ラビング処理をしなかった以外は実施例1と同様に作製した液晶セルを偏光顕微鏡で観察したところ、液晶は垂直配向していなかった。
また、実施例1と同様に作製した液晶セルを用いて、電圧保持率の評価、残留電荷の緩和の評価、高温放置後の評価及び紫外線照射後の電圧保持率の評価を行った。結果は、後述する表3、表4及び表5に示す。<Comparative Example 9>
NMP (9.34 g) was added to the polyimide powder (F) (1.65 g) obtained in Synthesis Example 6, and dissolved by stirring at 70 ° C. for 40 hours. To this solution was added 10 mass% NMP solution (0.50 g) of 3-AMP (0.05 g as 3-AMP), NMP (3.43 g), and BCS (12.4 g), and 15 hours at 50 ° C. The liquid crystal aligning agent [21] was obtained by stirring. Abnormalities such as turbidity and precipitation were not observed in this liquid crystal alignment treatment agent, and it was confirmed that the resin component was uniformly dissolved.
Using the obtained liquid crystal aligning agent [21], a liquid crystal cell was produced in the same manner as in Example 1, and the pretilt angle was evaluated. The results are shown in Table 2 described later. In addition, when the liquid crystal cell produced like Example 1 was observed with the polarization microscope except having not rubbed, the liquid crystal was not vertically aligned.
Further, using the liquid crystal cell produced in the same manner as in Example 1, evaluation of voltage holding ratio, evaluation of relaxation of residual charge, evaluation after standing at high temperature, and evaluation of voltage holding ratio after ultraviolet irradiation were performed. The results are shown in Table 3, Table 4 and Table 5 described later.
<比較例10>
合成例6で得たポリイミド粉末(G)(1.65g)にNMP(9.34g)を加え、70℃にて40時間攪拌して溶解させた。この溶液に3−AMPの10質量%NMP溶液(1.16g)(3−AMPとして0.116g)、NMP(2.83g)、及びBCS(12.4g)を加え、50℃にて15時間攪拌することで、液晶配向処理剤[22]を得た。この液晶配向処理剤に濁りや析出などの異常は見られず、樹脂成分は均一に溶解していることが確認された。
得られた液晶配向処理剤[22]を用い、実施例1と同様に液晶セルを作製し、プレチルト角の評価を行った。結果は、後述する表2に示す。なお、ラビング処理をしなかった以外は実施例1と同様に作製した液晶セルを偏光顕微鏡で観察したところ、液晶は均一に垂直配向していることが確認された。
また、実施例1と同様に作製した液晶セルを用いて、電圧保持率の評価、残留電荷の緩和の評価、高温放置後の評価及び紫外線照射後の電圧保持率の評価を行った。結果は、後述する表3、表4及び表5に示す。<Comparative Example 10>
NMP (9.34 g) was added to the polyimide powder (G) (1.65 g) obtained in Synthesis Example 6, and dissolved by stirring at 70 ° C. for 40 hours. To this solution was added 10 mass% NMP solution (1.16 g) of 3-AMP (0.116 g as 3-AMP), NMP (2.83 g), and BCS (12.4 g), and 15 hours at 50 ° C. By stirring, a liquid crystal aligning agent [22] was obtained. Abnormalities such as turbidity and precipitation were not observed in this liquid crystal alignment treatment agent, and it was confirmed that the resin component was uniformly dissolved.
Using the obtained liquid crystal aligning agent [22], a liquid crystal cell was produced in the same manner as in Example 1, and the pretilt angle was evaluated. The results are shown in Table 2 described later. In addition, when the liquid crystal cell produced similarly to Example 1 was observed with the polarization microscope except having not rubbed, it was confirmed that the liquid crystal was uniformly vertically aligned.
Further, using the liquid crystal cell produced in the same manner as in Example 1, evaluation of voltage holding ratio, evaluation of relaxation of residual charge, evaluation after standing at high temperature, and evaluation of voltage holding ratio after ultraviolet irradiation were performed. The results are shown in Table 3, Table 4 and Table 5 described later.
本発明の液晶配向処理剤は、液晶配向膜にした際、液晶のプレチルト角を大きくする効果を有しており、少ない使用割合でも液晶を垂直に配向させることができ、また、液晶配向処理剤の塗布液に貧溶媒を混合したときにも析出が発生しにくい。さらにこれら特性に加え、電圧保持率が高く、かつ高温下に長時間曝された後であっても、直流電圧により蓄積する電荷の緩和が速く、かつバックライトの紫外線に長時間曝された後でも電圧保持率の低下を抑制できる液晶配向膜が得られる液晶配向処理剤が得られる。更には過酷な使用環境での長期使用に耐えうる信頼性の高い液晶表示素子を提供することができる。その結果、TN素子、STN素子、TFT液晶素子、更には、垂直配向型の液晶表示素子などに有用である。
なお、2008年1月11日に出願された日本特許出願2008−004992号の明細書、特許請求の範囲、及び要約書の全内容をここに引用し、本発明の明細書の開示として、取り入れるものである。The liquid crystal aligning agent of the present invention has the effect of increasing the pretilt angle of the liquid crystal when formed into a liquid crystal aligning film, and can align the liquid crystal vertically even with a small use ratio. Precipitation does not easily occur when a poor solvent is mixed with the coating solution. In addition to these characteristics, the voltage holding ratio is high, and even after being exposed to high temperatures for a long time, the charge accumulated by the DC voltage is quickly relaxed, and after being exposed to the ultraviolet light of the backlight for a long time. However, the liquid crystal aligning agent from which the liquid crystal aligning film which can suppress the fall of a voltage holding rate is obtained is obtained. Furthermore, a highly reliable liquid crystal display element that can withstand long-term use in a harsh use environment can be provided. As a result, it is useful for TN elements, STN elements, TFT liquid crystal elements, and vertical alignment type liquid crystal display elements.
The entire contents of the specification, claims, and abstract of Japanese Patent Application No. 2008-004992 filed on January 11, 2008 are incorporated herein as the disclosure of the specification of the present invention. Is.
Claims (13)
(A)成分:下記の式[1]で表される繰り返し単位の構造式を有するポリアミド酸をイミド化させた重合体であり、該重合体中の分子内にカルボキシル基を有するポリイミド。
(B)成分:分子内に1級アミノ基を1個と窒素含有芳香族複素環とを有し、かつ前記1級アミノ基が脂肪族炭化水素基又は非芳香族環式炭化水素基に結合しているアミン化合物。
Component (A): A polyimide obtained by imidizing a polyamic acid having a structural formula of a repeating unit represented by the following formula [1], and having a carboxyl group in the molecule of the polymer.
Component (B): It has one primary amino group and a nitrogen-containing aromatic heterocyclic ring in the molecule, and the primary amino group is bonded to an aliphatic hydrocarbon group or a non-aromatic cyclic hydrocarbon group. Amine compound.
但し、Y3は、炭素数1〜10の直鎖又は分岐アルキレン基、炭素数1〜10の不飽和アルキレン基、シクロプロパン環、シクロブタン環、シクロペンタン環、シクロヘキサン環、シクロヘプタン環、シクロオクタン環、シクロノナン環、シクロデカン環、シクロウンデカン環、シクロドデカン環、シクロトリデカン環、シクロテトラデカン環、シクロペンタデカン環、シクロヘキサデカン環、シクロヘプタデカン環、シクロオクタデカン環、シクロノナデカン環、シクロイコサン環、トリシクロエイコサン環、トリシクロデコサン環、ビシクロヘプタン環、デカヒドロナフタレン環、ノルボルネン環、及びアダマンタン環からなる群から選ばれる1種である;
Y4が、単結合、−O−、−NH−、−S−、−SO2−、炭素数1〜19の炭化水素基、−CO−O−、−O−CO−、−CO−NH−、−NH−CO−、−CO−、−CF2−、−C(CF3)2−、−CH(OH)−、−C(CH3)2−、−Si(CH3)2−、−O−Si(CH3)2−、−Si(CH3)2−O−、−O−Si(CH3)2−O−、シクロプロパン環、シクロブタン環、シクロペンタン環、シクロヘキサン環、シクロヘプタン環、シクロオクタン環、シクロノナン環、シクロデカン環、シクロウンデカン環、シクロドデカン環、シクロトリデカン環、シクロテトラデカン環、シクロペンタデカン環、シクロヘキサデカン環、シクロヘプタデカン環、シクロオクタデカン環、シクロノナデカン環、シクロイコサン環、トリシクロエイコサン環、トリシクロデコサン環、ビシクロヘプタン環、デカヒドロナフタレン環、ノルボルネン環、アダマンタン環、ベンゼン環、ナフタレン環、テトラヒドロナフタレン環、アズレン環、インデン環、フルオレン環、アントラセン環、フェナントレン環、フェナレン環、ピロール環、イミダゾール環、オキサゾール環、チアゾール環、ピラゾール環、ピリジン環、ピリミジン環、キノリン環、ピラゾリン環、イソキノリン環、カルバゾール環、プリン環、チアジアゾール環、ピリダジン環、トリアジン環、ピラゾリジン環、トリアゾール環、ピラジン環、ベンズイミダゾール環、ベンゾイミダゾール環、チノリン環、フェナントロリン環、インドール環、キノキサリン環、ベンゾチアゾール環、フェノチアジン環、オキサジアゾール環、アクリジン環、オキサゾール環、ピペラジン環、ピペリジン環、ジオキサン環、及びモルフォリン環からなる群から選ばれる1種である;
Y5が、ピロール環、イミダゾール環、オキサゾール環、チアゾール環、ピラゾール環、ピリジン環、ピリミジン環、キノリン環、ピラゾリン環、イソキノリン環、カルバゾール環、プリン環、チアジアゾール環、ピリダジン環、ピラゾリン環、トリアジン環、ピラゾリジン環、トリアゾール環、ピラジン環、ベンズイミダゾール環、ベンゾイミダゾール環、チノリン環、フェナントロリン環、インドール環、キノキサリン環、ベンゾチアゾール環、フェノチアジン環、オキサジアゾール環、及びアクリジン環からなる群から選ばれる1種である。The liquid crystal aligning agent according to claim 8, wherein the component (B) is an amine compound comprising a combination in which Y 3 , Y 4 and Y 5 in the formula [7] are each selected from the following groups or rings. .
However, Y 3 represents a linear or branched alkylene group having 1 to 10 carbon atoms, unsaturated alkylene group having 1 to 10 carbon atoms, cyclopropane ring, cyclobutane ring, cyclopentane ring, cyclohexane ring, cycloheptane ring, cyclooctane Ring, cyclononane ring, cyclodecane ring, cycloundecane ring, cyclododecane ring, cyclotridecane ring, cyclotetradecane ring, cyclopentadecane ring, cyclohexadecane ring, cycloheptadecane ring, cyclooctadecane ring, cyclononadecane ring, cycloicosane ring, tricyclo One selected from the group consisting of an eicosane ring, a tricyclodecosan ring, a bicycloheptane ring, a decahydronaphthalene ring, a norbornene ring, and an adamantane ring;
Y 4 is a single bond, —O—, —NH—, —S—, —SO 2 —, a hydrocarbon group having 1 to 19 carbon atoms, —CO—O—, —O—CO—, —CO—NH. -, - NH-CO -, - CO -, - CF 2 -, - C (CF 3) 2 -, - CH (OH) -, - C (CH 3) 2 -, - Si (CH 3) 2 - , —O—Si (CH 3 ) 2 —, —Si (CH 3 ) 2 —O—, —O—Si (CH 3 ) 2 —O—, cyclopropane ring, cyclobutane ring, cyclopentane ring, cyclohexane ring, Cycloheptane ring, cyclooctane ring, cyclononane ring, cyclodecane ring, cycloundecane ring, cyclododecane ring, cyclotridecane ring, cyclotetradecane ring, cyclopentadecane ring, cyclohexadecane ring, cycloheptadecane ring, cyclooctadecane ring, cyclononadecane Ring, cycloicosane ring, tricycloeicosane ring, tricyclodecosan ring, bicycloheptane ring, decahydronaphthalene ring, norbornene ring, adamantane ring, benzene ring, naphthalene ring, tetrahydronaphthalene ring, azulene ring, indene ring, fluorene ring , Anthracene ring, phenanthrene ring, phenalene ring, pyrrole ring, imidazole ring, oxazole ring, thiazole ring, pyrazole ring, pyridine ring, pyrimidine ring, quinoline ring, pyrazoline ring, isoquinoline ring, carbazole ring, purine ring, thiadiazole ring, pyridazine Ring, triazine ring, pyrazolidine ring, triazole ring, pyrazine ring, benzimidazole ring, benzimidazole ring, thionoline ring, phenanthroline ring, indole ring, quinoxaline ring, benzothiazole ring, One selected from the group consisting of an enothiazine ring, an oxadiazole ring, an acridine ring, an oxazole ring, a piperazine ring, a piperidine ring, a dioxane ring, and a morpholine ring;
Y 5 is a pyrrole ring, imidazole ring, oxazole ring, thiazole ring, pyrazole ring, pyridine ring, pyrimidine ring, quinoline ring, pyrazoline ring, isoquinoline ring, carbazole ring, purine ring, thiadiazole ring, pyridazine ring, pyrazoline ring, triazine From the group consisting of ring, pyrazolidine ring, triazole ring, pyrazine ring, benzimidazole ring, benzimidazole ring, thioline ring, phenanthroline ring, indole ring, quinoxaline ring, benzothiazole ring, phenothiazine ring, oxadiazole ring, and acridine ring One kind to be chosen.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009548952A JP5229236B2 (en) | 2008-01-11 | 2009-01-08 | Liquid crystal aligning agent and liquid crystal display element using the same |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2008004992 | 2008-01-11 | ||
JP2008004992 | 2008-01-11 | ||
JP2009548952A JP5229236B2 (en) | 2008-01-11 | 2009-01-08 | Liquid crystal aligning agent and liquid crystal display element using the same |
PCT/JP2009/050154 WO2009088046A1 (en) | 2008-01-11 | 2009-01-08 | Liquid crystal aligning agent and liquid crystal display device using the same |
Publications (2)
Publication Number | Publication Date |
---|---|
JPWO2009088046A1 JPWO2009088046A1 (en) | 2011-05-26 |
JP5229236B2 true JP5229236B2 (en) | 2013-07-03 |
Family
ID=40853158
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2009548952A Active JP5229236B2 (en) | 2008-01-11 | 2009-01-08 | Liquid crystal aligning agent and liquid crystal display element using the same |
Country Status (5)
Country | Link |
---|---|
JP (1) | JP5229236B2 (en) |
KR (1) | KR101536028B1 (en) |
CN (1) | CN101910931B (en) |
TW (1) | TWI480647B (en) |
WO (1) | WO2009088046A1 (en) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101626900B1 (en) * | 2009-12-21 | 2016-06-03 | 삼성디스플레이 주식회사 | Vertical alignment layer and liquid crystal display including the same |
JP5552894B2 (en) * | 2010-05-14 | 2014-07-16 | Jsr株式会社 | Liquid crystal aligning agent and liquid crystal display element |
KR101806351B1 (en) * | 2011-02-01 | 2018-01-11 | 삼성디스플레이 주식회사 | Vertical alignment layer and liquid crystal display including the same |
JP6183212B2 (en) * | 2011-11-01 | 2017-08-23 | 日産化学工業株式会社 | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element |
CN104204925A (en) * | 2012-03-30 | 2014-12-10 | 日产化学工业株式会社 | Polyimide-based liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element |
WO2014024893A1 (en) * | 2012-08-10 | 2014-02-13 | 日産化学工業株式会社 | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element |
CN104838311B (en) * | 2012-11-30 | 2017-12-19 | 日产化学工业株式会社 | Manufacture method, liquid crystal orientation film and the liquid crystal display cells of liquid crystal orientation film |
WO2016076413A1 (en) * | 2014-11-13 | 2016-05-19 | 日産化学工業株式会社 | Liquid crystal alignment treatment agent, liquid crystal alignment film, and liquid crystal display element |
JP6786861B2 (en) * | 2016-04-26 | 2020-11-18 | 宇部興産株式会社 | Polyimide precursor, polyimide, polyimide film, polyimide laminate, polyimide / hard coat laminate |
KR101856727B1 (en) | 2016-06-21 | 2018-05-10 | 주식회사 엘지화학 | Liquid crystal alignment composition, method of preparing liquid crystal alignment film, and liquid crystal alignment film using the same |
CN110989247B (en) * | 2019-12-03 | 2023-03-17 | Tcl华星光电技术有限公司 | Liquid crystal display panel and preparation method thereof |
JP7512879B2 (en) | 2020-12-21 | 2024-07-09 | Jnc株式会社 | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element using the same |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003096034A (en) * | 2001-09-27 | 2003-04-03 | Chisso Corp | Phenylenediamine derivative, liquid crystal aligned film and liquid crystal display element |
WO2004052962A1 (en) * | 2002-12-11 | 2004-06-24 | Nissan Chemical Industries, Ltd. | Novel diaminobenzene derivative, polyimide precursor and polyimide obtained therefrom, and aligning agent for liquid crystal |
WO2004099289A1 (en) * | 2003-05-07 | 2004-11-18 | Nissan Chemical Industries, Ltd. | Alignment agent for liquid crystal |
JP2007248637A (en) * | 2006-03-14 | 2007-09-27 | National Institute For Materials Science | Liquid crystal alignment layer, liquid crystal aligning agent and liquid crystal display device |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002020487A (en) * | 2000-07-13 | 2002-01-23 | Jsr Corp | Alkylfluorenediamine, polyamic acid, imidated polymer, liquid crystal orienting agent, method for forming liquid crystal oriented film, and liquid crystal display element |
JP4013052B2 (en) * | 2002-09-25 | 2007-11-28 | 日産化学工業株式会社 | Liquid crystal aligning agent and liquid crystal display element |
AU2003286430A1 (en) * | 2002-12-10 | 2004-06-30 | Canon Kabushiki Kaisha | Process for producing crystalline thin film |
TWI409298B (en) * | 2006-03-24 | 2013-09-21 | Jnc Corp | Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display device |
-
2009
- 2009-01-08 KR KR1020107014926A patent/KR101536028B1/en active IP Right Grant
- 2009-01-08 JP JP2009548952A patent/JP5229236B2/en active Active
- 2009-01-08 CN CN2009801021322A patent/CN101910931B/en active Active
- 2009-01-08 WO PCT/JP2009/050154 patent/WO2009088046A1/en active Application Filing
- 2009-01-09 TW TW098100666A patent/TWI480647B/en active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003096034A (en) * | 2001-09-27 | 2003-04-03 | Chisso Corp | Phenylenediamine derivative, liquid crystal aligned film and liquid crystal display element |
WO2004052962A1 (en) * | 2002-12-11 | 2004-06-24 | Nissan Chemical Industries, Ltd. | Novel diaminobenzene derivative, polyimide precursor and polyimide obtained therefrom, and aligning agent for liquid crystal |
WO2004099289A1 (en) * | 2003-05-07 | 2004-11-18 | Nissan Chemical Industries, Ltd. | Alignment agent for liquid crystal |
JP2007248637A (en) * | 2006-03-14 | 2007-09-27 | National Institute For Materials Science | Liquid crystal alignment layer, liquid crystal aligning agent and liquid crystal display device |
Also Published As
Publication number | Publication date |
---|---|
TWI480647B (en) | 2015-04-11 |
CN101910931B (en) | 2012-05-30 |
TW200951582A (en) | 2009-12-16 |
WO2009088046A1 (en) | 2009-07-16 |
JPWO2009088046A1 (en) | 2011-05-26 |
KR20100103554A (en) | 2010-09-27 |
KR101536028B1 (en) | 2015-07-10 |
CN101910931A (en) | 2010-12-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5003682B2 (en) | Liquid crystal alignment treatment agent and liquid crystal display element using the same | |
JP5382351B2 (en) | Liquid crystal aligning agent and liquid crystal display element using the same | |
JP5229236B2 (en) | Liquid crystal aligning agent and liquid crystal display element using the same | |
JP5177150B2 (en) | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element | |
JP5904121B2 (en) | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element | |
JP5729299B2 (en) | Diamine compound, polyamic acid, polyimide and liquid crystal alignment treatment agent | |
KR102224531B1 (en) | Liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element | |
JP5975227B2 (en) | Liquid crystal aligning agent, liquid crystal alignment film, liquid crystal display element, and method for manufacturing liquid crystal display element | |
JP2018083943A (en) | Composition, liquid crystal orientation treatment agent, liquid crystal orientation film and liquid crystal display element | |
WO2010074269A1 (en) | Liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element | |
JPWO2015033921A1 (en) | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element | |
JP5831712B2 (en) | Coating liquid for forming polyimide film, liquid crystal aligning agent, polyimide film, liquid crystal aligning film and liquid crystal display element | |
WO2016140288A1 (en) | Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display element | |
WO2014142168A1 (en) | Liquid crystal aligning agent containing crosslinkable compound having photoreactive group | |
JP5218062B2 (en) | Liquid crystal alignment treatment agent and liquid crystal display element using the same | |
WO2013094618A1 (en) | Liquid crystal aligning agent, liquid crystal alignment film, liquid crystal display element using same, and compound | |
JP6102752B2 (en) | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element | |
JP6575770B2 (en) | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element | |
JPWO2016076412A1 (en) | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20111228 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20121127 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130125 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20130219 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20130304 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20160329 Year of fee payment: 3 |
|
R151 | Written notification of patent or utility model registration |
Ref document number: 5229236 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R151 |
|
S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
S533 | Written request for registration of change of name |
Free format text: JAPANESE INTERMEDIATE CODE: R313533 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |